"URL","Uniprot ID","PMID","Abstract"
https://pharos.nih.gov/idg/targets/Q9UKE5,Q9UKE5,28334814,"Here we present the result of a 4-stage genome-wide association study composed of 5,953 adolescent idiopathic scoliosis patients and 8,137 controls. Overall, we identified three novel susceptible loci including rs7593846 at 2p14 near MEIS1 , rs7633294 at 3p14.1 near MAGI1 and rs9810566 at 3q26.2 near TNIK"
https://pharos.nih.gov/idg/targets/Q9UKE5,Q9UKE5,27106596,"Exome sequencing of the index in each family revealed the same homozygous truncating mutation in TNIK that results in complete loss of the protein. TNIK is a kinase with a well-established role in dendrite development and synaptic transmission. The phenotype we observe in human patients who lack TNIK is consistent with the previously published Tnik (-/-) phenotype in the murine model"
https://pharos.nih.gov/idg/targets/Q9UKE5,Q9UKE5,26995282,"results provide new evidence that TNIK may be involved in the proliferation of multiple myeloma IM-9 cells and in the anti-cancer activity of dovitinib via inhibition of the endogenous Wnt signaling pathway."
https://pharos.nih.gov/idg/targets/Q9UKE5,Q9UKE5,26645429,"Endogenous substrates of TNIK were identified in neurons, along with consensus sequences for TNIK."
https://pharos.nih.gov/idg/targets/Q9UKE5,Q9UKE5,26499327,"High expression of TNIK in colorectal cancer was associated with recurrence in stage II and III colorectal cancer patients."
https://pharos.nih.gov/idg/targets/Q9UKE5,Q9UKE5,26269113,"Our results demonstrated that TNIK might play a crucial role in pancreatic carcinogenesis and serve as a novel therapeutic target of pancreatic cancer."
https://pharos.nih.gov/idg/targets/Q9UKE5,Q9UKE5,25160513,"nuclear p-TNIK expression was studied in hepatocellular carcinoma, and p-TNIK nuclear expression was associated with poor prognosis and is a candidate prognostic marker for hepatocellular carcinoma"
https://pharos.nih.gov/idg/targets/Q9UKE5,Q9UKE5,23355318,"Dynamic change of TNIK offers a way to protect cells from outside stimulus."
https://pharos.nih.gov/idg/targets/Q9UKE5,Q9UKE5,22904686,"TNIK mediates proliferation and survival of EBV-transformed B-cells."
https://pharos.nih.gov/idg/targets/Q9UKE5,Q9UKE5,21710359,"TNIK is essential for the activation of both the canonical Wnt pathway and the JNK pathway, and serves as a pro-survival factor."
https://pharos.nih.gov/idg/targets/Q9UKE5,Q9UKE5,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9UKE5,Q9UKE5,19023125,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9UKE5,Q9UKE5,18519826,"Clinical trial and genome-wide association study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9UKE5,Q9UKE5,15342639,"TNIK is a specific effector of Rap2 to regulate actin cytoskeleton"
https://pharos.nih.gov/idg/targets/Q9UL54,Q9UL54,23585562,"tau is a good substrate for PSK1 and PSK2 phosphorylation with mass spectrometric analysis of phosphorylated tau revealing more than 40 tau residues as targets of these kinases."
https://pharos.nih.gov/idg/targets/Q9UL54,Q9UL54,22683681,"TAOK2 is essential for dendrite morphogenesis; TAOK2 downregulation impairs basal dendrite formation without affecting apical dendrites."
https://pharos.nih.gov/idg/targets/Q9UL54,Q9UL54,19242545,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9UL54,Q9UL54,17158878,"PSK1-alpha is a bifunctional kinase that associates with microtubules, and JNK- and caspase-mediated removal of its C-terminal microtubule-binding domain permits nuclear translocation of the N-terminal region of PSK1-alpha and its induction of apoptosis"
https://pharos.nih.gov/idg/targets/Q9UL54,Q9UL54,16893890,"the TAK1-JNK pathway is activated by osmotic stress, while blocking TAK1-mediated NF-kappaB activation; TAO2 regulates TAK1 pathways"
https://pharos.nih.gov/idg/targets/Q9UL54,Q9UL54,12665513,"mediates signaling from carbachol to p38 mitogen-activated protein kinase and ternary complex factors"
https://pharos.nih.gov/idg/targets/Q9UL54,Q9UL54,12639963,"PSK interacts with microtubules and affects their organization and stability independently of PSK kinase activity"
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,26910843,"High MST3 expression is associated with breast cancer."
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,25456499,"This study demonistrated that MST3 kinase phosphorylates TAO1/2 to enable Myosin Va function in promoting spine synapse development."
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,23889253,"This review notes that in the SOK1 and MST4 germinal center kinase III family of proteins, exon 1 encodes a 5' untranslated region, but this is not the case for MST3."
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,23296203,"These data provide molecular understanding of the mechanism by which MO25 isoforms regulates the activity of STE20 family protein kinases."
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,22493453,"results show that a STRADalpha-rac1-PAK1 pathway regulates cell polarity and invasion in LKB1-null cells. It also suggests that while the function of LKB1 and STRADalpha undoubtedly overlap, they may also have mutually exclusive roles"
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,22229648,"mechanism of regulation of MST3"
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,21985334,"Striatin orchestrates the regulation of Mst3 by PP2A."
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,21277991,"Mst3 is up-regulated and plays an important role in hypoxia-induced apoptosis of human trophoblasts."
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,20174665,"Screening in Jurkat T-cells with a short-hairpin-RNA (shRNA) library identifies serine/threonine kinase 24 STK24 is important for HIV-1 replication"
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,20124694,"five crystal structures of the catalytic domain of MST3 are presented, including a complex with ADP and manganese, a unique cofactor preferred by the enzyme, and a complex with adenine."
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,19782762,"The mammalian sterile 20-like serine/threonine protein kinase 3 (Mst3) plays an essential role in the staurosporine-induced apoptosis of HeLa cells."
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,19604147,"Our results reveal that H2O2-induced MST3-mediated cell death involves suppressing both a JNK survival pathway and up-regulation of HO-1."
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,19328558,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,19240061,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,18040775,"study demonstrated the essential role of Mst3, a human Ste20-like protein kinase, in the oxidative stress-induced apoptosis of trophoblasts of term placenta in normal spontaneous delivery"
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,17046825,"MST3 inhibits cell migration in a fashion dependent on autophosphorylation and may regulate paxillin phosphorylation through tyrosine phosphatase PTP-PEST"
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,16314523,"Activation of NDR2 is a multistep process involving phosphorylation of the hydrophobic motif site Thr444/2 by MST3."
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,15304321,"Mst3 contains signals which may cooperate to control the subcellular distribution of Mst3."
https://pharos.nih.gov/idg/targets/Q9Y6E0,Q9Y6E0,12107159,"Proteolytic activation of Mst3 by caspases."
https://pharos.nih.gov/idg/targets/Q9Y6R4,Q9Y6R4,26802931,"IL-21 expression is promoted by MEKK4 in malignant T cells and is associated with progression risk in cutaneous T-cell lymphoma"
https://pharos.nih.gov/idg/targets/Q9Y6R4,Q9Y6R4,25173755,"Mutations in genes such as AKT2, CCNA1, MAP3K4, and TGFBR1, were associated significantly with Epstein-Barr-positive gastric tumors, compared with EBV-negative tumors."
https://pharos.nih.gov/idg/targets/Q9Y6R4,Q9Y6R4,24452333,"Map3k4 haploinsufficiency is the cause of T-associated sex reversal."
https://pharos.nih.gov/idg/targets/Q9Y6R4,Q9Y6R4,24036211,"MTK1 was identified in the HER2/HER3-HRG mediated extracellular acidification and cell migration pathway in breast cancer cells."
https://pharos.nih.gov/idg/targets/Q9Y6R4,Q9Y6R4,23760366,"MAP3K4 is sufficiently mediate the TGFbeta-induced phosphorylation of p38 MAPK in MEFs and HaCaT cells."
https://pharos.nih.gov/idg/targets/Q9Y6R4,Q9Y6R4,22732089,"we have identified a reduced IL-1A response, related to a low MAP3K4 expression and high expression of its inhibitor GSK3beta, identifying a novel key player in Crohn's disease."
https://pharos.nih.gov/idg/targets/Q9Y6R4,Q9Y6R4,22309839,"For the first time we report a significant association between nicotine dependence and DRD5, NPY1R MAP3K4 single nucleotide polymorphism."
https://pharos.nih.gov/idg/targets/Q9Y6R4,Q9Y6R4,21152872,"The upstream molecule of the TRAIL-induced MAPK activation is MEKK, as opposed to ASK1, via the mediation of its signal through JNK/p38 in a caspase-8-dependent manner."
https://pharos.nih.gov/idg/targets/Q9Y6R4,Q9Y6R4,20624154,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9Y6R4,Q9Y6R4,20221403,"CIN85 binding to a C-terminal motif within hTTP leads to the increased phosphorylation of hTTP, possibly through enhanced association with MEKK4"
https://pharos.nih.gov/idg/targets/Q9Y6R4,Q9Y6R4,17496914,"In this review, the role of MKK4 in cancer development appears complex, as some studies support a pro-oncogenic role for MKK4, while others suggest it may have tumor suppressor functions."
https://pharos.nih.gov/idg/targets/Q9Y6R4,Q9Y6R4,16256071,"Taken together, these results indicate a novel role for CIN85 in the regulation of cellular stress response via the MAPK pathways."
https://pharos.nih.gov/idg/targets/Q9Y6R4,Q9Y6R4,16157600,"MEKK4 is the MAPK kinase kinase for TRAF4 regulation of the JNK pathway"
https://pharos.nih.gov/idg/targets/Q9Y6R4,Q9Y6R4,12878610,"Axin utilizes distinct regions for competitive MEKK1 and MEKK4 binding and JNK activation."
https://pharos.nih.gov/idg/targets/Q8WXR4,Q8WXR4,27582493,"MYO3A is more efficient than MYO3B at increasing formation and elongation of stable microvilli on the surface of cultured epithelial cells."
https://pharos.nih.gov/idg/targets/Q8WXR4,Q8WXR4,26785147,"The structures of Myo3 in complex with Espin1 not only elucidate the mechanism of the binding, but also reveal a Myo3-induced release of Espin1 auto-inhibition mechanism."
https://pharos.nih.gov/idg/targets/Q8WXR4,Q8WXR4,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8WXR4,Q8WXR4,20200978,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,28069384,"miR-34c-3p may regulate triple-negative breast cancer progression by directly targeting the 3'-untranslated region of mitogen-activated protein kinase kinase kinase 2 (MAP3K2)."
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,27498924,"Study found miR-186 expression significantly decreased in lung cancer tissues and cells and MAP3K2 expression increased in the same cancer tissues. Also, results confirmed that MAP3K2 is a target gene of miR-186 and both expression correlated with prognosis."
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,25382779,"SMYD3-mediated methylation of MAP3K2 increases mutant K-Ras-induced activation of ERK1/2. (Review)"
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,25304384,"HBXIP activated ERK1/2 through up-regulating MEKK2."
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,25190348,"MEKK2 has a novel function as a regulator of ubiquitylation-dependent paxillin redistribution in breast tumour cells."
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,25012295,"EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells."
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,24975362,"Inhibitors of apoptosis proteins regulate myogenic differentiation by directly suppressing MEKK2/3-MEK5-ERK5 signaling."
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,24847881,"methylation of MAP3K2 by SMYD3 increases MAP kinase signalling and promotes the formation of Ras-driven carcinomas"
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,24801835,"Restoration of miR17/20a in solid tumor cells enhances the natural killer cell antitumor activity by targeting Mekk2"
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,24491810,"results strongly support a role for MEKK2 as a regulator of signaling that modulates breast tumor cell spread area and migration through control of focal adhesion stability"
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,22139075,"Data suggest that MEKK2 and MLK3 represent untargeted kinases in tumor biology for potential therapeutic development."
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,21804577,"Hepatitis B virus X protein enhances the growth of hepatoma cells through upregulation of MEKK2."
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,20830310,"Calcium regulation of EGF-induced ERK5 activation is mediated through interaction of MEKK2 with the adaptor protein Lad1."
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,20174665,"Screening in Jurkat T-cells with a short-hairpin-RNA (shRNA) library identifies MAP3K2, a member of mitogen-activated protein kinase kinase family (serine/threonine protein kinase), is important for HIV-1 replication"
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,19773279,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,19690195,"The ability of MEKK2 to discriminate tumor from normal cells was orthogonally confirmed."
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,19289468,"Loss of MADD expression resulted in reduced Grb2 and Sos1/2 recruitment to the TNFR1 complex and decreased Ras and MEKK1/2 activation"
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,18761086,"Through interaction with MEKK2, XIAP functions in an ubiquitin ligase dependent manner to evoke a second wave of NF-kappaB activation, resulting in the modulation of NF-kappaB target gene expression."
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,15988011,"MEKK2 is dimerized and activated by the novel protein Mip1."
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,15075238,"Unlike ERK5 and MEK5, their upstream activator MEKK2 is localized mainly in the cytosol of resting cells, and translocates into the nucleus upon EGF stimulation"
https://pharos.nih.gov/idg/targets/Q9Y2U5,Q9Y2U5,14734742,"MEKK2 is a potent activator of the c-Jun N-terminal kinase pathway in fibroblast-like synoviocytes in rheumatoid arthritis."
https://pharos.nih.gov/idg/targets/O95747,O95747,24393035,"the WNK-regulated SPAK/OSR1 kinases directly phosphorylate the N[K]CCs and KCCs, promoting their stimulation and inhibition respectively."
https://pharos.nih.gov/idg/targets/O95747,O95747,23034389,"SPAK and OSR1, which are often coexpressed in cells, can form functional heterodimers."
https://pharos.nih.gov/idg/targets/O95747,O95747,22989884,"Data show that intracellular association between WNK1 and oxidative stress-responsive 1 (OSR1) is required for stimulation of OSR1 and Na(+), K(+), Cl(-)-Cotransporter NKCC1 and NKCC2 activities by osmotic stress."
https://pharos.nih.gov/idg/targets/O95747,O95747,20889219,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O95747,O95747,20819979,"OXSR1 and WNK3 transcripts were substantially overexpressed in subjects with schizophrenia relative to comparison subjects."
https://pharos.nih.gov/idg/targets/O95747,O95747,19177573,"crystal structure of OSR1 kinase domain has been solved at 2.25 A; OSR1 forms a domain-swapped dimer in an inactive conformation, in which P+1 loop and alphaEF helix are swapped between dimer-related monomers"
https://pharos.nih.gov/idg/targets/O95747,O95747,18831043,"The first crystal structure of an OSR1 fragment encompassing the catalytic domain of the enzyme, is reported."
https://pharos.nih.gov/idg/targets/O95747,O95747,18270262,"The WNK1-SPAK/OSR1 signalling pathway plays a key role in controlling the phosphorylation and activity of NCC."
https://pharos.nih.gov/idg/targets/O95747,O95747,17721439,"These results provide the first molecular insight into the mechanism by which the SPAK and OSR1 kinases specifically recognize their upstream activators and downstream substrates."
https://pharos.nih.gov/idg/targets/O95747,O95747,16832045,"OSR1 and sterile20-related, proline-, alanine-rich kinase are likely links between WNK lysine deficient protein kinase 1 and solute carrier family 12 in a pathway that contributes to volume regulation and blood pressure homeostasis in mammals"
https://pharos.nih.gov/idg/targets/O95747,O95747,16669787,"data establish that the CCT domain functions as a multipurpose docking site, enabling SPAK/OSR1 to interact with substrates (NKCC1) and activators (WNK1/WNK4)"
https://pharos.nih.gov/idg/targets/O95747,O95747,16389068,"OXSR1 kinase is shown to interact with the three RELT family members RELT, RELL1, and RELL2 by in vitro co-immunoprecipitation; additionally, OXSR1 phosphorylates RELT family members in an in vitro kinase assay."
https://pharos.nih.gov/idg/targets/O95747,O95747,16263722,"WNK1 and SPAK/OSR1 mediate the hypotonic stress signaling pathway to cation-chloride-coupled cotransporters"
https://pharos.nih.gov/idg/targets/O95747,O95747,14707132,"isolation and characterization of OSR1 (oxidative stress-responsive 1), one of two human Fray homologs. OSR1 is a 58-kDa protein of 527 amino acids that is widely expressed in mammalian tissues and cell lines"
https://pharos.nih.gov/idg/targets/O95747,O95747,12386165,"interacts with cation chloride cotransporters"
https://pharos.nih.gov/idg/targets/Q9Y4K4,Q9Y4K4,27023625,"MAP4K5 expression is decreased or lost in majority of pancreatic ductal adenocarcinoma."
https://pharos.nih.gov/idg/targets/Q9Y4K4,Q9Y4K4,16699725,"The -822G/A polymorphism in the promoter region of the MAP4K5 gene is associated with reduced risk of type 2 diabetes in Han Chinese from Shanghai."
https://pharos.nih.gov/idg/targets/Q9Y4K4,Q9Y4K4,12591926,"TNF signaling leads to oligomerization, ubiquitination, and activation of GCKR and activation of the SAPK pathway in a manner that depends upon TRAF2 polyubiquitination and oligomerization and Ubc13 function"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,28687621,"High MEK1 expression is associated with neuroblastoma."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,28533310,"TNFRSF14 and MAP2K1 mutations are the most frequent genetic alterations found in pediatric-type follicular lymphoma (PTFL) and occur independently in most cases, suggesting that both mutations might play an important role in PTFL lymphomagenesis."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,28423638,"Data show that combined therapy using HER2 inhibitor and BRAF/MEK inhibitor presented more significant redifferentiation effect on papillary thyroid cancer cells harboring BRAFV600E than BRAF/MEK inhibitor alone."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,28190454,"somatic mutations in MAP2K1 are a common cause of extracranial arteriovenous malformation"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,28178421,"High MEK1 expression is associated with inflammation."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,27956260,"There are no other biomarkers correlated with treatment responses following MEK1/2 inhibition."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,27862862,"mutations in MAP2K1, which are frequently associated with neurological complications and intellectual disability, can be associated with a milder clinical and neurocognitive profile more typical of individuals with Noonan syndrome. Variability of expression may arise from a complex interplay between RAS/MAPK pathway genotype, epigenetics, medical and obstetric factors, and environmental influences."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,27693558,"Lgr4 is a critical positive factor for skin tumorigenesis by mediating the activation of MEK1/ERK1/2 and Wnt/beta-catenin pathways."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,27597420,"The BRAF/MAP2K1-mut LCH cells had a more immature state than BRAF/MAP2K1-wt LCH cells. Authors also found the BRAFV600E and MAP2K1 mutations were significantly associated with pERK expression."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,27588400,"High MEK1 expression is associated with infant acute lymphoblastic leukemia."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,27169363,"MEK1 is constitutively and mainly phosphorylated at the Thr-292, Ser-298, Thr-386, and Thr-388 residues in vivo, and combinations of phosphorylations at these four residues produce at least six phosphorylated variants of MEK1. The phosphorylation statuses of Thr-292, Ser-298, Thr-386, and Thr-388 residues vary widely during activation and deactivation of the MAPK pathway."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,27098723,"the purpose of this paper was to investigate MAPK downstream signalling molecules in Natural killer cell phenotypes from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,26980021,"There was no statistically significant association between BRAF or MAP2K1 mutation and anatomic site, unifocal versus multifocal presentation, or clinical outcome in Langerhans cell histiocytosis."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,26973648,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,26967560,"High MEK1 expression is associated with liver cancer."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,26860843,"MEK1 mutation is associated with central nervous system metastases of non-small cell lung cancer."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,26858456,"Endocytosis separates EGF receptors from endogenous fluorescently labeled HRas and diminishes receptor signaling to MAP kinases in endosomes."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,26825960,"Specific inhibition of BRAF oncogene, MEK or p38 signaling was associated with decreases in DIO3 expression in papillary thyroid cancer cells"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,26625317,"Data show that mitogen-activated protein kinase kinases MEK1/2 inhibitor pimasertib (MEKI) sensitized the cells to apoptosis through its ability to promote a G1 cell cycle arrest."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,26544513,"Data show that Ba/F3 cells transformed with mutant HRAS protien indicated equal sensitivity towards Map kinase kinase (MEK) and mTOR serine-threonine kinase (mTOR) inhibition."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,26426381,"NOTCH1, TP53, and MAP2K1 mutations in splenic diffuse red pulp small B-cell lymphoma are associated with progressive disease."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,26384399,"Our data demonstrate that MEK inhibitors can inhibit breast cancer stem cells and may have clinical potential for the prevention of metastasis in certain cases in which tumors are MAPK dependent."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,26358373,"Data show that src kinases (SRC) and mitogen-activated protein kinase kinase 1 (MEK) co-inhibition by saracatinib and PD0325901 respectively can be broadly effective in tumor growth control of a wide panel of non-small cell lung cancer (NSCLC) cell lines."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,26324360,"MEK1 Mutations are associated with Low-grade Serous Ovarian Cancer."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,26208478,"Findings suggest that triple therapy directed against BRAF/MEK/ErbB3 may be able to provide durable control of BRAF mutated metastatic melanoma."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,26163823,"MEK1 levels are upregulated at transcriptional level whereas MEK2 levels are downregulated at posttranslational level."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,26155939,"at clinically relevant concentrations, cDDP binds to and inhibits MEK1/2 and both the binding and inhibitory activity are related to its interaction with Cu bound to MEK1/2"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,26143635,"Studies indicate that concurrent inhibition of proto-oncogene protein B-raf (BRAF) and Map kinase kinase (MEK) improved the most effective therapeutic modality as compared as single BRAF or MEK inhibition for patients with metastatic melanoma (MM)."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,26034353,"SGK1 inhibits intestinal epithelial cell apoptosis and promotes proliferation via the MEK/ERK/p53 pathway in colitis."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25943894,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25899310,"Langerhans cell histiocytosis cells can harbor additional genetic alterations in the RAS-RAF-MEK pathway which, in the case of MAP2K1, may be responsible for ERK activation in a wild type BRAF setting."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25729732,"The MAP2K1 mutation analysis of three hairy cell leukemia cases, one hairy cell leukemia-variant case, and three splenic marginal zone lymphoma cases revealed negative results."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25722381,"MEK1/2 inhibitor trametinib showed similar PFS and a response rate as docetaxel in patients with previously treated KRAS-mutant-positive non-small cell lung carcinoma."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25713071,"Data indicate that cyclic AMP signaling reduces the expression of sirtuin 6 deacetylase via inhibition of the c-Raf-MEK1-ERK1/2 pathway."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25710724,"Data show that licochalcone A (LicoA) suppresses solar UV-induced cyclooxygenase (COX-2) expression by acting as a potent inhibitor of enzymes PI3K, MEK1, and B-Raf."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25541062,"MEK1/2 inhibitor potentiated the anti-tumor effects of cisplatin in KRAS-dependent lung cancer cells and an animal model through inhibition of BIM degradation"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25534823,"Findings establish that the convergence of 2 distinct Ras effector pathways on mammalian target of rapamycin signaling maintains neurofibromatosis type 1 mouse optic glioma growth."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25463315,"We documented three novel mutations in the BRAF gene in cardio-facio-cutaneous syndrome patients and correlated clinical findings with causative mutations in the BRAF or MEK1/MEK2 genes"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25425646,"CCR7 can also promote survival of mDCs through a novel MEK1/2-ERK1/2-AMPK signaling axis."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25408231,"MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25370473,"our data indicate that preexisting MEK1(P124) mutations are associated with a reduced response to BRAF inhibitor therapy and identify a subset of patients with BRAF-mutant melanoma likely to benefit from combination therapies"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25351745,"MEK1 mutations define a distinct subset of lung cancers ( approximately 1%) with potential sensitivity to MEK inhibitors. Mutations are predominantly transversions, in keeping with a strong association with smoking."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25202140,"33% of Langerhans cell histiocytosis cases with wild-type BRAF and none with BRAFV600E harbored somatic mutations in MAP2K1 (6 in-frame deletions and 1 missense mutation) that induced extracellular signal-regulated kinase (ERK) phosphorylation in vitro."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25194980,"MAP2K1 missense mutations were found in 2 of 11 patients with cadiofaciocutaneous syndrome: Pro124Gln and Asp67Asn."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25188412,"Sphingosine-1-phosphate promotes extravillous trophoblast cell invasion by activating MEK/ERK/MMP-2 signaling pathways via S1P/S1PR1 axis activation."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25164676,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,25155755,"X-ray crystallography reveals a regulatory role for BRAF in the MAPK pathway independent of its kinase activity but dependent on interaction with MEK."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,24982505,"This is the first report of MAP2K1 mutations in Langerhans cell histiocytosis(LCH) that occur in 50% of BRAF wild-type cases. The mutually exclusive nature of MAP2K1 and BRAF mutations implicates a critical role of oncogenic MAPK signaling in LCH."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,24909280,"Data indicate that combined PI3K inhibitor LY294002 and mitogen activated protein kinase kinase (MEK) inhibitor AZD6244 showed synergistic effect on inhibition of SKOV3/DDP cell growth by inducing apoptosis and blocking cell cycle."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,24709918,"Findings support the hypothesis that BDNF and MEK1 mRNA expression levels are more obviously decreased in patients with treatment-resistant depression."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,24681949,"Treatment of cells with sirtuin inhibitors, or siRNA knockdown of SIRT1 or SIRT2 proteins, increases MEK1 acetylation and subsequent phosphorylation of the extracellular signal-regulated kinase."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,24501087,"our data emphasizes the importance of the translational regulation of p21 by the MEK1/2-ERK1/2-p70S6K pathway to negatively control the cell cycle progression."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,24445144,"Activated MEK1 is associated with chordoma."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,24419498,"Studies suggest that MAP Kinase Kinase 1 (MEK1) inhibitors represent a new treatment option in BRAF and NRAS mutated melanoma."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,24418364,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,24241536,"high frequency of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,24211253,"MEK1-YAP interaction is critical for liver cancer cell proliferation and maintenance of transformed phenotypes both in vitro and in vivo."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,24132923,"Combined therapy targeting both MEK and STAT3, but not either single pathway, resulted in complete regression of selumetinib-resistant tumors"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,24091658,"Phosphorylated-FAKSer732 was barely detectable during interphase while its levels strongly increased in mitotic cells upon activation of the EGFR/MEK/ERK/CDK5 axis in an integrin-independent manner."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,24011934,"Data indicate that dual targeted inhibitors of PI3K/mTOR in combination with inhibitors of RAS/ERK signalling as a potentially effective approach to treating ovarian cancer."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,23923067,"activation of RAF1-MEK1-ERK/AKT axis may determine the resistance of non-small cell lung cancer cell lines bearing wild type EGFR to erlotinib"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,23852369,"inhibition of MEK partially inhibited MTOR in a cell-type-dependent manner"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,23746211,"Authors demonstrate that HIV-1 Nef expression mediates phosphorylation of Mek1 on serine298 and Pak2 on serine192/197 in T cell lines as well as primary human T cells."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,23746211,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,23727904,"genetic association study in Han population in China: Data suggest that SNPs in MEK1 (rs28730804) and in RSK3 (rs2229712) demonstrate gene-gene interaction that affects antidepressant drug outcome in female patients with major depressive disorder."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,23698777,"Data show that hepatitis C virus NS5A-transactivated protein 9 (NS5ATP9) knockdown activated mitogen-activated protein kinase kinase/extracellular signal regulated kinases 1/2 signaling under C virus nonstructural protein 5A (NS5A) expression."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,23698055,"Substituted 3-benzylcoumarins as allosteric MEK1 inhibitors: design, synthesis and biological evaluation as antiviral agents."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,23684925,"Report a synthetic lethal interaction between PI3K/mTOR and MEK inhibitors in rhabdomyosarcoma."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,23555914,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,23524336,"MEK1 is a novel outcome for signalling through the canonical MAPK pathway that is a naturally occurring,pathway regulated dominant negative to block signalling to ERK-p90RSK"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,23423222,"Gene expression changes due to neurofibromin modulation but independent of NRAS and MEK1/2 regulation in malignant peripheral nerve sheath tumor cells indicated bone morphogenetic protein 2 (Bmp2) signaling as a key pathway."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,23360980,"The ability of MEK to activate C-Raf was only partially dependent on MEK kinase activity but required MEK binding to C-Raf, suggesting that the binding results in a conformational change that increases C-Raf susceptibility to phosphorylation"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,23241949,"Myt1 is inactivated by MEK1 mediated phosphorylation to fragment the Golgi complex in G2 and for the entry of cells into mitosis."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,23237773,"JTP-74057 is a novel MEK1/2 inhibitor able to sustain MEK in an unphosphorylated form resulting in pronounced suppression of the downstream signaling pathways involved in cellular proliferation."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,23225884,"A novel nuclear function of MEK1 triggers a complex pattern of early T cell activation, followed by a late inhibition through its interaction with silencing mediator of retinoid and thyroid hormone receptor (SMRT)."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,23157514,"DiRas3 interacts with C-RAF and downregulates MEK1 activity to restrict cell migration."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,23001481,"These data show that the MAPK-ERK pathway plays an important role in the regulation of hepatitis C virus gene expression and replication."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22946697,"Data indicate that of the 32 cardio-facio-cutaneous syndrome (CFC) patients, 28 (88%) had a known mutation in a gene that is causative for CFC, including BRAF (n = 21), MEK1 (n = 2), MEK2 (n = 4), and KRAS (n = 1)."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22946047,"integrin-triggered, RIAM-dependent MEK activation represents a key feedback event required for efficient focal adhesion disassembly."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22935974,"osteosarcoma patients whose tumors expressed pMEK1 had a poorer clinical outcome than those whose tumors did not."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22902540,"IL1beta treatment reduces SHBG production in HepG2 cells by the down-regulation of HNF-4A via the MAPK kinase (MEK)-1/2 and c-Jun N-terminal kinase (JNK) MAPK signaling pathways."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22833572,"C-MYC as a key driver of cell proliferation downstream of RAF-->MEK1/2-->ERK signaling."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22805292,"Data show substantial clinical activity of MEK1/2 inhibitor trametinib in melanoma and suggest that MEK is a valid therapeutic target."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22805291,"Define the maximum tolerated dose and recommended phase 2 dose of MEK1/2 inhibitor trametinib and to assess its safety, pharmacokinetics, pharmacodynamics, and response rate in individuals with advanced solid tumours."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22791812,"a Ras-Raf-MEK1, but not MEK2, signaling cascade is necessary and sufficient for Erk2 nuclear localization that works in concert with TGF-beta to promote EMT."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22773810,"Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22752157,"VRK2A can form a high molecular size complex with both MEK1 and KSR1; the KSR1 complex assembled and retained by VRK2A in the endoplasmic reticulum can have a modulatory effect on the signal mediated by MAPK,locally affecting the magnitude of its responses"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22707717,"observed that, although MEK1 negatively regulates TLR2 signaling in EC, MEK1 promotes TLR2 signaling in monocytes"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22588879,"Activating MEK1 exon 3 mutations identified herein and concurrent with V600E/KBRAF do not cause BRAF inhibitor resistance in melanoma."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22546605,"These results suggest that EGF is secreted from A549 cells by MMP and increases claudin-2 expression mediated via the activation of an EGFR/MEK/ERK pathway."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22495818,"These data indicate that MED28 regulates cellular migration in a MEK1-dependent manner in human breast cancer cells, reinforcing the important cellular roles of MED28."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22357202,"Inhibition of extracellular signal regulated kinase 1/2 and c-jun N-terminal kinases increases, but that inhibition of p38 mitogen-activated protein kinase decreases M. tuberculosis-induced CD44 surface expression in THP-1 human monocytes."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22327936,"A total of six (3.5%) activating mutations in MAP2K1 were thus identified among 172 of specimens or cell lines for human epithelial tumors."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22298595,"Findings indicate that Ras-induced nuclear accumulation of activated MEK1/2 was reliant on downregulation of the spatial regulator Sef."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22241220,"The induction of CDK1, cyclin B1 mRNA and protein were shown to be dependent on the activation of MEK/extracellular signal-regulated kinase (ERK) signaling."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22197931,"Screening a cohort of individuals with melanoma revealed the presence of recurring somatic MAP2K1 and MAP2K2 mutations, which occurred at an overall frequency of 8%."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22188669,"These results indicate that activation of MAPK may play a significant role in aberrant expression of miRNAs and their associated phenotypes in pancreatic cancer."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22180573,"Our data suggest that the miR-1826 plays an important role as a tumor suppressor by downregulating beta-catenin and MEK1 in von Hippel-Lindau-inactivated renal cancers."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22052387,"LPS increased IL-8 and IL-6 and decreased EVT invasion through activation of MEK1/2 MAPK signaling"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,22037177,"the activation of PI3K and MEK pathways is not the only mechanism of EGFR-resistance"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,21965271,"conclude that graded increases in the MEK1 signaling module are correlated with M1-MMP expression, renal epithelial cell tumor phenotype, invasive activity and nuclear grade"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,21835307,"The BRAF/MEK/ERK pathway is upregulated in progressive retinal arterial macroaneurysm patients, caused by mutation in IGFBP7."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,21713404,"TGF-beta1 undergo a switch into mesenchymal cells and PI3K/Akt and MAPK/Erk1/2 signaling pathways serve to regulate TGF-beta1-induced epithelial-to-mesenchymal transition of A549 cells."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,21707777,"These findings suggest that the upregulation of PGRN via the p38MAPK and MEK1/2 signaling pathway in Helicobacter pylori-infected gastric epithelial cells may contribute to the carcinogenic process."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,21705440,"In an isogenic cell system that extended these findings into other cancer cell lines, the MEK1(F129L) mutant exhibited higher intrinsic kinase activity than wild-type MEK1 [MEK1(WT)], leading to potent activation of ERK and downstream targets"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,21621846,"These results suggest the regulatory role of MEK in TIM-3 transcription by human CD4+ T cells and mast cells"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,21567396,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,21458501,"Data show that mitogen-activated protein kinase kinases direct mitochondrial biogenesis by selectively inducing PGC-1beta expression."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,21447798,"Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,21383288,"Thus, MEK1(C121S) or functionally similar mutations are predicted to confer drug resistance of neoplasms to combined MEK/RAF inhibition."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,21336309,"oncogenic Ras efficiently activates the ERK pathway both by activating Raf and by inhibiting MEK SUMOylation, thereby inducing carcinogenesis"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,21179471,"decreased mir-424 expression and increased levels of MEK1 or cyclin E1 in senile hemangioma may cause abnormal cell proliferation in the tumor"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,21131601,"Data suggest a novel mechanism for MEK1 in regulating the sensitivity to TGF-beta signaling by stabilizing TbetaRII."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,20956560,"Nek10 physically associated with Raf-1 and MEK1 in a Raf-1-dependent manner, and the formation of this complex was necessary for Nek10-mediated MEK1 activation."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,20926789,"We have uncovered an IL-2- and IL-4-driven MEK1 induction mechanism that results in heightened ERK1/2 activation in asthmatic T cells"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,20885957,"Apoptosis induction by MEK1/2 inhibition in human lung cancer cells is mediated by Bim."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,20676060,"Here, the authors show that an MEK-cofilin signalling module has an important function for the migration of human T cells in 3D environments."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,20610816,"The C-terminal ILLHPWF motif that is well conserved among Trib family proteins is required for MEK1 binding, enhancement of ERK phosphorylation, enhanced self-renewal activity of bone marrow cells and leukemogenic activity by Trib1."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,20512084,"SH3GL2 participates in the regulation of apoptosis through the MEK-ERK signal pathway by adjusting EGFR in the laryngeal carcinoma cell line Hep2"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,20433920,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,20404718,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,20354455,"MEK1 mutations exclusive with EGFR, K-ras, and B-raf mutations at kinase domain is associated with lung cancer."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,20354455,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,20302979,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,20299489,"results show that PMA activates the MEK-ERK pathway and strongly induces miRNA-34a expression, which in turn inhibits cell proliferation by repressing the expression of MEK1"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,20179161,"Pin1 plays an important role in the overexpression of HER-2 through Pin1-MEK1-activator protein-2alpha signaling in breast cancer."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,20172001,"These results demonstrate that MEK1 and MEK2 act differently and that herpes simplex virus type 2 hijacks host MEK1 for its own amplification."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,20056645,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,20019835,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,20007706,"Data show that the FGF2-induced ERK MAP kinase strongly increased the Runx2 protein level through an increase in acetylation and a decrease in ubiquitination."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19858308,"This study demonstrated that H. pylori LPS may be a pathogenic factor causing gastric tumors by enhancing cell proliferation and inflammation via the MAPK cascade in gastric epithelial cells."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19835659,"In suicide brain, the interaction of MEK1 with ERK1 and ERK2 is increased along with decreased phosphorylation and catalytic activity of ERK1/2."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19816936,"Data show that oncogenic level of ERK1/2 phosphorylation appears to be MEK1 and MEK2 dependent in basal condition."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19802003,"Data show that in hypoxic conditions or coexpressed with a constitutively active form of HIF-1alpha, c-Kit mutants activate the Ras/Raf/Mek/Erk pathway, stimulate proliferation and transform melanocytes."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19681119,"Investigated the prevalence of PTPN11, HRAS, KRAS, NRAS, BRAF, MEK1, and MEK2 mutations in a relatively large cohort of primary embryonal Rhabdomyosarcoma (RMS) tumors. No mutation was observed in BRAF and MEK genes."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19625741,"Meaasurement of ERK 1/2 in csf from patients iwht neuropsychiatric disorders and evidence for the presence of the activated form."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19567590,"Data provide a basis for rational combination of MEK and PI3K inhibitors in basal-like cancers with both intact and deleted PTEN."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19500021,"Different mutations in the MAPK pathway play distinct roles in the growth and invasion of thyroid cancer cells"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19453261,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19447520,"SGK1 expression during liver regeneration is a part of a signaling pathway that is necessary for enhancing ERK signaling activation through modulating the MEK/ERK complex formation."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19411838,"One MAP kinase kinase 1 mutation is found in 1 of 37 melanoma tumor samples and another MEK1 mutation in 1 of 45 colon cancer samples."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19342664,"activation of MEK1 selectively down-regulates human rhinovirus-induced expression of CXCL10 via modulation of IFN regulatory factor-1 interactions with the gene promoter in human airway epithelial cells"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19261809,"TNF-alpha abrogated TGFbeta1-induced SMalphaA gene expression at the level of transcription without disrupting phosphorylation of regulatory Smads."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19206169,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19164283,"MEK1/2 phosphorylates ERK1/2, which phosphorylates Sp1 and AP-1 that in turn bind to their respective binding sites to regulate the expression of human VIL2 in ESCC cells."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19156172,"Spectrum of MEK1 gene mutations in cardio-facio-cutaneous syndrome and genotype-phenotype correlations"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19156172,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19153083,"MEK1 binds directly to betaarrestin1, influencing both its phosphorylation by ERK and the timing of its isoprenaline-stimulated internalization"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19133693,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19056740,"active CaMKII directly phosphorylates MEK1 in vitro, which could be abrogated by CaMKII inhibitor"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19014680,"MEK1 & MEK2 isoforms have similar transforming properties & are able to induce formation of metastatic intestinal tumors in mice; results suggest MEK2 plays a more important role than MEK1 in sustaining proliferation of human colorectal cancer cells"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,19001375,"the molecular interactions of arrestin2 and arrestin3 and their individual domains with the components of the two MAPK cascades, ASK1-MKK4-JNK3 and c-Raf-1-MEK1-ERK2"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,18660489,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,18632602,"analysis of the MEK1 mutation in lung adenocarcinoma"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,18617556,"Esophageal cells from GERD patients with Barrett's esophagus have elevated MEK1 phosphorylation and decreased MEK1/MEK2 activity."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,18593598,"WNK2 controls a RhoA-mediated cross-talk mechanism that regulates the efficiency with which MEK1 can activate ERK1/2 upon growth factor stimulation."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,18569454,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,18533112,"MEK1 is the critical isoform regulating tumor cell proliferation in vitro and in vivo."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,18434598,"MEK1/ERK regulation of GRASP55-mediated Golgi linking is a control point in cell cycle progression"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,18424438,"the induction of inflammatory genes by farnesol is mediated by the activation of the NF-kappaB pathway and involves MEK1/2-ERK1/2-MSK1-dependent phosphorylation of p65/RelA(Ser(276))"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,18413255,"study describes the biochemical characterization of novel BRAF and MEK germline mutations in cardio-facio-cutaneous syndrome"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,18390968,"Phase I trial of MEK1/2 inhibitor AZD6244 in tumor patients."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,18192500,"Has a role in epithelial cell proliferation and lung remodeling after toxic injury."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,18060073,"BRAF and MEK1/2 mutations may be more common than anticipated in ovarian cancer which could have important implications for treatment of patients with this disease and suggests potential new therapeutic avenues"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,18042262,"the results of HRAS, BRAF and MAP2K1/2 mutation screening in a large cohort of patients with CS and CFC"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,17981815,"study reports data concerning the biochemical functions of novel MEK1 and MEK2 mutants found in patients with cardio-facio-cutaneous syndrome, as well as the roles of these genes in the MAPK signaling cascade"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,17951252,"modulation of phosphatidylinositol 3-kinase/Akt/GSK3beta signaling cascades can be beneficial for protecting or facilitating recovery from cellular LeTx intoxication in cells that depend on basal MEK1 activity for proliferation."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,17704260,"3 novel mutations for MEK1 (E44G, T55P, D67N) were found in cardio-facio-cutaneous syndrome. A novel mutation in exon 2 was found in Noonan syndrome."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,17667937,"WNK2 is involved in the modulation of growth factor-induced cancer cell proliferation through the MEK1/ERK1/2 pathway."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,17490600,"analysis of the ATPase activity of phospho-MEK-1 uncoupled from downstream ERK phosphorylation"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,17461449,"These results indicated that the activation of CXCR4 and its signaling pathways (MEK1/2 and Akt) are essential for CXCL12-induced cholangiocarcinoma cell invasion."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,17419998,"Mek1/2 are functionally redundant in the epidermis, where they act as a linear relay in the MAPK pathway to mediate development and homeostasis."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,17366577,"mutational analysis of KRAS, BRAF, and MAP2K1/2 in 56 patients with CFC syndrome; comparison of the genotype-phenotype correlation of CFC with that of Costello syndrome suggest a significant clinical overlap but not genotype overlap."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,17260965,"allosteric inhibitors have a dynamic range in the type of MEK1 activation states and nucleotide complexes that they can bind."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,17197157,"Further studies confirm that promoter activity correlates with protein expression by demonstrating reduced SMAD3 protein expression in A549 cells and airway smooth muscle cells after treatment with MEK1 inhibitors."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,17182854,"MEK1 plays an in vivo role in Golgi reorganization, which regulates cell cycle progression."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,17101779,"MEK1 exports PPARgamma from the nucleus, and this finding was supported by small interfering RNA knockdown of MEK1 and use of a cell-permeable interaction-blocking peptide, which prevented tetradecanoyl phorbol acetate-induced export of PPARgamma."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,17054908,"Our data suggest that overexpression of TNFalpha leads to topical GC insensitivity by reducing GR nuclear translocation in keratinocytes."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,17038630,"Inhibition of overactive ras-MEK-ERK pathway in HepG2 cells can correct the defect in VLDL assembly leading to the secretion of VLDL-sized particles, similar to primary hepatocytes, implicating the MEK-ERK cascade in VLDL assembly in the HepG2 model."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,16957420,"Taxotere and MEK1/2 inhibitors have the potential to suppress mammary tumor growth in vivo."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,16861903,"REVIEW. surprises yielded by the analysis of the role of B-Raf and Raf-1 and of their downstream effectors using conditional knockouts"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,16820947,"Results describe the roles of MEK1/ERK and AKT/PKB pathways on the effects of granulocyte macrophage colony-stimulating factor (GM-CSF) and M-CSF on tumor progression of lung cancer."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,16454711,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,16439621,"findings demonstrate that heterogeneous de novo missense mutations in three genes within the mitogen-activated protein kinase pathway, BRAF, MEK1 and MEK2 cause cardio-facio-cutaneous syndrome"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,16239230,"PP2A ABalphaC and ABdeltaC holoenzymes function as positive regulators of Raf1-MEK1/2-ERK1/2 signaling by targeting Raf1"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,16086581,"results suggest that activated JNK can, in turn, activate not only jun but also raf that, in turn, activates MEK that can then cross-activate JNK in a positive feedback loop"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15979847,"The ability of constitutively-active human MEK1 to stimulate ERK phosphorylation and to induce the neoplastic transformation of NIH 3T3 cells required the integrity of the D-site was found."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15888452,"Cdc2 inhibits growth factor receptor-mediated ERK activation during mitosis by primarily targeting signaling proteins that are upstream of MEK1"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15757891,"RAS-MEK-ERK1/2 signaling pathway can sensitize cells to TRAIL-induced apoptosis by up-regulating DR4 and DR5"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15665520,"whereas MAPKK-1 signaling is required for VEGF synthesis only and PI3K activation activity was lowered in hypoxia."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15657590,"The induction of the raf-1/MEK1 pathway blocks IGF-1-mediated intracellular neuroendocrine hormone regulation. This pathway may be a therapeutic target in gastrointestinal carcinoid tumor therapy."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15657353,"Selesctive inhibitors potentiate apoptosis induction by sulindac sulfide, an NSAID, suggesting a novel strategy for the prevention or treatment of colorectal cancer."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15638726,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15615716,"Blockade of MEK1 by PD98059 suppresses c-Fos and Fra-1 expression and, thus, affects two counteractive signals for IL-8 mRNA."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15572374,"MEK1 facilitates ligand-initiated transcriptional activation while targeting the Ah receptor for degradation"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15557124,"Integrin alphav controls melanoma cell survival in 3D-collagen through a pathway involving p53 regulation of MEK1 signaling."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15543157,"X-ray structures of human MEK1 and MEK2, each determined as a ternary complex with MgATP and an inhibitor to a resolution of 2.4 A and 3.2 A, respectively"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15538402,"Arsenic trioxide and inhibitors of this enzyme my be combined as anticancer agents for acute promyelocytic leukemia."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15297310,"Detailed pathway analysis revealed that BM stromal cells stimulate STAT3 via the IL-6R, and MEK1/ERK1 pathways, via IL-6R-independent mechanisms"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15292274,"Molecular cross-talk between MEK1/2 and mTOR signaling during recovery of 293 cells from hypertonic stress."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15284233,"Has distinct ways to contribute to a regulated ERK activity and cell cycle progression."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15069060,"in non-transformed human colonocytes, MEK activation following flagellin/TLR5 engagement is a key modulator for NFkappaB-independent, IL-8 and MIP3alpha expression."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15021912,"Plk3 may be a key protein kinase mediating MEK1 function in the Golgi fragmentation pathway during cell division."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,15020233,"Glycogen synthase kinase-3beta is tyrosine-phosphorylated by mitogen-activated protein kinase kinase 1 in fibroblasts."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,14672918,"Stress-related signaling pathways in epithelial cells are modulated by hypoxia and confer protection from reoxygenation, since hypoxia and chemical inhibition of p38mapk and MEK1/2 similarly increase cytolysis resulting from O2-."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,14656894,"MEK1,2 response element that mediates angiotensin II-stimulated PAI-1 promoter activation and shows that activation of this element requires Sp1 and AP-1 co-activation."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,14581471,"RhoA binds to the amino terminus of MEKK1 and regulates its kinase activity."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12917419,"constituitively activated in choroidal melanoma cell lines, independent of Ras, and regulated by B-RafV599E"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12839928,"results show that p38-mediated dephosphorylation of MEK1,2 mediates initiation of apoptosis"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12807433,"Distribution of total MEK1 between Alzheimer disease[AD] and age-matched control cases was similar but increased levels of activated phospho-MEK1 were specifically localized to neuronal intracytoplasmic granular structures in severe AD"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12775419,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12689928,"Inhibition of the upstream MAPK kinase inhibited the phosphorylation of ERK; modulated the levels of Bcl-2, Mcl-1, and cFLIP; and induced G2M cell-cycle arrest or apoptosis"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12682854,"The 1,25(OH)(2)D3-responsive element in cystatin A gene is identical to TRE, T2 (-272 to -278). Suppression of Raf-1/MEK1/ERK1,2 signaling pathway increases cystatin A expression of normal human keratinocytes."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12663662,"serum stimulation of fibroblasts in floating matrices does not result in ERK translocation to the nucleus. In addition, there was decreased serum activation of upstream members of the ERK signaling pathway, MEK and Raf"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12612059,"Inhibition of either phosphatidylinositol 3-kinase (PI3-K) or Mek1/2 signaling pathways completely abrogated the IGF-I-induced increase in VEGF secretion and promoter activity"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12609978,"the dramatic activation of an endomembrane-associated MEK1 without the corresponding activation of the MEK substrate ERK during normal G(2)/M"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12531514,"Data show that p-MEK1/2 and p-ERK1/2 are present in neurons in the initial stages of neurofibrillary degeneration in Alzheimer's disease, before deposition of beta-amyloid."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12522135,"the NH(2)-terminal end of MEK is important not only for substrate interaction but also for catalytic activity"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12482669,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12456688,"Ubiquitylation of MEKK1 inhibits its phosphorylation of MKK1 and MKK4 and activation of the ERK1/2 and JNK pathways"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12370306,"MEK1 has an activation domain that forms a hydrophobic binding pocket for enzyme inhibitor PD184352"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12167619,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12089333,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12063167,"Activation of a Src-dependent Raf-MEK1/2-ERK signaling pathway is required for IL-1alpha-induced upregulation of beta-defensin 2 in human middle ear epithelial cells."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,12032872,"MEK1 activity ad dual-phosphorylation were undetectable in expanding and self-renewing hematopoietic progenitors (HP). Adding IL-3, inducing maturation and cell death in HP, led to sustained high levels of MEK1 activity and dual-phosphorylation."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,11948406,"PAK1 primes MEK1 for phosphorylation by Raf-1 kinase during cross-cascade activation of the ERK pathway"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,11891225,"Laminin-10/11 and fibronectin differentially prevent apoptosis induced by serum removal via phosphatidylinositol 3-kinase/Akt- and MEK1/ERK-dependent pathways (Laminin 10; separate entry for Laminin 11)."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,11726657,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,11579140,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,11409852,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,11260070,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,11134045,"MEK1 interacts with and phosphorylates ERK2.  This interaction is mediated via a conserved N-terminal docking site in MEK1.  Note that this interaction was demonstrated using rat ERK2."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,11134045,"MEK1 interacts with ERK1.  This interaction is mediated via a conserved N-terminal docking site in MEK1."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,11044099,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,10982368,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,10799874,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,10780709,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,10509564,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,9621077,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,9564043,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,9558095,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,9325171,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,9223324,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q02750,Q02750,8621729,"A-Raf interacts with MEK1 and activates MEK1 by phosphorylation."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,8621729,"MEK1 interacts with B-Raf."
https://pharos.nih.gov/idg/targets/Q02750,Q02750,8621729,"c-Raf interacts with MEK1 and activates MEK1 by phosphorylation."
https://pharos.nih.gov/idg/targets/Q12851,Q12851,27151888,"These studies demonstrate, for the first time, that GCK is a molecular therapeutic target in DLBCL tumors and that inhibiting GCK may significantly extend DLBCL patient survival."
https://pharos.nih.gov/idg/targets/Q12851,Q12851,25075558,"Data indicate 4-substituted 1H-pyrrolo[2,3-b]pyridines as potent inhibitors against TGFbeta-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2)."
https://pharos.nih.gov/idg/targets/Q12851,Q12851,24072714,"Intermediates in the guanine nucleotide exchange reaction of Rab8 protein catalyzed by guanine nucleotide exchange factors Rabin8 and GRAB."
https://pharos.nih.gov/idg/targets/Q12851,Q12851,22433857,"Data suggest that the Rabin8-Rab8-Sec15 interaction may couple the activation of Rab8 to the recruitment of the Rab8 effector and is involved in the regulation of vesicular trafficking for primary cilium formation."
https://pharos.nih.gov/idg/targets/Q12851,Q12851,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q12851,Q12851,20332113,"CCM3 is located on the Golgi apparatus, forming a complex with proteins of the germinal center kinase III (GCKIII) family and GM130, a Golgi-resident protein."
https://pharos.nih.gov/idg/targets/Q12851,Q12851,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O95819,O95819,28061846,"Interactions between MAP4K4 gene variants and environmental factors may contribute to MAP4K4 attenuation in T cells, leading to non-obese T2D."
https://pharos.nih.gov/idg/targets/O95819,O95819,27174326,"of the five variants, SNP rs2236935T/C was significantly associated with type 2 diabetes mellitus (T2DM) in this study population; conclude that MAP4K4 gene is associated with T2DM in a Chinese Han population, and MAP4K4 gene variants may contribute to the risk toward the development of T2DM"
https://pharos.nih.gov/idg/targets/O95819,O95819,27044870,"Results reveal that endothelial Map4k4 is critical for lymphatic vascular development by regulating endothelial cells (EC)quiescence and lymphatic EC fate."
https://pharos.nih.gov/idg/targets/O95819,O95819,27010469,"MAP4K4 promotes the epithelial-mesenchymal transition and invasiveness of hepatocellular carcinoma cells"
https://pharos.nih.gov/idg/targets/O95819,O95819,26918832,"This report identifies HGK methylation/downregulation in T cells as a potential biomarker for non-obese type 2 diabetes"
https://pharos.nih.gov/idg/targets/O95819,O95819,26722431,"miR-194 regulated the progression of hepatocellular carcinoma through directly inhibiting the expression of MAP4K4"
https://pharos.nih.gov/idg/targets/O95819,O95819,26549737,"The results of the present study suggested that inhibition of MAP4K4 may be a therapeutic strategy for gastric cancer."
https://pharos.nih.gov/idg/targets/O95819,O95819,25799996,"loss of MAP4K4 function suppressed pathological angiogenesis in disease models, identifying MAP4K4 as a potential therapeutic target"
https://pharos.nih.gov/idg/targets/O95819,O95819,24244164,"that MAP4K4, a known mediator of inflammation, is involved in KS aetiology by regulating KSHV lytic reactivation"
https://pharos.nih.gov/idg/targets/O95819,O95819,24233838,"results reveal a key target of SOX2 expression and highlight the unexpected context-dependent role for MAP4K4, a pluripotent activator of several mitogen-activated protein kinase pathways, in regulating tumor cell survival."
https://pharos.nih.gov/idg/targets/O95819,O95819,23543740,"TRAF1.NIK is a central complex linking canonical and non-canonical pathways by disrupting the TRAF2-cIAP2 ubiquitin ligase complex"
https://pharos.nih.gov/idg/targets/O95819,O95819,23094072,"Common polymorphisms in MAP4K4 are associated with insulin resistance and beta-cell dysfunction, possibly via this gene's role in inflammatory signaling."
https://pharos.nih.gov/idg/targets/O95819,O95819,22824148,"Elevated MAP4K4 expression is closely associated with lung adenocarcinoma progression with independent prognostic value in predicting overall survival for patients with lung adenocarcinoma."
https://pharos.nih.gov/idg/targets/O95819,O95819,21196414,"MAP4K4 overexpression is an independent predictor of poor prognosis of Hepatocellular Carcinoma patients, and inhibition of its expression might be of therapeutic significance"
https://pharos.nih.gov/idg/targets/O95819,O95819,20857524,"Data show that down-regulation of hepatocyte progenitor kinase-like kinase (HGK) can obviously inhibit the migration and invasion of HepG2 cells in vitro, and suggest that HGK may be a new therapeutic target for treatment of hepatocellular carcinoma."
https://pharos.nih.gov/idg/targets/O95819,O95819,19690174,"Results identify MAP4K4 as a key upstream mediator of TNF-alpha action on the beta cell, preventing tumor necrosis factor-alpha-induced decrease of IRS-2 and inhibition of glucose-stimulated insulin secretion."
https://pharos.nih.gov/idg/targets/O95819,O95819,18981001,"MAP4K4 expression significantly correlated with overall and recurrence-free survival (P=0.025 and 0.004) independent of age, tumor size, differentiation, and stage."
https://pharos.nih.gov/idg/targets/O95819,O95819,17227768,"MAP4K4 silencing prevents TNFa-induced insulin resistance in human skeletal muscle and restores appropriate signaling inputs to enhance glucose uptake"
https://pharos.nih.gov/idg/targets/O95819,O95819,16537454,"studies of the promigratory role of MAP4K4 showed that the knockdown of this transcript inhibited the migration of multiple carcinoma cell lines, indicating a broad role in cell motility"
https://pharos.nih.gov/idg/targets/O95819,O95819,14966141,"MAP4K4 is a putative effector of Rap2, a Ras family small GTP-binding protein, mediating the activation of JNK by Rap2"
https://pharos.nih.gov/idg/targets/O95819,O95819,12612079,"The STE20 kinase HGK is broadly expressed in human tumor cells and can modulate cellular transformation, invasion, and adhesion."
https://pharos.nih.gov/idg/targets/O95819,O95819,12387898,"interaction with GBP3"
https://pharos.nih.gov/idg/targets/O94804,O94804,28430576,"Binding of phosphatidylinositol 4,5-biphosphate to ezrin induces a conformational change permitting the insertion of the LOK C-terminal domain to wedge apart the membrane and F-actin-binding domains of ezrin. The N-terminal LOK kinase domain can then access a site 40 residues distal from the consensus sequence that collectively direct phosphorylation of the appropriate threonine residue."
https://pharos.nih.gov/idg/targets/O94804,O94804,27177495,"The gene signature of OPA1, CTSA, NDUFA1, STK10 and PRDX1 was able to identify patients post-implant with a sensitivity of 91% and a specificity of 86% in discrimination between post-implant group and healthy controls."
https://pharos.nih.gov/idg/targets/O94804,O94804,23842845,"STK10 functions as a tumor suppressor gene, and dysfunction of STK10 activity either through polymorphism or somatic mutations may confer anti-apoptotic effects contributing to carcinogenesis."
https://pharos.nih.gov/idg/targets/O94804,O94804,23209304,"It was shown that lymphocyte-oriented and STE20 kinase were sufficient to restrict ezrin function to the apical domain. Both kinases were enriched in microvilli and locally activated there."
https://pharos.nih.gov/idg/targets/O94804,O94804,21905501,"genetic polymorphism is associated with aspirin-intolerant asthma in a Korean population"
https://pharos.nih.gov/idg/targets/O94804,O94804,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O94804,O94804,20306291,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O94804,O94804,19255442,"These studies identify a new ERM kinase of importance in lymphocytes and confirm the role of ezrin-radixin-moesin phosphorylation in regulating cell shape and motility."
https://pharos.nih.gov/idg/targets/O94804,O94804,12639966,"Stk10 is a novel polo-like kinase kinase that cooperates with hSlk to regulate Plk1 function in human cells"
https://pharos.nih.gov/idg/targets/O94804,O94804,11903060,"Opposing roles of serine/threonine kinases MEKK1 and LOK in regulating the CD28 responsive element in T-cells"
https://pharos.nih.gov/idg/targets/Q6ZN16,Q6ZN16,20362554,"\"ASK3 gene\" is a novel member of apoptosis signal-regulating kinases and that it plays a pivotal role in the signal transduction pathway implicated in apoptotic cell death triggered by cellular stresses."
https://pharos.nih.gov/idg/targets/Q8N4C8,Q8N4C8,25747578,"MINK plays a functional role in the IRES-mediated translation of EV71 viral RNA and may provide a potential target for the development of specific antiviral strategies against EV71 infection"
https://pharos.nih.gov/idg/targets/Q8N4C8,Q8N4C8,22665485,"Misshapen-like kinase 1 (MINK1) is a novel component of striatin-interacting phosphatase and kinase (STRIPAK) and is required for the completion of cytokinesis."
https://pharos.nih.gov/idg/targets/Q8N4C8,Q8N4C8,22037766,"MINK1 interacts with and phosphorylates PRICKLE1 and PRICKLE2."
https://pharos.nih.gov/idg/targets/Q8N4C8,Q8N4C8,21048137,"MINK interaction with Rap2 plays a critical role in maintaining the morphological integrity of dendrites and synaptic transmission."
https://pharos.nih.gov/idg/targets/Q8N4C8,Q8N4C8,18752142,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8N4C8,Q8N4C8,17165161,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8N4C8,Q8N4C8,16760206,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8N4C8,Q8N4C8,15469942,"results suggest that human Misshapen/NIKs-related kinase beta (hMINK beta) plays an important role in cytoskeleton reorganization, cell adhesion, and cell motility(hMINKbeta)"
https://pharos.nih.gov/idg/targets/Q8N4C8,Q8N4C8,12668260,"Analysis of the coding region of the NIK gene in progressive supranuclear palsy (PSP) patients through single strand conformation polymorphism and direct sequencing does not support a pathogenic role of the NIK gene in PSP."
https://pharos.nih.gov/idg/targets/Q8NEV4,Q8NEV4,27582493,"MYO3A is more efficient than MYO3B at increasing formation and elongation of stable microvilli on the surface of cultured epithelial cells."
https://pharos.nih.gov/idg/targets/Q8NEV4,Q8NEV4,27063751,"A homozygous mutation, MYO3A:c.1841C>T (p.S614F), was identified to be responsible for non-syndromic congenital deafness in two members of a Kazakh family in China."
https://pharos.nih.gov/idg/targets/Q8NEV4,Q8NEV4,26841241,"Study reports an amino acid substitution in MYO3A motor-head domain disrupting its ATPase activity that can cause autosomal dominant progressive hereditary hearing loss. Also, these results uncovered a novel interaction between MYO3A and PCDH15 shedding new light on the function of myosin IIIA at stereocilia tips."
https://pharos.nih.gov/idg/targets/Q8NEV4,Q8NEV4,26785147,"The structures of Myo3 in complex with Espin1 not only elucidate the mechanism of the binding, but also reveal a Myo3-induced release of Espin1 auto-inhibition mechanism."
https://pharos.nih.gov/idg/targets/Q8NEV4,Q8NEV4,25402663,"Data suggest that, in enterocytes, MYO3A autophosphorylation of kinase domain at Thr184/Thr188 regulates kinase activity, translocation of MYO3A to tips of microvilli, and stability of actin cytoskeleton."
https://pharos.nih.gov/idg/targets/Q8NEV4,Q8NEV4,24214986,"The differential regulation of the kinase and motor activities allows for MYO3A to precisely self-regulate its concentration in the actin bundle-based structures of cells."
https://pharos.nih.gov/idg/targets/Q8NEV4,Q8NEV4,20826793,"Results suggest that Myo3A motor activity is regulated through a mechanism involving concentration-dependent autophosphorylation."
https://pharos.nih.gov/idg/targets/Q8NEV4,Q8NEV4,20610541,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8NEV4,Q8NEV4,20090771,"Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8NEV4,Q8NEV4,19229853,"behavioral inhibition-associated SNPs appear to be associated with differences in MYO3A- but not GAD2 lymphoblastoid-mRNA expression levels"
https://pharos.nih.gov/idg/targets/Q8NEV4,Q8NEV4,19229853,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8NEV4,Q8NEV4,18229949,"A model in which the activity and concentration of myosin IIIA localized to the tips of actin bundles mediates the morphology of the tips in sensory cells."
https://pharos.nih.gov/idg/targets/Q8NEV4,Q8NEV4,17074769,"the actomyosin-ADP state may be important for the ability of myosin III to function as a cellular transporter and actin cross-linker in the actin bundles of sensory cells"
https://pharos.nih.gov/idg/targets/Q8NEV4,Q8NEV4,17012748,"myosin IIIA can spend a majority of its ATP hydrolysis cycling time on actin"
https://pharos.nih.gov/idg/targets/Q8NEV4,Q8NEV4,16385451,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8NEV4,Q8NEV4,12672820,"class III myosin is an actin-based motor protein having a protein kinase activity"
https://pharos.nih.gov/idg/targets/Q8NEV4,Q8NEV4,12032315,"mutation in humans causes progressive nonsyndromic hearing loss DFNB30"
https://pharos.nih.gov/idg/targets/P45985,P45985,28733031,"MKK4 activates non-canonical NFkappaB signaling by promoting NFkappaB2-p100 processing."
https://pharos.nih.gov/idg/targets/P45985,P45985,28319306,"the expression level of MAP2K4 was inversely associated with the expression of miR-802 in tongue squamous cell carcinoma (TSCC) tissues; demonstration that the MAP2K4 expression was upregulated in TSCC cell lines; elevated expression of miR-802 inhibited TSCC cell viability and invasion through inhibiting MAP2K4 expression"
https://pharos.nih.gov/idg/targets/P45985,P45985,27594411,"Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression"
https://pharos.nih.gov/idg/targets/P45985,P45985,27509166,"Association between MKK4 promoter polymorphism and breast cancer risk in Kashmiri population"
https://pharos.nih.gov/idg/targets/P45985,P45985,27353001,"Manipulating the expression of both miR-222 and miR-25 influenced diverse gene expression changes in thyroid cells. Increased expression of miR-25 reduced MEK4 and TRAIL protein expression, and cell adhesion and apoptosis are important aspects of miR-25 functioning in thyroid cells."
https://pharos.nih.gov/idg/targets/P45985,P45985,27173611,"These results suggest that ROCK may be important in IL-1-induced signaling through MKK4 to JNK and the activation of p38 MAPK."
https://pharos.nih.gov/idg/targets/P45985,P45985,26856463,"In Chinese Han ischemic stroke patients rs3826392 C/A genotype carriers showed significantly higher IL-1b serum levels."
https://pharos.nih.gov/idg/targets/P45985,P45985,26554761,"the presence of the -1304T > G polymorphism is likely to decrease risk of cancer (Meta-Analysis)"
https://pharos.nih.gov/idg/targets/P45985,P45985,26080319,"The plasma level of protein MAP2K4 was found to suggestively associate negatively with the volume of the left entorhinal cortex in asymptomatic older twins."
https://pharos.nih.gov/idg/targets/P45985,P45985,26028649,"MKK4 is activated in vitro by reduced Trx but not oxidized Trx in the absence of an upstream kinase, suggesting that autophosphorylation of this protein occurs due to reduction of Cys-246 and Cys-266 by Trx."
https://pharos.nih.gov/idg/targets/P45985,P45985,25732927,"Data suggest a genetic interaction between MAP2K4 and HLA-DRB1, and the importance of rs10468473 and MAP2K4 splice variants in the development of autoantibody-positive RA."
https://pharos.nih.gov/idg/targets/P45985,P45985,25244576,"knockdown of Sec8 enhances the binding of JIP4 to MAPK kinase 4, thereby decreasing the phosphorylation of MAPK kinase 4, JNK, and p38."
https://pharos.nih.gov/idg/targets/P45985,P45985,25019290,"MAP2K4 increases human prostate cancer metastasis, and prolonged over expression induces long term changes in cell signaling pathways leading to independence from p38 MAPK and JNK."
https://pharos.nih.gov/idg/targets/P45985,P45985,24721794,"Demonstrate that Mkk4 is a negative regulator of the TGF-beta1 signaling associated with atrial remodeling and arrhythmogenesis with age."
https://pharos.nih.gov/idg/targets/P45985,P45985,24556602,"MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells."
https://pharos.nih.gov/idg/targets/P45985,P45985,24532253,"Lipopolysaccharide induced miR-181a promotes pancreatic cancer cell migration via targeting PTEN and MAP2K4."
https://pharos.nih.gov/idg/targets/P45985,P45985,23960075,"Arrestin-3 directly interacts with MKK7 and promotes JNK3alpha2 phosphorylation by both MKK4 and MKK7 in vitro as well as in intact cells."
https://pharos.nih.gov/idg/targets/P45985,P45985,23921907,"Single nucleotide polymorphisms in MAP2K4 gene is associated with gastric cancer."
https://pharos.nih.gov/idg/targets/P45985,P45985,23653187,"If both p53 and the SAPKK MKK4 are simultaneously inactivated, persistent polo-like kinase 4 activity combined with the lack of SAPK-mediated inhibition of centrosome duplication conspire to induce supernumerary centrosomes under stress."
https://pharos.nih.gov/idg/targets/P45985,P45985,23355465,"MicroRNA-92a negatively regulates Toll-like receptor (TLR)-triggered inflammatory response in macrophages by targeting MKK4 kinase"
https://pharos.nih.gov/idg/targets/P45985,P45985,23299404,"Rs12939944 located in the MAP2K4 intron was associated with decreased risk."
https://pharos.nih.gov/idg/targets/P45985,P45985,22828509,"Crystal structures combined with small-angle X-ray scattering experiments revealed that the apo form of non-phosphorylated MAP2K4 (npMAP2K4) exists in a transient state which has a longer conformation compared with the typical kinase folding."
https://pharos.nih.gov/idg/targets/P45985,P45985,22730327,"SEPW1 silencing increases MKK4, which activates p38gamma, p38delta, and JNK2 to phosphorylate p53 on Ser-33 and cause a transient G(1) arrest."
https://pharos.nih.gov/idg/targets/P45985,P45985,22526163,"Results suggest that the functional -1304G variant in the MKK4 promoter decreases the risk of PCa by increasing the promoter activity."
https://pharos.nih.gov/idg/targets/P45985,P45985,22335172,"the functional -1304G variant in the MKK4 promoter contributes to a decreased risk of cervical cancer"
https://pharos.nih.gov/idg/targets/P45985,P45985,22158075,"Suggest that in pancreatic ductal adenocarcinomas, the MKK4 protein was directly related to high cell proliferation."
https://pharos.nih.gov/idg/targets/P45985,P45985,22154358,"Data suggest aberrant MAP2K protein (MKK3, MKK4, MKK6, and MKK7) expression indicates that altered cellular signal transduction mediated via JNK and p38 may be common in bladder cancer."
https://pharos.nih.gov/idg/targets/P45985,P45985,22154052,"Overexpression of MAP2K4 in osteosarcoma was correlated with poor treatment response, disease progression and poor overall survival."
https://pharos.nih.gov/idg/targets/P45985,P45985,21925502,"Building on the foundation of daring hypotheses: using the MKK4 metastasis suppressor to develop models of dormancy and metastatic colonization."
https://pharos.nih.gov/idg/targets/P45985,P45985,21915030,"The purpose of the study was to investigate the potential contribution of HPK1, MEKK1, TAK1, p-MKK4 to the development of extramammary Paget disease"
https://pharos.nih.gov/idg/targets/P45985,P45985,21896780,"8 out of 11 cancer-associated MAP2K4 mutations reduce MKK4 protein stability or impair its kinase activity"
https://pharos.nih.gov/idg/targets/P45985,P45985,21702039,"protective role of genetic variant MKK4 -1304T>G is restrained in nasopharyngeal carcinoma (NPC) with Epstein-Barr Virus (EBV) infection. These findings implicate the role of EBV and MKK4 -1304 T>G interaction as a causative factor for the NPC."
https://pharos.nih.gov/idg/targets/P45985,P45985,21638028,"MKK4 was identified as playing a key role in Tau-S422 phosphorylation in human neuroblastoma cells."
https://pharos.nih.gov/idg/targets/P45985,P45985,21575258,"MAP2K4 is targeted by genetic inactivation in ovarian cancer and restricted to high grade serous and endometrioid carcinomas in our cohort."
https://pharos.nih.gov/idg/targets/P45985,P45985,21518142,"Compared with the -1304TT genotype, patients with the -1304TG genotype had a significantly decreased risk of acute myeloid leukemia"
https://pharos.nih.gov/idg/targets/P45985,P45985,21487811,"These results indicated that MKK4 acts as a tumor suppressor and may represent an important therapeutic target for the treatment of ovarian cancer"
https://pharos.nih.gov/idg/targets/P45985,P45985,21372598,"Loss of MKK4 expression is associated with endometrial cancer."
https://pharos.nih.gov/idg/targets/P45985,P45985,21048031,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P45985,P45985,21030692,"These results suggest that JNK affects the association of alpha-catenin with the adherens junction complex and regulates adherens junctions."
https://pharos.nih.gov/idg/targets/P45985,P45985,20732303,"the crystal structures of human non-phosphorylated MKK4 kinase domain (npMKK4) complexed with AMP-PNP (npMKK4/AMP) and a ternary complex of npMKK4, AMP-PNP and p38alpha peptide (npMKK4/AMP/p38) were determined."
https://pharos.nih.gov/idg/targets/P45985,P45985,20554746,"Functional -1304G variant in the MKK4 promoter contributes to a decreased risk of lung cancer by increasing the promoter activity."
https://pharos.nih.gov/idg/targets/P45985,P45985,20554746,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P45985,P45985,20309881,"Data indicate that MKK4 gene knockdown in MDAH2774 cells over-expressing MKK4 increased invasion activity."
https://pharos.nih.gov/idg/targets/P45985,P45985,20156194,"Filamin A is a scaffold protein whose function is to link MKK4 and MKK7 together and promote JNK1 activation."
https://pharos.nih.gov/idg/targets/P45985,P45985,19861690,"Elevated MKK4 abundance inhibited cell proliferation and increased the phosphorylation and activity of p38 and PRAK. Thus, multiple microRNAs acting on a single target, the MKK4 mRNA, collectively influence MKK4 abundance during replicative senescence"
https://pharos.nih.gov/idg/targets/P45985,P45985,19638505,"We identified MEK4 as a proinvasion protein in six human prostate cancer cell lines and the target for genistein."
https://pharos.nih.gov/idg/targets/P45985,P45985,19610067,"Polymorphism in the promoter of MKK4 gene is associated with colorectal cancer."
https://pharos.nih.gov/idg/targets/P45985,P45985,19610067,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P45985,P45985,19513509,"Overexpression of mitogen-activated protein kinase kinase 4 and nuclear factor-kappaB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis."
https://pharos.nih.gov/idg/targets/P45985,P45985,19351817,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P45985,P45985,19351724,"An Ask1-MKK4-p38MAPK/JNK pathway reflects adipocyte stress associated with adipose tissue inflammation, linking visceral adiposity to whole-body insulin resistance in obesity."
https://pharos.nih.gov/idg/targets/P45985,P45985,19265040,"Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth."
https://pharos.nih.gov/idg/targets/P45985,P45985,19012245,"multiple copy number alterations in chromosome regions implicated in malignancy progression and indicated a strong expression of MAP2K4 and MCL1 genes in rhabdomyosarcoma"
https://pharos.nih.gov/idg/targets/P45985,P45985,19001375,"the molecular interactions of arrestin2 and arrestin3 and their individual domains with the components of the two MAPK cascades, ASK1-MKK4-JNK3 and c-Raf-1-MEK1-ERK2"
https://pharos.nih.gov/idg/targets/P45985,P45985,18713996,"JNK is differentially regulated by MKK4 and MKK7 depending on the stimulus."
https://pharos.nih.gov/idg/targets/P45985,P45985,18436711,"Disruption of signaling through MKK4 yields differential response in hypoxic colon cancer cells treated with oxaliplatin."
https://pharos.nih.gov/idg/targets/P45985,P45985,18408005,"JNK3 recruits MKK4 to the beta-arrestin-2 scaffold complex by binding to the MAPK docking domain (D-domain) located within the N terminus of MKK4."
https://pharos.nih.gov/idg/targets/P45985,P45985,18337456,"Cytosolic mRNA is shifted toward active polysomes in prostate tumor cells with higher levels of MKK4 protein, suggesting that MKK4 mRNA is translated more efficiently in these cells."
https://pharos.nih.gov/idg/targets/P45985,P45985,17675521,"PF4-stimulated immediate monocyte functions (oxygen radical formation) are regulated by p38 MAPK, Syk, and PI3K, whereas delayed functions (survival and cytokine expression) are controlled by Erk and JNK."
https://pharos.nih.gov/idg/targets/P45985,P45985,17389591,"TNF-induced TRAF2-RIP1-AIP1-ASK1 complex formation and for the activation of ASK1-JNK/p38 apoptotic signaling."
https://pharos.nih.gov/idg/targets/P45985,P45985,17322004,"The results suggest that JNK regulates human iNOS expression by stabilizing iNOS mRNA possibly by a tristetraprolin -dependent mechanism."
https://pharos.nih.gov/idg/targets/P45985,P45985,17178861,"LMP1-mediated DNA methyltransferase-1 (DNMT1) activation involves JN kinase."
https://pharos.nih.gov/idg/targets/P45985,P45985,17158870,"MKK4 decreases phosphatase and tensin homologue deleted from chromosome 10 (PTEN) and promotes survival in non-small-cell lung cancer (NSCLC) cells."
https://pharos.nih.gov/idg/targets/P45985,P45985,17009014,"Phosphorylated forms of MKK4, JNK, and c-Jun were detected in salivary infiltrating mononuclear cells in Sjogren's syndrome patients"
https://pharos.nih.gov/idg/targets/P45985,P45985,16964394,"p38 MAPK and JNK pathways play an important role in VEGF secretion from malignant glioma cells under normoxic conditions."
https://pharos.nih.gov/idg/targets/P45985,P45985,16802349,"JNK (c-Jun N-terminal kinase) function might be modulated by targeting MKK-7 to suppress cytokine-mediated fibroblast-like synoviocytes (FLS) activation while leaving other stress responses intact."
https://pharos.nih.gov/idg/targets/P45985,P45985,16709574,"Bax is phosphorylated by stress-activated JNK and/or p38 kinase and phosphorylation of Bax leads to mitochondrial translocation prior to apoptosis"
https://pharos.nih.gov/idg/targets/P45985,P45985,16627982,"Homozygous deletion or reduced expression of MKK4 may contribute to the development of ovarian serous carcinoma."
https://pharos.nih.gov/idg/targets/P45985,P45985,16388335,"The present study demonstrates that HSP cells compared to controls are more sensitive to DNA damages induced by H2O2 treatment, and that JNK phosphorylation levels are increased in HSP fibroblasts after hydrogen peroxide and serum stimuli."
https://pharos.nih.gov/idg/targets/P45985,P45985,16339111,"These results indicate that SPC stimulates the proliferation of hADSCs through the Gi/Go-PLC-JNK pathway and that LPA receptors may be responsible in part for the SPC-induced proliferation"
https://pharos.nih.gov/idg/targets/P45985,P45985,16197369,"an independent role for p38 MAPK and JNK in LPA-induced IL-8 expression and secretion via NF-kappaB and AP-1 transcription respectively in human bronchial epithelial cells."
https://pharos.nih.gov/idg/targets/P45985,P45985,16167336,"Our results demonstrate that radioresistance of Saos2 osteosarcoma cells is due to NFkappaB-mediated inhibition of JNK"
https://pharos.nih.gov/idg/targets/P45985,P45985,15911620,"JIP1 and JIP3, have a cross-talk that leads to the regulation of the ASK1-SEK1-JNK signal during glucose deprivation; cross-talk between JIP3 and JIP1 is mediated through SEK1-JNK2 and Akt1."
https://pharos.nih.gov/idg/targets/P45985,P45985,15737736,"Pharmacological inhibition of oxidative stress diminished the elevated p38, JNK activity and PARP cleavage, and enhanced PD cybrid viability."
https://pharos.nih.gov/idg/targets/P45985,P45985,15670787,"Taken together, our data suggested that the JNK/c-Jun signaling cascade plays a crucial role in Cd-induced neuronal cell apoptosis and provides a molecular linkage between oxidative stress and neuronal apoptosis."
https://pharos.nih.gov/idg/targets/P45985,P45985,15623633,"Loss of Mkk4 protein expression is associated with pancreatic carcinoma progression"
https://pharos.nih.gov/idg/targets/P45985,P45985,15592684,"Our investigations revealed significantly reduced mRNA expression of metastases suppressor gene Mkk4 in breast cancer brain metastasis."
https://pharos.nih.gov/idg/targets/P45985,P45985,15496400,"CYLD has a role in megative regulation of JNK signaling"
https://pharos.nih.gov/idg/targets/P45985,P45985,15328343,"PP5 plays an important role in the survival of cells in a low oxygen environment by suppressing a hypoxia-induced ASK-1/MKK4/JNK signaling cascade that promotes an apoptotic response"
https://pharos.nih.gov/idg/targets/P45985,P45985,15262961,"AP-1 and JNK have roles in reactive oxygen species activation in tobacco-induced mucin production in lung cells"
https://pharos.nih.gov/idg/targets/P45985,P45985,15256484,"save th"
https://pharos.nih.gov/idg/targets/P45985,P45985,14716300,"Apoptosis signaling triggered by ascididemin is routed via CASP2 and JNKK to mitochondria."
https://pharos.nih.gov/idg/targets/P45985,P45985,14661062,"MMP-9 inhibition activity of resveratrol and its inhibition of JNK and PKC-delta may have a therapeutic potential in cancer."
https://pharos.nih.gov/idg/targets/P45985,P45985,14511403,"JNK and p38 MAPK activities in UVA-induced signaling pathways leading to AP-1 activation and c-Fos expression"
https://pharos.nih.gov/idg/targets/P45985,P45985,13130464,"JNK, MKK-4, and MKK-7 form an active signaling complex in rheumatoid arthritis and this novel JNK signalsome is activated in response to IL-1 and migrates to the nucleus"
https://pharos.nih.gov/idg/targets/P45985,P45985,12788955,"docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates"
https://pharos.nih.gov/idg/targets/P45985,P45985,12730213,"regulation of fibroblast functions important for wound healing by basal JNK activity"
https://pharos.nih.gov/idg/targets/P45985,P45985,12714585,"in the setting of wild-type PTEN, PI3K- and MKK4/JNK-dependent pathways cooperate to maintain cell survival."
https://pharos.nih.gov/idg/targets/P45985,P45985,12456688,"Ubiquitylation of MEKK1 inhibits its phosphorylation of MKK1 and MKK4 and activation of the ERK1/2 and JNK pathways"
https://pharos.nih.gov/idg/targets/P45985,P45985,12368275,"Jun N-terminal kinase has a role in IL-4 induction"
https://pharos.nih.gov/idg/targets/P45985,P45985,12223490,"JNK-dependent phosphorylation and thus inactivation of Mcl-1 may be one of the mechanisms through which oxidative stress induces cellular damage"
https://pharos.nih.gov/idg/targets/P45985,P45985,11754110,"There appears to be consistent rate of genetic inactivation of MAP2K4 among most tumor types, including breast cancer."
https://pharos.nih.gov/idg/targets/Q56UN5,Q56UN5,27935962,"Mitogen-activated protein kinase kinase kinase 19 (MAP3K19) is overexpressed in the lungs of chronic obstructive pulmonary disease (COPD) patients."
https://pharos.nih.gov/idg/targets/P46734,P46734,28628118,"High MKK3 expression is associated with lung cancer."
https://pharos.nih.gov/idg/targets/P46734,P46734,27717867,"The study identifies MKK3 as a negative regulator of mitochondrial function and inflammatory responses to cigarette smoke and suggests that MKK3 could be a therapeutic target."
https://pharos.nih.gov/idg/targets/P46734,P46734,27418173,"The results revealed upregulation of MEK3, as well as phosphorylated MEK3 and phosphorylated p38 MAPK, in CMM patients. These results provide a \"fingerprint\" for mechanistic studies of CMM in the future and highlight the importance of MEK3-p38 MAPK activation in CMM."
https://pharos.nih.gov/idg/targets/P46734,P46734,27181679,"MEK2 was essential for the phosphorylation of MKK3/MKK6 and p38 MAPK that directly impacted on cyclin D1 expression."
https://pharos.nih.gov/idg/targets/P46734,P46734,26573508,"MKK3 overexpression upregulated the cyclin-dependent kinase inhibitors, p16 INK4A and p15 INK4B in hepatocellular carcinoma cells was Bim1, was downregulated following MKK3 overexpression."
https://pharos.nih.gov/idg/targets/P46734,P46734,26149640,"miR-21 targets MKK3 in vivo and in vitro, inhibiting the downstream factors IL-6 and TNF-alpha, in ischemia pretreatment protection from ischemia-reperfusion induced kidney injury."
https://pharos.nih.gov/idg/targets/P46734,P46734,24742347,"The interaction of HIV-1 Tat with cellular transcription factors CDK9 and Sp1 is required for Tat activation of MAP2K3-, MAP2K6-, and IRF7-mediated luciferase transcription"
https://pharos.nih.gov/idg/targets/P46734,P46734,24487387,"study detected higher MKK3 activation in isolated peripheral blood mononuclear cells from septic patients compared with nonseptic controls"
https://pharos.nih.gov/idg/targets/P46734,P46734,24480516,"Our results suggest that asthma is associated with MKK3 over-expression in CD8+ cells; we have also demonstrated that MKK3 may be critical for airway neutrophilia"
https://pharos.nih.gov/idg/targets/P46734,P46734,24112539,"MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3."
https://pharos.nih.gov/idg/targets/P46734,P46734,23825110,"study concludes MAP2K3 is a reproducible obesity locus that may affect body weight via complex mechanisms involving appetite regulation and hypothalamic inflammation"
https://pharos.nih.gov/idg/targets/P46734,P46734,23535064,"The interaction of HIV-1 Tat with cellular transcription factors CDK9 and Sp1 is required for Tat activation of MAP2K3-, MAP2K6-, and IRF7-mediated luciferase transcription"
https://pharos.nih.gov/idg/targets/P46734,P46734,22696064,"miR-20a acts in a feedback loop to repress the expression of MKK3 and to negatively regulate the p38 pathway-mediated VEGF-induced endothelial cell migration and angiogenesis"
https://pharos.nih.gov/idg/targets/P46734,P46734,22164285,"the balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC"
https://pharos.nih.gov/idg/targets/P46734,P46734,22154358,"Data suggest aberrant MAP2K protein (MKK3, MKK4, MKK6, and MKK7) expression indicates that altered cellular signal transduction mediated via JNK and p38 may be common in bladder cancer."
https://pharos.nih.gov/idg/targets/P46734,P46734,21368234,"The p38 MAPK pathway transgene is dispensable for the development of natural killer (NK)T cells; however, NKT cell cytokine production and NKT-mediated liver damage are highly dependent on activation of this pathway."
https://pharos.nih.gov/idg/targets/P46734,P46734,21206905,"LFA-1-induced stabilization of ARE-containing mRNAs in T cells is dependent on HuR, and occurs through the Vav-1, Rac1/2, MKK3 and p38MAPK signaling cascade"
https://pharos.nih.gov/idg/targets/P46734,P46734,21137025,"MAP2K3 is identified as a protein to promote senescence in human breast epithelial cells."
https://pharos.nih.gov/idg/targets/P46734,P46734,21048031,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P46734,P46734,20805296,"Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P46734,P46734,19672773,"Data provide evidence that p38 Map kinase (MAPK) pathway is activated leading to increased upregulation of mixed lineage kinase 3, MKK3/6, MSK1, and Mapkapk2, upon treatment of BCR/ABL expressing cells with dasatinib."
https://pharos.nih.gov/idg/targets/P46734,P46734,19047046,"as a mediator of SF- and Src-stimulated NF-kappaB activity. Finally, the Src/Rac1/MKK3/6/p38 and Src/TAK1/NF-kappaB-inducing kinase pathways exhibited cross-talk at the level of MKK3."
https://pharos.nih.gov/idg/targets/P46734,P46734,17438131,"Cytokine activation of MAPK14 and apoptosis is opposed by ACTN4 targeting of protein phosphatase 2A for site-specific dephosphorylation of MEK3."
https://pharos.nih.gov/idg/targets/P46734,P46734,17406030,"Mitogen-activated protein kinase (MAPK) kinase 3 (MKK3) is a key activator of p38 MAPK in glioma; MKK3 activation is strongly correlated with p38 activation in vitro and in vivo."
https://pharos.nih.gov/idg/targets/P46734,P46734,16709574,"Bax is phosphorylated by stress-activated JNK and/or p38 kinase and phosphorylation of Bax leads to mitochondrial translocation prior to apoptosis"
https://pharos.nih.gov/idg/targets/P46734,P46734,15797859,"p38 mediates EGF receptor activation after oxidant injury; Src activates MMK3, which, in turn, activates p38; and the EGF receptor signaling pathway plays a critical role in renal epithelial cell dedifferentiation"
https://pharos.nih.gov/idg/targets/P46734,P46734,15778394,"MKK3 and MKK6 make individual contributions to p38 activation in fibroblast-like synoviocytes after cytokine stimulation"
https://pharos.nih.gov/idg/targets/P46734,P46734,15677464,"H-Ras-specific activation of Rac-MKK3/6-p38 pathway has a role in invasion and migration of breast epithelial cells"
https://pharos.nih.gov/idg/targets/P46734,P46734,15516490,"MAP kinase kinase3- and 6-dependent activation of the alpha-isoform of p38 MAP kinase is required for the cytoskeletal changes induced by neutrophil adherence and influences subsequent neutrophil migration toward endothelial cell junctions"
https://pharos.nih.gov/idg/targets/P46734,P46734,15375157,"a specific requirement for p150(Glued)/dynein/functional microtubules in activation of MKK3/6 and p38 MAPKs in vivo."
https://pharos.nih.gov/idg/targets/P46734,P46734,13679851,"MKK3 is selectively activated by the new subfamily of Ste20-like kinases."
https://pharos.nih.gov/idg/targets/P46734,P46734,12589052,"TAK1- and MKK3-mediated activation of p38 are facilitated by Smad7"
https://pharos.nih.gov/idg/targets/P46734,P46734,12377770,"role in pathway that promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells"
https://pharos.nih.gov/idg/targets/P46734,P46734,12054652,"interacts with phospholipase c-beta 2"
https://pharos.nih.gov/idg/targets/P46734,P46734,11980910,"role in activating Mirk protein kinase"
https://pharos.nih.gov/idg/targets/P46734,P46734,11971971,"Results show that oncogenic ras provokes premature senescence by sequentially activating the MEK-ERK and MKK3/6-p38 pathways in normal, primary cells."
https://pharos.nih.gov/idg/targets/Q9H2G2,Q9H2G2,26094769,"SLK interacts with Tpr and alpha-actinin-4 in cells, and these protein-protein interactions may control the subcellular localization and the biological activity of SLK."
https://pharos.nih.gov/idg/targets/Q9H2G2,Q9H2G2,24958772,"SLK activated ERMs, together with Galphai, are critical for the correct localization of LGN-NuMA force generator complexes and hence for proper spindle orientation."
https://pharos.nih.gov/idg/targets/Q9H2G2,Q9H2G2,23985322,"The fact that SLK (LOSK) phosphorylates only a minor isoform 1A of p150(Glued) suggests that transport and microtubule-organizing functions of dynactin are distinctly divided between the two isoforms"
https://pharos.nih.gov/idg/targets/Q9H2G2,Q9H2G2,23209304,"It was shown that lymphocyte-oriented and STE20 kinase were sufficient to restrict ezrin function to the apical domain. Both kinases were enriched in microvilli and locally activated there."
https://pharos.nih.gov/idg/targets/Q9H2G2,Q9H2G2,19525980,"Studies define an interaction between Neu and SLK signaling in the regulation of cancer cell motility."
https://pharos.nih.gov/idg/targets/Q9H2G2,Q9H2G2,18287541,"Protein kinase LOSK is required for radial microtubule organization and for the proper localization of Golgi complex in various cell types."
https://pharos.nih.gov/idg/targets/Q9H2G2,Q9H2G2,17321610,"we show that a novel isoform of SPS1-related proline alanine-rich kinase (SPAK/STE20) is involved in this inflammatory signaling cascade"
https://pharos.nih.gov/idg/targets/Q9H2G2,Q9H2G2,16837460,"v-Src-dependent down-regulation of the Ste20-like kinase SLK through casein kinase II."
https://pharos.nih.gov/idg/targets/Q9H2G2,Q9H2G2,16385451,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9H2K8,Q9H2K8,26646899,"Results show that three CpG loci within FYN were hypermethylated in obese individuals, while obesity was associated with lower methylation of CpG loci within PIWIL4 and TAOK3."
https://pharos.nih.gov/idg/targets/Q9H2K8,Q9H2K8,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q92918,Q92918,24362026,"CUL7/Fbxw8 ubiquitin ligase-mediated HPK1 degradation revealed a direct link and novel role of CUL7/Fbxw8 ubiquitin ligase in the MAPK pathway, which plays a critical role in cell proliferation and differentiation."
https://pharos.nih.gov/idg/targets/Q92918,Q92918,23460610,"HPK1 is critically involved in LFA-1-mediated polymorphonuclear neutrophils trafficking during acute inflammation."
https://pharos.nih.gov/idg/targets/Q92918,Q92918,22801218,"Pdcd4 knockdown up-regulates MAP kinase kinase kinase kinase 1 (MAP4K1) expression and increases phosphorylation of c-Jun."
https://pharos.nih.gov/idg/targets/Q92918,Q92918,22541691,"QVD and 1,25D-induced differentiation was accompanied by increased signaling by Hematopoietic Progenitor Kinase 1(HPK1), and the expression of transcription factors known to be involved in monocytic differentiation was increased."
https://pharos.nih.gov/idg/targets/Q92918,Q92918,22421156,"results indicate that uncleaved HPK1 is a positive regulator of vitamin D-induced differentiation in acute myeloid leukemia cells, but the cleaved HPK1 fragment inhibits differentiation"
https://pharos.nih.gov/idg/targets/Q92918,Q92918,22105350,"HPK1 negatively regulates T cell activation by reducing the persistence of signaling microclusters."
https://pharos.nih.gov/idg/targets/Q92918,Q92918,21915030,"The purpose of the study was to investigate the potential contribution of HPK1, MEKK1, TAK1, p-MKK4 to the development of extramammary Paget disease"
https://pharos.nih.gov/idg/targets/Q92918,Q92918,19706536,"Results suggest HPK1-mediated phosphorylation of CARMA1 as an additional regulatory mechanism tuning the NF-kappaB response upon TCR stimulation."
https://pharos.nih.gov/idg/targets/Q92918,Q92918,19141650,"Restoring wild-type HPK1 protein in pancreatic cancer cells led to the increase in p21 and p27 protein expression and cell cycle arrest. HPK1 may function as a novel tumor suppressor and its loss plays a critical role in pancreatic cancer."
https://pharos.nih.gov/idg/targets/Q92918,Q92918,17895239,"Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway"
https://pharos.nih.gov/idg/targets/Q92918,Q92918,17712048,"HPK1-C as a suppressor of antiapoptotic Bcl-2 proteins and provide a molecular basis for our understanding of CD95L-independent activation-induced cell death of lymphocytes."
https://pharos.nih.gov/idg/targets/Q92918,Q92918,17353368,"A novel negative feedback loop involves HPK-1-dependent serine phosphorylation of SLP-76 and 14-3-3 protein recruitment, which tunes T cell activation."
https://pharos.nih.gov/idg/targets/Q92918,Q92918,17024227,"Our work explains growth factor-independent survival during monocytic differentiation by caspase-mediated processing of HPK1 towards HPK1-N."
https://pharos.nih.gov/idg/targets/Q92918,Q92918,16449643,"Pdcd4 suppresses tumor progression in colon carcinoma cells by the novel mechanism of down-regulating MAP4K1 transcription, with consequent inhibition of c-Jun activation and AP-1-dependent transcription."
https://pharos.nih.gov/idg/targets/Q92918,Q92918,16341093,"suppression or activation of NFkappaB by HPK1 determines sensitivity to activation-induced cell death"
https://pharos.nih.gov/idg/targets/Q92918,Q92918,15743830,"Full activation of HPK1 is dependent on autophosphorylation of threonine 165 and phosphorylation of serine 171, which is a target site for protein kinase D (PKD) in vitro."
https://pharos.nih.gov/idg/targets/Q92918,Q92918,15364934,"PP4 is a positive regulator for HPK1 and the HPK1-JNK signaling pathway"
https://pharos.nih.gov/idg/targets/Q92918,Q92918,12522005,"The catalytic activity of a hematopoietic cell-restricted, Ste20-related S/TPK, HPK1, is positively regulated by exposure to physiological concentrations of PGE2. HPK1 is a negative regulator of PGE2-induced FOS gene transcription."
https://pharos.nih.gov/idg/targets/O14733,O14733,29037961,"Our findings indicate that GADD45 essentially suppresses the MKK7-JNK pathway and suggest that differentially expressed GADD45 family members fine-tune stress-inducible JNK activity."
https://pharos.nih.gov/idg/targets/O14733,O14733,28890347,"The latter insight is likely to promote the production of allosteric MAP2K7 inhibitors."
https://pharos.nih.gov/idg/targets/O14733,O14733,28561662,"Combination BRAF and MEK inhibition has also been shown to improve overall survival in patients with V600E-mutated melanoma. Responses to therapy are often rapid, and treatment is not associated with immune-related adverse events."
https://pharos.nih.gov/idg/targets/O14733,O14733,28263969,"MEK activation cooperates with Cdkn2a and Pten inactivation to induce melanoma"
https://pharos.nih.gov/idg/targets/O14733,O14733,28120412,"the p.Glu116Lys rare variant in MAP2K7 predisposes its carriers to develop COPD, which would provide a useful genetic biomarker for COPD susceptibility in Chinese."
https://pharos.nih.gov/idg/targets/O14733,O14733,27861856,"In an Eastern Chinese population, carriers of MAP2K7 rs3679T variant genotypes had an increased risk of NSCLC."
https://pharos.nih.gov/idg/targets/O14733,O14733,27369075,"Therefore, EGF is suggested to induce E-cadherin down-regulation at the transcriptional level through the MEK/ERK pathway, which might result in, at least in part, the induction of cellular morphological changes and cell migration in LoVo cells."
https://pharos.nih.gov/idg/targets/O14733,O14733,27028764,"We found that the MKK7 p.Glu116Lys rare polymorphism was significantly associated with lung cancer risk, progression and prognosis"
https://pharos.nih.gov/idg/targets/O14733,O14733,26987717,"Crystal structures of the wild type and C218S mutant of MAP2K7 were determined. Cys218 plays a crucial role in configuring an auto-inhibition form of MAP2K7."
https://pharos.nih.gov/idg/targets/O14733,O14733,26649302,"our study suggested that black rice anthocyanins extract suppress metastasis in breast cancer cells by targeting the RAS/RAF/MAPK pathway"
https://pharos.nih.gov/idg/targets/O14733,O14733,26443849,"a widespread role for the JNK-CELF2 axis in controlling splicing during T-cell activation, including a specific role in propagating JNK signaling."
https://pharos.nih.gov/idg/targets/O14733,O14733,26364603,"MKK7 undergoes neddylation in human breast cancer cells"
https://pharos.nih.gov/idg/targets/O14733,O14733,26351322,"combined pan-RAF and MEK inhibition can overcome intrinsic and acquired resistance to single-agent RAF/MEK inhibition, supporting dual pan-RAF and MEK inhibition as a novel therapeutic strategy for BRAF- and KRAS-mutant cancers"
https://pharos.nih.gov/idg/targets/O14733,O14733,25959272,"we explored the effects of selumetinib in combination with gefitinib in a panel of TNBC cells, in order to evaluate whether the simultaneous blockade of the EGFR and the RAS/MEK/ERK pathway might increase the antitumor activity of selumetinib in TNBC."
https://pharos.nih.gov/idg/targets/O14733,O14733,25899612,"This review will focus on the science and clinical findings related to targeted therapies that inhibit BRAF or MEK as well as the immunotherapies that block the CTLA-4 or PD-1 pathways"
https://pharos.nih.gov/idg/targets/O14733,O14733,25737554,"The crystal structure of JNK1 in complex with the second docking site of MKK7, was determined, revealing two different binding modes of the docking motif correlating with observations from NMR exchange spectroscopy."
https://pharos.nih.gov/idg/targets/O14733,O14733,25428880,"In conclusion, the expression of hepatitis B virus core protein sensitized hepatocytes to TNF-alpha-induced apoptosis by disrupting the interaction between MKK7 and RACK1."
https://pharos.nih.gov/idg/targets/O14733,O14733,25343485,"BCR-ABL promotes PTEN downregulation through a MEK dependent pathway."
https://pharos.nih.gov/idg/targets/O14733,O14733,24912525,"Activation of TAK1 by HIV-1 Vpr leads to increased levels of phosphorylated IKK-beta and MKK7 in cells"
https://pharos.nih.gov/idg/targets/O14733,O14733,24634165,"Combination of AAG8 antagonist and very low concentration of a MEK inhibitor synergistically restricts the growth of drug-resistant cells."
https://pharos.nih.gov/idg/targets/O14733,O14733,24533778,"MKK7 is a major functional target of miR-493, and its suppression thwarts liver metastasis of colon cancer cells."
https://pharos.nih.gov/idg/targets/O14733,O14733,24104474,"Gadd45B protects the liver through two entirely different processes: binding MKK7 to block damaging signal transduction or binding CAR to coactivate anabolic transcription. (Review)"
https://pharos.nih.gov/idg/targets/O14733,O14733,23900681,"downregulation of MOR may activate JNK signal transduction pathway via regulating MKK7 phosphorylation level so as to inhibit the proliferation of hepatoma carcinoma cells and cause tumor growth retardation."
https://pharos.nih.gov/idg/targets/O14733,O14733,23341463,"Data indicate that WDR62 dimerization is required for JNK2 and MKK7beta1 recruitment."
https://pharos.nih.gov/idg/targets/O14733,O14733,22903704,"Overexpressed RACK1 augments JNK activity and thereby promotes hepatocellular carcinoma growth through directly binding to MKK7 and enhancing MKK7 activity."
https://pharos.nih.gov/idg/targets/O14733,O14733,22899651,"the results imply that reduced function of the MAP2K7-c-Jun N-terminal kinase (JNK) signalling cascade may underlie some of the neurochemical changes and core symptoms in schizophrenia."
https://pharos.nih.gov/idg/targets/O14733,O14733,22509080,"Data show that HBx can induce HepG2 cell apoptosis via a novel active MLK3-MKK7-JNKs signaling module to upregulate FasL protein expression."
https://pharos.nih.gov/idg/targets/O14733,O14733,22267733,"a novel function for the stress kinase MKK7 as a regulator of the circadian clock in mammalian cells at steady state."
https://pharos.nih.gov/idg/targets/O14733,O14733,22159816,"Alpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis-diammined dichloridoplatium."
https://pharos.nih.gov/idg/targets/O14733,O14733,22154358,"Data suggest aberrant MAP2K protein (MKK3, MKK4, MKK6, and MKK7) expression indicates that altered cellular signal transduction mediated via JNK and p38 may be common in bladder cancer."
https://pharos.nih.gov/idg/targets/O14733,O14733,21749326,"WDR62 associates directly with the MKK7beta1 isoform independently of JNK binding, but fails to interact with MKK7alpha1."
https://pharos.nih.gov/idg/targets/O14733,O14733,21148294,"MKK7 works as a cytoplasmic anchoring protein for JNK1 in various cells, but exhibits aberrant nuclear entry in Jurkat cells; work suggests aberrant subcellular organization of JNK pathway may render certain tumor cells resistant to Fas-mediated apoptosis"
https://pharos.nih.gov/idg/targets/O14733,O14733,21074392,"Taxol induces apoptosis in chronic myelogenous leukemia cells by inducing intracellular oxidative stress and JNK activation pathway."
https://pharos.nih.gov/idg/targets/O14733,O14733,20156194,"Filamin A is a scaffold protein whose function is to link MKK4 and MKK7 together and promote JNK1 activation."
https://pharos.nih.gov/idg/targets/O14733,O14733,18713996,"JNK is differentially regulated by MKK4 and MKK7 depending on the stimulus."
https://pharos.nih.gov/idg/targets/O14733,O14733,18436711,"Disruption of signaling through MKK7 yields differential response in hypoxic colon cancer cells treated with oxaliplatin."
https://pharos.nih.gov/idg/targets/O14733,O14733,18343408,"The results suggest the occurrence of a large complex containing at least an MKK7-Gadd45 beta:Gadd45 beta-MKK7 tetrameric unit whose complexity could be further increased by the dimeric nature of the isolated MKK7."
https://pharos.nih.gov/idg/targets/O14733,O14733,18222647,"p38 MAPK inhibitors SB202190 and SB203580 activated JNK via MLK-3/MKK7 pathway."
https://pharos.nih.gov/idg/targets/O14733,O14733,17485467,"Association of Gadd45beta with MKK7 involves a network of interactions mediated by its putative helices alpha3 and alpha4 and loops 1 and 2"
https://pharos.nih.gov/idg/targets/O14733,O14733,16802349,"data indicate that only MKK-7 is required for JNK activation in fibroblast-like synoviocytes after cytokine stimulation"
https://pharos.nih.gov/idg/targets/O14733,O14733,16533805,"MKK7 contains three JNK-docking sites that interact to selectively bind JNK and contribute to JNK signal transmission and specificity"
https://pharos.nih.gov/idg/targets/O14733,O14733,16442502,"report the cloning of hMKK7gamma1, the human homolog of murine MKK7gamma1"
https://pharos.nih.gov/idg/targets/O14733,O14733,16243842,"Activation of TAK1 by HIV-1 Vpr leads to increased levels of phosphorylated IKK-beta and MKK7 in cells"
https://pharos.nih.gov/idg/targets/O14733,O14733,13130464,"JNK, MKK-4, and MKK-7 form an active signaling complex in rheumatoid arthritis and this novel JNK signalsome is activated in response to IL-1 and migrates to the nucleus."
https://pharos.nih.gov/idg/targets/O14733,O14733,11891214,"ML-1 activated a MAP kinase and an extracellular signal-regulated kinase (ERK)1/2 but not p38 or the c-Jun N-terminal kinase (JNK)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,28504475,"Identification of a MAP3K1 variant should prompt an evaluation for disorders of sex development in female siblings of the proband"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,28178648,"Polymorphism of MAP3K1 is associated with breast cancer."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,28029147,"SNP variants at the MAP3K1/SETD9 gene boundary associate with somatic PIK3CA variants in breast cancers."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,26237449,"CSN6 positively regulates c-Jun in a MEKK1-dependent manner"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,26050649,"BAALC conferred chemoresistance in acute myeloid leukemia cells by upregulating ATP-binding cassette proteins in an ERK-dependent manner, which can be therapeutically targeted by MEK inhibitor"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,26019450,"MiR-451 inhibited the proliferation of esophageal squamous cell carcinoma cells by targeting CDKN2D and MAP3K1 expression."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,26018553,"Mekk1 mediates p53 protein stability in the presence of Mdm2 and reduces p53 ubiquitination, suggesting an interference with Mdm2-mediated degradation of p53 by the ubiquitin-proteasome pathway."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,25899310,"There were 3 specimens with mutations in MAP3K1 (MEKK1), including two truncation mutants, T779fs and T1481fs; T1481fs encoded an unstable and nonfunctional protein when expressed in vitro."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,25529635,"We propose that the cancer risk alleles act to increase MAP3K1 expression in vivo and might promote breast cancer cell survival."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,25352737,"Single nucleotide polymorphisms in ALDOB, MAP3K1, and MEF2C are associated with cataract."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,24759887,"Results demonstrate that MAP3K1 rs889312 is closely correlated with outcome among diffuse-type gastric cancer in a Chinese population."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,24595411,"The present meta-analysis suggests that MAPKKK1 rs889312-C allele and rs16886165-G allele might be risk factors for breast cancer, especially in Europeans and Asians."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,24253898,"MAP3K1 protein expression level in breast cancer cells was higher than that in normal mammary gland cells."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,24135036,"MAP3K1 mutations tilt the balance in the sex-determining pathways by downregulating SOX9 and FGF9."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,23634849,"MAP3K1 single nucleotide polymorphism rs889312 was confirmed to be associated with breast cancer risk (P = 0.04, OR 1.15, 95% CI 1.01-1.30)."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,23225170,"FGFR2 and MAP3K1 SNPs have an additive effect on an increased risk of familial breast cancer in a South-American population."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,22468730,"We also observed that four Single Nucleotide Polymorphisms (SNPs) were associated with severe asthma"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,22110214,"High MEK1 is associated with hepatocellular carcinoma."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,21921033,"Novel phosphorylation-dependent ubiquitination of tristetraprolin by mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1) and tumor necrosis factor receptor-associated factor 2 (TRAF2)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,21364884,"Apoptosis induced by cytoskeletal disruption requires distinct domains of MEKK1."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,21152872,"The upstream molecule of the TRAIL-induced MAPK activation is MEKK, as opposed to ASK1, via the mediation of its signal through JNK/p38 in a caspase-8-dependent manner."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,21129722,"mutations in MAP3K1 that result in 46,XY DSD with partial or complete gonadal dysgenesis implicate this pathway in normal human sex determination"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,21048223,"Data show that MEKK-1 plays an integral role in IL-1beta modulation of Caco-2 TJ barrier function by regulating the activation of the canonical NF-kappaB pathway and the MLCK gene."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,20940704,"Han11 was required to allow coupling of MEKK1 to DYRK1 and HIPK2."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,20923779,"MAP/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,20809358,"MAP3K1 rs889312 polymorphism is associated with increased risk of breast cancer in BRCA1 mutation carriers"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,20809358,"Meta-analysis of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,20605201,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,20554749,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,20417875,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,20237344,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,20145138,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,20128690,"These results of MAP3K1, previously reported as an Axin1 inter-actor in c-Jun NH(2)-terminal kinase pathway, is also involved in the canonical Wnt signalling pathway and positively regulates expression of Wnt target genes."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,19843670,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,19789366,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,19617217,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,19513748,"MEKK1 may be a potential target for development of anti-invasion and metastasis drugs."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,19453261,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,19289468,"Loss of MADD expression resulted in reduced Grb2 and Sos1/2 recruitment to the TNFR1 complex and decreased Ras and MEKK1/2 activation"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,19262425,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,19232126,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,19094228,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,19028704,"FGFR2 and MAP3K1 are involved in breast cancer susceptibility and confer their effects primarily in ER+ and PR+ tumors."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,19028704,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,18984593,"IPS-1 requires TRAF6 and MEKK1 to activate NF-kappaB and mitogen-activated protein kinases that are critical for the optimal induction of type I interferons"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,18973230,"Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,18785201,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,18784253,"The activation of TORC1 through MEKK1-mediated phosphorylation, is reported."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,18521924,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,18467339,"MAP3K1 protects against acute lung injury induced by nickel."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,18437204,"Meta-analysis of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,18434448,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,18420486,"MEKK-1 mediates cytokine-induced JNK- and NF-kappaB activation, and this event is necessary for iNOS expression and cell death in pancreatic islet cells."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,18355772,"The differences in the effects of the FGFR2 and MAP3K1 SNPs between BRCA1 and BRCA2 carriers point to differences in the biology of BRCA1 and BRCA2 breast cancer tumors and confirm the distinct nature of breast cancer in BRCA1 mutation carriers."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,18355772,"Meta-analysis of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,18308848,"Signaling pathways that augment or diminish beta-cell MEKK-1 activity may aid in the generation of novel therapeutic strategies in the treatment of type 1 diabetes."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,18287093,"MEK functions to enhance GCN2-dependent eIF2alpha phosphorylation rather than suppressing dephosphorylation"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,18032450,"reduction of upstream MEKK1 signals uncovers analogous but differential roles of JNK1 and JNK2 in a biological process"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,17997823,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,17997823,"Heterozygote carriers and minor allele homozygote carriers for SNP rs889312 in the MAP3K1 gene were less likely to be lymph node positive at breast cancer diagnosis (P = 0.044) relative to major allele homozygote carriers."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,17889508,"A pathway comprising PKCs>Raf-1>MEK-1>ERK-1/-2 mediates the effect of gastrin on the CgA promoter, and strongly suggests that enhanced phosphorylation of Sp1 and CREB is crucial for CgA transactivation through the G protein-coupled CCK-B/gastrin receptor."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,17397260,"The results suggest that multiple cellular signaling pathways can reactivate the virus in a genetically homogeneous cell population. Further analysis revealed that the Raf/MEK/ERK/Ets-1 pathway mediates Ras-induced reactivation."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,17301822,"Caspase-3 and the p38alpha MAP kinase were activated during TIMP-1-induced UT-7 cells erythroid differentiation."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,16760432,"MEKK1 transmits wound signals, leading to the transcriptional activation of genes involved in Extracellular Matrix homeostasis, epithelial cell migration, and wound reepithelialization."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,16714289,"Pge2 abolished the MEKK1-induced MMP-1 promoter luciferase activity."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,16434970,"Induction of Nur77 nuclear export by MEKK1 required a prolonged MEKK1 activation and was attenuated by Akt activation. Expression of constitutively active Akt prevented MEKK1-induced Nur77 nuclear export."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,16046415,"Galpha13-induced VASP phosphorylation that involves activation of RhoA and MEKK1, phosphorylation and degradation of IkappaB, release of PKA catalytic subunit from the complex with IkappaB and NF-kappaB, and subsequent phosphorylation of VASP"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,16044153,"MEKK1 plays a key role in Bcr-Abl-induced STAT3 activation and in ES cells' capacity for LIF-independent self-renewal and may thus be involved in Bcr-Abl-mediated leukemogenesis in stem cells"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,15299005,"glutathione s-transferaase Mu suppresses MEKK1-mediated apoptosis and functions as a negative regulator of MEKK1."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,15205333,"The G(i)-Ras-MEKK1 signaling pathway mediates lysophosphatidic acid-stimulated ovarian cancer cell migration by facilitating focal adhesion kinase redistribution to focal contacts."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,14612408,"coexpression of constitutive-active MEKK1 inhibited orphan receptor TR3 transcriptional activity and TR3-induced proliferation in lung cancer cells"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,14500727,"subdomain VIII of MEKK1 is involved not only in binding to, but also in discrimination of, protein substrates"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,12878610,"Axin utilizes distinct regions for competitive MEKK1 and MEKK4 binding and JNK activation."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,12600818,"conclude that Ras regulates TNF-alpha-induced chemokine expression by activating the AP-1 pathway and enhancing transcriptional function of NF-kappaB, whereas MEKK1 activates both the AP-1 and NF-kappaB pathways"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,12584189,"MEKK1 is activated by GSK3beta"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,12456688,"Ubiquitylation of MEKK1 inhibits its phosphorylation of MKK1 and MKK4 and activation of the ERK1/2 and JNK pathways"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,12228228,"mechanism by which the MEKK1-dependent JNK/SAPK pathway is negatively regulated by PAK through phosphorylation of serine 67"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,12185592,"The difference of suppression in pancreatic cancer cells and non-pancreatic cancer cells suggested that the MEKK1 pathway mainly contributes to cell survival in pancreatic cancer cells"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,12079429,"the NOx-induced cell proliferation via activation of MEKK1 might contribute to lung tissue damage caused by NOx"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,11971971,"Results show that oncogenic ras provokes premature senescence by sequentially activating the MEK-ERK and MKK3/6-p38 pathways in normal, primary cells."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,11971970,"Results suggest that the conserved AR acetylation site contributes to a pathway governing prostate cancer cellular survival, as AR acetylation mutants are defective in MEKK1-induced apoptosis."
https://pharos.nih.gov/idg/targets/Q13233,Q13233,11903060,"Opposing roles of serine/threonine kinases MEKK1 and LOK in regulating the CD28 responsive element in T-cells"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,11782455,"caspase cleavage of MEKK1 is a dynamic regulatory mechanism that alters the subcellular distribution of MEKK1, changing its function to pro-apoptotic signaling"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,11756439,"MEK kinase 1 induces mitochondrial permeability transition leading to apoptosis"
https://pharos.nih.gov/idg/targets/Q13233,Q13233,11746500,"Modulation of human cytomegalovirus immediate early gene enhancer and promoter activity by MEKK1 is under the control of the NFkappaB/rel sites."
https://pharos.nih.gov/idg/targets/Q9P289,Q9P289,29232556,"Our work describes an MST4-ATG4B signaling axis that influences glioblastoma autophagy and malignancy"
https://pharos.nih.gov/idg/targets/Q9P289,Q9P289,28219358,"Low MST-4 expression is associated with Graves' disease."
https://pharos.nih.gov/idg/targets/Q9P289,Q9P289,25650755,"these data identify the MST4 kinase as a novel candidate to mediate human pituitary tumorigenesis in a hypoxic environment and position it as a potential therapeutic target."
https://pharos.nih.gov/idg/targets/Q9P289,Q9P289,25642822,"Findings reveal a mechanism by which TRAF6 is regulated and highlight a role for MST4 in limiting inflammatory responses."
https://pharos.nih.gov/idg/targets/Q9P289,Q9P289,25550858,"Our results suggest that MST4, STK25 and PDCD10 are upregulated in prostate cancer and may play roles in prostate tumorigenesis. MST4 may be a helpful marker for identifying prostate cancer."
https://pharos.nih.gov/idg/targets/Q9P289,Q9P289,24859810,"This study describes the key role of MST4 in facilitating the epithelial-mesenchymal transition process in hepatocellular carcinoma"
https://pharos.nih.gov/idg/targets/Q9P289,Q9P289,24374310,"Mutation of this residue was sufficient to switch the phosphorylation site preference for multiple kinases, including the serine-specific kinase PAK4 and the threonine-specific kinase MST4."
https://pharos.nih.gov/idg/targets/Q9P289,Q9P289,23889253,"In this review, the germinal center kinase III subfamily of mammalian Ste20 (sterile 20)-like group of serine/threonine protein kinases comprises Ste20-like/oxidant-stress-response kinase 1, MST3 mammalian Ste20-like kinase 3 and MST4."
https://pharos.nih.gov/idg/targets/Q9P289,Q9P289,23541896,"CCM3 forms a stable complex with MST4 in vivo to promote cell proliferation and migration synergistically in a manner dependent on MST4 kinase activity."
https://pharos.nih.gov/idg/targets/Q9P289,Q9P289,22750858,"crystal of the CCM3-MST4 C-terminal domain complex belonged to space group P4(1)2(1)2 or P4(3)2(1)2, with unit-cell parameters a = 69.10, b = 69.10, c = 117.57 A"
https://pharos.nih.gov/idg/targets/Q9P289,Q9P289,19386264,"These data define a brush border induction pathway downstream of the Lkb1/Strad/Mo25 polarization complex, yet separate from other polarity events."
https://pharos.nih.gov/idg/targets/Q9P289,Q9P289,17360971,"Results show that PDCD10 modulation of ERK signaling is mediated by MST4, and that PDCD10 may be a regulatory adaptor necessary for MST4 function, suggesting a link between cerebral cavernous malformation and the ERK-MAPK cascade via PDCD10/MST4."
https://pharos.nih.gov/idg/targets/Q9P289,Q9P289,12810671,"MST4 expression in prostate carcinoma tumor samples & cell lines correlated with tumorigenicity & AR status. Overexpression induced anchorage-independent growth & tumorigenesis.It may have a role in the signal transduction in prostate cancer progression."
https://pharos.nih.gov/idg/targets/Q9P289,Q9P289,11741893,"cloning of a germinal center iii kinase that induces apoptosis"
https://pharos.nih.gov/idg/targets/Q7L7X3,Q7L7X3,27108190,"This study reports a novel set of Dengue virus (DENV) NS1-interacting host cell proteins in the HepG2 cell line and proposes possible roles for human NEK2, TAO1, and COG1 in DENV infection."
https://pharos.nih.gov/idg/targets/Q7L7X3,Q7L7X3,24898139,"The TAO1 kinase is required for ensuring the normal congression of chromosomes. Depletion of TAO1 reduces the density of growing interphase and mitotic microtubules in human cells, showing TAO1's role in controlling microtubule dynamics."
https://pharos.nih.gov/idg/targets/Q7L7X3,Q7L7X3,23585562,"tau is a good substrate for PSK1 and PSK2 phosphorylation with mass spectrometric analysis of phosphorylated tau revealing more than 40 tau residues as targets of these kinases."
https://pharos.nih.gov/idg/targets/Q7L7X3,Q7L7X3,22075148,"Human TAO1 can phosphorylate and activate human MST2"
https://pharos.nih.gov/idg/targets/Q7L7X3,Q7L7X3,20162290,"Data do not support the notion that Tao1 is a component of the spindle checkpoint."
https://pharos.nih.gov/idg/targets/Q7L7X3,Q7L7X3,19904549,"the apparent role of the Tao1 kinase in spindle checkpoing signaling might in reality reflect an off-target effect produced by particular Tao1-directed siRNA oligonucleotides on Mad2"
https://pharos.nih.gov/idg/targets/Q7L7X3,Q7L7X3,19110211,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q7L7X3,Q7L7X3,18216281,"Spred1-MARKK binding has no effect on the activity of MARKK; therefore, it does not change microtubule (MT) stability."
https://pharos.nih.gov/idg/targets/Q7L7X3,Q7L7X3,18187620,"Knockdown of TAO kinase 1 (TAOK1) by siRNA inhibits HIV-1 replication in HeLa-derived TZM-bl cells"
https://pharos.nih.gov/idg/targets/Q7L7X3,Q7L7X3,17900936,"It is concluded that human TAO kinase 1 induces apoptosis in SH-SY5Y cells and the kinase domain is essential, but its catalytic activity seems to be dispensable in this case."
https://pharos.nih.gov/idg/targets/Q7L7X3,Q7L7X3,17417629,"Dual functions of TAO1 in regulating microtubule dynamics and checkpoint signalling may help to coordinate the establishment and monitoring of correct congression of chromosomes, thereby protecting genomic stability in human cells."
https://pharos.nih.gov/idg/targets/Q7L7X3,Q7L7X3,17396146,"TAO kinases are regulators of p38-mediated responses to DNA damage and are intermediates in the activation of p38 by ATM."
https://pharos.nih.gov/idg/targets/Q7L7X3,Q7L7X3,16407310,"Prostate-derived sterile 20-like kinase 2 (PSK2) regulates apoptotic morphology via C-Jun N-terminal kinase and Rho kinase-1"
https://pharos.nih.gov/idg/targets/Q13043,Q13043,28656802,"our results identified that mammalian sterile 20-like kinase 1 is a novel downstream target of pyruvate kinase M2, and knockdown of pyruvate kinase M2 contributes apoptosis via promoting nuclear translocation of mammalian sterile 20-like kinase 1 by enhancing Caspase-3-dependent cleavage."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,28152516,"TNFAIP8 regulates Hippo (MST1/2) signaling through its interaction with LATS1."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,28103766,"Findings indicate that long-term exposure to IM results in dysregulation of stem cell renewal-regulatory Hippo (MST1/2)/YAP signaling, and that inhibition of miR-181a using a microRNA sponge inhibitor resulted in decreased transcription of SOX2 and SALL4."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,28099921,"Data suggest that Hippo (MST1/2 protein kinases) - Yes associated protein 1 (YAP) pathway involved in carcinogenesis of pancreatic cancer and in the inhibition effect of stiehopus japonieus acidic mucopolysaccharide (SJAMP) to the proliferation of pancreatic cancer cell."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,27238285,"H-ras, via an Erk-dependent mechanism, downregulates Mst1/Mst2 activity by inducing the formation of inactive Mst1/Mst2 heterodimers."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,27125670,"Mst1 as a novel physiological negative regulator of IRF3 activation provides mechanistic insights into innate antiviral defense and potential antiviral prevention strategies."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,26457732,"STK4 was reduced in macrophages from human hepatoma patients and was inversely associated with the levels of IRAK1, IL-6, and phospho-p65 or phospho-STAT3. Serum STK4 levels were specifically decreased in HCC patients with high levels of IL-6."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,26117625,"Data indicate that two siblings with a serine/threonine kinase 4 (STK4) mutation with features of autosomal recessive (AR) hyperimmunoglobulin E syndrome and autoimmune cytopenias."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,26116501,"the kinase Mst1 controls selective CCR7-dependent functions in human mature dendritic cells."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,25367221,"The MST1/2-SAV1 complex, a core component of the Hippo pathway, promotes ciliogenesis."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,24813251,"Genetic inactivation of STK4 restores YAP1 levels, triggering cell death in hematologic malignancies."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,24633305,"Under diabetogenic conditions, MST1 was strongly activated in beta cells, and induced apoptosis via BIM upregulation, and impaired insulin secretion via phosphorylation of PDX1."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,24393845,"PHLPP1 is a binding protein for Mst1 and it modulates the Hippo pathway by dephosphorylating Mst1 at the inhibitory Thr(387) of Mst1."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,24255178,"Results indicate that changes in phosphorylation orchestrate interactions between kinases and phosphatases in Hippo (MST1/2 protein kinases) signaling, providing a putative mechanism for pathway regulation."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,23647599,"Inhibition of Mst1 kinase activation in cardiomyocytes protects against cell hypoxia."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,23419720,"Results indicated that Mst1 might be a promising anticancer target."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,22739148,"Low expression of MST1 may be related with the pathogenesis and prognosis of acute leukemia."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,22619175,"Data suggest that phosphoinositide-3-kinase/Akt and mammalian target of rapamycin (mTOR) pathway signaling differentially regulate phospho-Mst1-Thr-120/Thr-183."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,22294732,"STK4 deficiency is a novel human primary immunodeficiency syndrome."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,22174160,"MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,22112013,"Data indicate that dimerization domain of MST1 is unstructured as monomer and undergoes dimerization-induced folding. Data indicate that inhibitory domain of MST1 is disordered region both as single domain and as construct with dimerization domain."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,21730291,"Findings show a biological role for MICAL-1 in apoptosis and define a novel negative regulatory mechanism of MST-NDR signaling."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,21516123,"results show a novel PRX-I function to cause cell death in response to high levels of oxidative stress by activating MST1, which underlies the p53-dependent cytotoxicity caused by anticancer agents"
https://pharos.nih.gov/idg/targets/Q13043,Q13043,21512132,"MST1 was also found in androgen receptor (AR)-chromatin complexes, and enforced expression of MST1 reduced the binding of AR to a well-characterized, androgen-responsive region within the prostate-specific antigen promo"
https://pharos.nih.gov/idg/targets/Q13043,Q13043,21228115,"Phage microarrays containing colorectal cancer cDNA libraries were prepared to identify phage-expressed peptides recognized by tumor-specific autoantibodies from patient sera."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,21199877,"Through binding to MST1/2, RASSF1A supports maintenance of MST1/2 phosphorylation, promoting an active state of the MST kinases and favoring induction of apoptosis."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13043,Q13043,19962960,"these findings indicate that MST1 is a major determinant of RASSF2 protein stability, and suggest that RASSF2 acts in a complex manner that extends beyond simple protein-protein association to play an important role in MST1 regulation."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,19822666,"Data suggest thta MST kinases 1/2 serve to monitor cytoskeletal integrity and couple the JNK1/SAPK1 pathway to the regulation of the cell cycle regulatory protein p21Waf1."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,19062280,"findings identify NDR1/2 as novel proapoptotic kinases and key members of the RASSF1A/MST1 signaling cascade"
https://pharos.nih.gov/idg/targets/Q13043,Q13043,18986304,"Mst1 is a novel mediator of cardiac troponin I phosphorylation in the heart and may contribute to the modulation of myofilament function under a variety of physiological and pathophysiological conditions"
https://pharos.nih.gov/idg/targets/Q13043,Q13043,18510339,"Studies provide new insights into how MST1 substrate selectivity is modulated with implications for understanding apoptotic signaling through MST1 kinase."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,17932490,"Mst1 and its caspase cleavage products are direct inhibitors of Akt"
https://pharos.nih.gov/idg/targets/Q13043,Q13043,17726016,"Akt blocks MstI-triggered FOXO3 nuclear translocation by phosphorylating MstI, promoting cell survival."
https://pharos.nih.gov/idg/targets/Q13043,Q13043,17538946,"our results suggest that alteration of the Sav-RASSF1-Hpo tumor suppressor pathway may occur through hypermethylation of the CpG island promoter of MST1, MST2 and/or RASSF1A in human sarcomas"
https://pharos.nih.gov/idg/targets/Q13043,Q13043,15157167,"Mammalian Sterile20-like kinase 1 has a role in the regulation of apoptosis [review]"
https://pharos.nih.gov/idg/targets/Q13043,Q13043,12384512,"promotion of MST1-induced apoptosis by DAP4 by enabling colocalization of MST with p53"
https://pharos.nih.gov/idg/targets/Q13043,Q13043,11964314,"Caspase-catalyzed cleavage and activation of Mst1 correlates with eosinophil but not neutrophil apoptosis."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,29146188,"Our findings offer an insight for the new drug development of PAK1 inhibitor. We also provide a possible explanation for the phenomenon that the application of the chlorhexidine in peritoneal lavage inhibited the development of tumor."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,28753606,"Short-term treatment of nascent melanoma tumors with PAK inhibitors that block RhoJ signaling halts the growth of BRAF mutant melanoma tumors in vivo and induces apoptosis in melanoma cells in vitro via a BAD-dependent mechanism"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,28692051,"Results from our analysis showed that Pak1 overexpression, knockdown and Pak1 knockout cell line models showed that Pak1 confers protection to keratinocytes from UV-B-induced apoptosis and DNA damage via ATR."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,28278510,"autocrine VEGF and IL-8 promoted endothelial cell migration via the Src/Vav2/Rac1/PAK1 signaling pathway."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,28202661,"Given the central role of p21-Activated kinase 1 (PAK1) in vital signaling pathways, studies suggest that clinical development of PAK1 inhibitors will require careful investigation of their safety and efficacy."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,28186966,"this study shows that PAK1 may be a potential tumor marker and therapeutic target of prostate cancer"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,28055013,"the expression of PAK1 is inversely correlated with the level of miR-494 in human breast cancer samples. Furthermore, re-expression of PAK1 partially reverses miR-494-mediated proliferative and clonogenic inhibition as well as migration and invasion suppression in breast cancer cells"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,28052407,"The role of PAK1 in cancer drug resistance in BRAF-mutated cancer"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,27997893,"1alpha,25-Dihydroxy-Vitamin D3 leads to disruption of RAC1 and PAK1 activity with subsequent actin depolymerization of endometrial carcinoma cells."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,27913610,"Study acts as a further supplement of the genetic features of neuroendocrine tumors. Somatic mutations of three potential tumor-related genes (HRAS, PAK1 and MEN1) might contribute to the tumorigenesis of thymic neuroendocrine tumors with EAS."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,27542844,"These data provide insight into the mechanisms guiding PRL-mediated breast cancer cell motility and invasion and highlight a significant role for phosphoTyr-PAK1 in breast cancer metastasis."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,27474226,"Abnormalities in the PAK1 and PAK3 mRNA levels as well as their altered coexpression patterns were observed in the postmortem brain of subjects with depression. Dysregulated PAK1/PAK3 dependent signaling may be a key factor responsible for volumetric abnormalities observed in the hippocampus and in the prefrontal cortex in depression resulting in altered connectivity of these regions."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,27430434,"miR7 negatively regulates PAK1 protein expression but has no effect on PAK1 mRNA expression. Knockdown of PAK1 expression markedly suppressed thyroid cancer cell proliferation, migration and invasion."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,27260988,"The effect of PAK1 modulation on tumorigenesis, and on resistance to treatment with 5-fluorouracil (5-FU), was measured by sphere formation in vitro and by growth of xenografted tumors in vivo. The results show that PAK1 activity correlated with the expression of CSC markers and the CD44 isoform profile, and with tumor growth both in vitro and in vivo."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,27229476,"Our study revealed that PAK1 may play a crucial role in the progression of OSCC. Studying the role of PAK1 and its substrates is likely to enhance our understanding of oral carcinogenesis and potential therapeutic value of PAKs in oral cancer."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,27178741,"PAK1 confers TKI resistance in EGFR-mutant cells as well as in EGFR-wild-type cells."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,27122002,"Myricetin effectively suppressed the protein expression of p21-activated kinase 1 (PAK1)."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,27121078,"the oxidative stress-induced down-regulation of PAK1 activity could be involved in the loss of mesencephalic dopaminergic neurons."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,27117533,"To our knowledge, this is the first study illustrating the mechanistic role of Pak1 in causing gemcitabine resistance via multiple signaling crosstalks, and hence Pak1-specific inhibitors will prove to be a better adjuvant with existing chemotherapy modality for pancreatic ductal adenocarcinoma (PDAC)"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,27060895,"High p21-activated kinase 1 and cell division control protein 42 homolog expressions are closely related to the clinicopathological features and poor prognosis of cervical carcinoma, serving as unfavorable prognostic factors."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,27056567,"Pak1 expression is not associated with breast cancer recurrence and resistance to tamoxifen."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,27044328,"VEGF-induced angiogenesis and vascular permeability are inhibited by BET bromodomain suppression through blocking of VEGFR2-mediated activation of PAK1 and eNOS"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,27027431,"Studies indicate that PAK1 expression may be a predictive marker of overall survival and disease-specific survival in patients with solid tumors."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,27012601,"Data show association of G protein-coupled receptor kinase-interacting protein 1 (GIT1), p21-activated kinase interacting exchange factor (betaPIX), and p21 protein (Cdc42/Rac)-activated kinase 1 (PAK1) with centrosomes."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,27003261,"PAK1 nuclear translocation is ligand-dependent: only PRL but not E2 stimulated PAK1 nuclear translocation"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26944939,"these data strongly support a critical interplay between prolactin and estrogen via PAK1 and suggest that ligand-independent activation of ERalpha through prolactin/PAK1 may impart resistance to anti-estrogen therapies."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26918678,"PAK1-cofilin phosphorylation mechanism to mediate lung adenocarcinoma cells migration promoted by apelin-13"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26898755,"Our results from clinical samples also suggest that Threonine 209 phosphorylation by Pak1 could be a potential therapeutic target and of great clinical relevance with implications for Runx3 inactivation in cancer cells where Runx3 is known to be oncogenic. The findings presented in this study provide evidence of Runx3-Threonine 209 phosphorylation as a molecular switch in dictating the tissue-specific dualistic functions"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26884861,"PAK-1 overexpression may be involved in colorectal carcinoma progression and could be considered an independent predictor of disease recurrence."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26809475,"Formation of filopodia by membrane glycoprotein M6a (Gpm6a) requires actin regulator coronin-1a (Coro1a), known to regulate plasma membrane localization and activation of Rac1 and its downstream effector Pak1."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26774265,"Combination of a PAK1 inhibitor such as FRAX597 with cytotoxic chemotherapy deserves further study as a novel therapeutic approach to pancreatic cancer treatment."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26547035,"Data indicate that NOTCH1 receptor intracellular domain (NOTCH1-IC) physically interacts with serine-threonine-protein kinase PAK 1 (PAK1) in intact cells."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26423403,"overexpression of PAK1, NEK6, AURKA, and AURKB genes in patients with Colorectal adenomatous polyp and colorectal cancer in the Turkish population."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26379399,"beta-elemene enhances radiosensitivity of gastric cancer cells by inhibiting Pak1 signaling."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26377044,"These findings indicate that genetic variants in PAK1 gene may contribute to susceptibility to lung cancer in the Chinese population."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26324182,"p120 participates in the progress of gastric cancer through regulating Rac1 and Pak1."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26257058,"These findings suggest that small-molecule inhibitors of Pak1 may have a therapeutic role in the ~25% of ovarian cancers characterized by PAK1 gene amplification."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26255026,"Cx43 increases serum induced filopodia formation via activation of p21-activated protein kinase 1."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26218748,"Pak1 promote endometrial cancer cell proliferation."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26160174,"There is a major role of the CK2alpha-interacting protein CKIP-1 in activation of PAK1 for neoplastic prostate cells transformation."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26104863,"Pak1 is an important factor in the initiation and progression of atherogenesis."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26078008,"Pak1 and Pak2 counteract centrosome separation in a kinase-dependent manner."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26036343,"PAK1 overexpression and activation in inflammation and colitis-associated cancer promote NF-kappaB activity via suppression of PPARgamma in intestinal epithelial cells."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26023713,"Study indicates that PAK1 is important in metastasis and progression of primary esophageal small cell carcinoma. The contribution of PAK1 to clinical outcomes may be involved in regulating DNA damage pathway."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,26004135,"Rich1 negatively regulates the epithelial cell cycle, proliferation and adhesion by CDC42/RAC1-PAK1-Erk1/2 pathway."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25981171,"This study showed that PAK1 messenger RNA levels were significantly downregulated specifically in deep layer 3 pyramidal cells in patient with schizophrenia."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25956913,"Studied the role of PAK1/Crk axis in transduction of the oncogenic KRAS signal in non-small cell lung cancer (NSCLC)."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25888627,"PAK1-mediated MORC2 phosphorylation promotes gastric tumorigenesis"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25791829,"PAK1 and PAK4 expression were associated with colorectal cancer metastasis and infiltration"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25766321,"these findings provide important evidence that PAK1 can positively regulate RUFY3 expression, which contribute to the metastatic potential of gastric cancer cells"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25746720,"TGFbeta1 induces apoptosis and epithelial-mesenchymal transition in prostate cancer cells via activation of P38-MAPK and Rac1/Pak1 respectively."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25675297,"results unraveled that oncogenic activation of PAK1 defines an important mechanism for maintaining stem-like phenotype and sunitinib resistance through NF-kappaB/IL-6 activation in RCC."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25596744,"Data show that group I p21-activated kinases (Paks) Pak1 and Pak2 were much more abundant than Pak3 in meningioma."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25569743,"Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25472536,"A pivotal role for PRL/PAK1 signaling in breast cancer metastasis.[review]"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25466889,"High Phosphorylation of tyrosine 285 of PAK1 protein is associated with breast cancer."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25456130,"These results reveal a leukemic pathway involving FAK/Tiam1/Rac1/PAK1 and demonstrate an essential role for these signaling molecules in regulating the nuclear translocation of Stat5 in leukemogenesis."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25447917,"miR-221-3p has an effect on PAK1 gene expressions in breast cancer cell lines"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25416031,"PAK1 role in cardiac physiology such as egulation of cardiac excitability and contractility has been identified."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25415869,"Studies indicate a p21-activated kinase PAK1 inhibitor series were discovered."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25412958,"we demonstrated that the overexpression of PAK1 is closely associated with the clinicopathological features of BC, suggesting that PAK1 may play an important role in the development and progression of Bladder cancer"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25388666,"Provide first evidence for existence of a previously unknown Erk5/KLF2/PAK1 axis, which may limit undesired cell migration in unperturbed endothelium and lower its sensitivity for migratory cues that promote vascular diseases including atherosclerosis."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25327287,"Moreover, the up-regulation of Axl was induced by TGF-beta1, further activated phosphatidylinositol 3-kinase (PI3K)/Akt and PAK1 translocation, and resulted in greater cell motility, invasion, and chemoresistance in vitro and in vivo"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25228413,"Increased p21-activated kinase is associated with invasive papillary thyroid cancers."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25215948,"PAK1 is an essential controller of inflammatory macrophage polarization, regulating immune responses against pathogenic stimuli."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25182632,"PAK1 is a novel prognostic marker for pathologically confirmed human pancreatic cancer. Reduced expression of PAK1 correlates with poor histological differentiation in pancreatic cancer."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25159681,"high PAK1 expression in PTs is predictive of node metastasis and can be easily integrated in the clinical decision process for personalized therapeutics of GEJA."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25125660,"findings offered evidence that JAK2 phosphorylates and stabilizes functions of PAK1 that promote EMT and radioresistance in lung cancer cells"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25074413,"results provide evidence for a functional role of MET/PAK1 signalling in pancreatic adenocarcinoma"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,25019394,"PAK1 and Snail1 are involved in the formation of estrogen-independent phenotype of breast cancer cells showing the potential role of both proteins as markers of hormone resistance of breast tumors."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,24954107,"Data indicate that p21-activated kinase 1 (PAK1) is a target of miR-145."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,24935174,"Amplified PAK1, as well as KRAS amplification/mutation, may represent unique opportunities for developing targeted therapeutics for the treatment of gastric cancer."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,24859002,"Describe here an invadopodia disassembly model, where a signalling axis involving TrioGEF, Rac1, Pak1, and phosphorylation of cortactin, causes invadopodia dissolution."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,24811999,"Review of the role of PAK1 in gastrointestinal inflammation and progression to cancer."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,24634274,"PAK1 is associated with the aggressive tumor behavior and poor prognosis of head and neck cancer."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,24561527,"identified fibronectin, a component of the extracellular matrix and a mesenchymal marker, as a transcriptional target of Pak1 signaling"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,24347489,"blocking PI3K/Akt signaling pathway by LY294002 or Akt siRNA could remarkably inhibit the PAK1 activation and cell invasion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,24236193,"PAK1 is overexpressed during tumorigenic progression and its upregulation correlates with malignant properties mainly relevant to invasion and metastasis."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23986795,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23885116,"These findings identify CK2 as an upstream activating kinase of PAK1, providing a novel mechanism for PAK1 activation."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23811795,"The results identified Mgat5-mediated beta-1-6-GlcNAc branched N-glycosylation and following activation of EGFR as a potential novel upstream molecular event for PAK1-induced anoikis resistance in hepatoma cells."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23811286,"PAK1 stimulates colorectal cancer cell survival by up-regulation of HIF-1alpha."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23746211,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23744893,"These data illustrate the complex interaction between the substratum and PRL/PAK1 signaling in human breast cancer cells and suggest a pivotal role for PRL-dependent PAK1 tyrosyl phosphorylation in MMP secretion."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23737530,"Data indicate that depletion of NFATc1, cyclin D1, CDK6, or CDK4 levels attenuated MCP1-induced Pak1 phosphorylation/activation and resulted in decreased aortic smooth muscle cells (HASMCs) F-actin stress fiber formation, migration, and proliferation."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23653349,"PAK1 can stimulate MEK activity in a kinase-independent manner, probably by serving as a scaffold to facilitate interaction of C-RAF."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23622267,"Group I p21-activated kinases augment Tax-mediated transcriptional activation of human T-cell leukemia virus type 1 long terminal repeats in a kinase-independent manner."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23613712,"no significant change in PAK1 level detected in the schizophrenia subjects"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23576562,"Data indicate a signaling pathway from ErbB2 to p21-Activated kinase-1 (Pak1) to beta-catenin that is required for efficient transformation of mammary epithelial cells."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23559827,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23535073,"Taken together, our results provide evidence for a functional role of PAK1 in BRAF wild-type melanoma and therapeutic use of PAK inhibitors in this indication."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23516476,"Klotho endows hepatoma cells with resistance to anoikis via VEGFR2/PAK1 activation in hepatocellular carcinoma."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23499762,"Cytokine-induced migration correlated with phosphorylation of PAK1 in primary myeloma cells & cell lines. Downregulation of PAK1 with siRNA in INA-6 cells resulted in decreased cytokine-driven migration."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23393142,"analysis of synergistic activation of p21-activated kinase 1 by phosphatidylinositol 4,5-bisphosphate and Rho GTPases"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23340249,"PAK1 phosphorylates serine (Ser) 2152 of the actin-binding protein filamin A to a greater extent when PAK1 is tyrosyl phosphorylated by JAK2."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23338047,"These results suggest that Pak1 plays important roles at multiple stages of EC progression."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23333386,"these findings demonstrate that miR-221 affects the MEK/ERK pathway by targeting PAK1 to inhibit the proliferation ofendothelial progenitor cells."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23321640,"Data suggest that regulation of PAK-PIX interactions controls neurite outgrowth by influencing the activity of several important mediators of actin filament polymerization and retrograde flow, as well as integrin-dependent adhesion to laminin."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23317503,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23300274,"High expression of the PAK1 gene was significantly associated with resistance to all three PI3K inhibitors in lymphomas."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23298303,"Positive rates of Rac1, Pak1 and Rock1 expression in normal tissue, dysplasia and gastric carcinoma show an increasing trend and are correlated with tumor lymph node metastasis and TNM stage."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23258534,"Gene array data revealed reduced expression of matrix metalloproteinase 9 with the ablation of either Pak1 or Pak6 gene expression in PC3 cells."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23246867,"data suggest that glucose-mediated activation of Cdc42 leads to activation of PAK1 and prompts activation of its downstream targets Raf-1, MEK1/2 and ERK1/2 to elicit F-actin remodeling and recruitment of insulin granules to the plasma membrane"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23233484,"Results support a role for the PAK4 and PAK1 in the proliferation of mutant KRAS-driven colorectal carcinoma cells via pathways not involving RAF/MEK/ERK and PI3K/AKT signaling."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23227982,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23055517,"PAK1 phosphorylates MCAK and regulates both its localization and function."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23038262,"PAK1 negatively regulates the expression of TFPI and additionally contributes to increased TF activity."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23019370,"Pak-1 interacts with Wnt signaling to regulate tissue polarity and gene expression."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,23017497,"Phosphoproteome analyses reveal specific implications of Hcls1, p21-activated kinase 1 and Ezrin in proliferation of a myeloid progenitor cell line downstream of wild-type and ITD mutant Fms-like tyrosine kinase 3 receptors."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,22983922,"Results show a strong positive correlation between advanced stage and grade and PAK1 expression in skin cnacer."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,22945935,"In the title."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,22848689,"the role of PAK1 in the promotion of cell motility, cell invasiveness and the down regulation of p120-catenin through CRK serine 41 phosphorylation in NSCLC cells"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,22845716,"PI3K, Rac1 and PAK1 may play important roles in the pathogenesis of EMPD."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,22493453,"results show that a STRADalpha-rac1-PAK1 pathway regulates cell polarity and invasion in LKB1-null cells. It also suggests that while the function of LKB1 and STRADalpha undoubtedly overlap, they may also have mutually exclusive roles"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,22465675,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,22458949,"In both anterior cingulate cortex (ACC) and dorsolateral prefrontal cortex (DLPFC), study found a reduction of Duo expression and PAK1 phosphorylation in schizophrenia. Cdc42 protein expression was decreased in ACC but not in DLPFC"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,22416254,"PAK1 plays an important role in regulating the migration, invasion and production and activity of MMPs in RA FLS, which is mediated by the JNK pathway."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,22369945,"these results provide evidence that PAK1 specifically phosphorylates beta-catenin at S663 and that this phosphorylation is essential for the PAK1-mediated transcriptional activation of beta-catenin."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,22293972,"Pak1 is overexpressed in gastric cancer and plays an important role in the metastasis of gastric cancer. The mechanism by which Pak1 induces cancer metastasis may involve activation of ERK and JNK."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,22252525,"Data suggest that targeting P21-activated protein kinase1 (PAK1) may represent a novel treatment strategy for developing novel chemotherapeutic agents."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,22153498,"crystal structures of the phosphorylated and unphosphorylated PAK1 kinase domain."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,22130069,"Smad4 suppresses the PAK1, which promotes the PUMA destabilization"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,22105362,"PAK1 as a breast cancer oncogene that coordinately regulates multiple signaling pathways"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,22105346,"A Rac-PAK1-Ajuba feedback loop integrates spatiotemporal signaling with actin remodeling at cell-cell contacts and stabilizes preassembled cadherin complexes."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,22100495,"In colorectal neoplasms p-21 activated kinase 1 knockdown inhibits beta-catenin signalling and blocks cell proliferation and migration."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,22096607,"Findings demonstrate that Pak1 phosphorylates BAD directly at S111, but phosphorylated S112 through Raf-1."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,21982772,"These results provide evidence for the importance of PAK1 activation during influenza virus infection and its association with ERK in regulating virus replication."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,21969371,"Inhibition or ablation of p21-activated kinase (PAK1) disrupts glucose homeostatic mechanisms in vivo."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,21892329,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,21822311,"a Rac1/PAK1 cascade controls beta-catenin S675 phosphorylation and full activation in colon cancer cells"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,21748785,"results suggest that CIB1 positively regulates cell migration and is necessary for the recruitment of FAK to the focal adhesions. Furthermore, CIB1-induced cell migration is dependent on MAP kinase signaling and its function is attenuated by PAK1"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,21727092,"increased activation of associated PAK1 can contribute to enhanced Cx43 dephosphorylation and impaired intercellular coupling that may underlie slow conduction in heart failure"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,21722895,"Interleukin-1beta up-regulates Pak1 expression in endometrial stromal cells and Pak1 immunoreactivity is increased in endometriotic cysts."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,21719533,"Adapter protein Nck sequesters PAK1 in the cytoplasm and that coexpression of both PAK1 and Nck inhibits the amplifying effect of PRL-induced PAK1 on cyclin D1 promoter activity."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,21653999,"Contribution of the PAK family member, PAK1, in growth factor signaling and tumorigenesis."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,21562048,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,21310649,"The importance of PIK3K/PAK in neoplasm transformation and progression, their disregulation detected in oral squamous cell carcer may provide early diagnosis and aid in the design of new therapies."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,21209852,"the PI3K/PAK1/ERK signaling pathway has a role in LPA-stimulated breast cancer cell migration"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,21070974,"These findings expand the role of phosphoinositides in kinase signaling and suggest how altered phosphoinositide metabolism may upregulate Pak1 activity in cancer cells."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20811717,"Results suggest that activated Pak1 regulates colorectal cancer metastasis requiring an ERK-dependent phosphorylation of FAK at Ser-910."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20729389,"Data show that the protective effects of atrial natriuretic peptide against lipopolysaccharide-induced vascular leak are mediated at least in part by PAK1-dependent signaling leading to endothelial cell barrier enhancement."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20595063,"P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20594957,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20591216,"Expression of PAK1 is an early molecular event in the tumorigenesis of gastric carcinoma. It is also closely correlated the development of gastric carcinoma and the patients' prognosis."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20526801,"Rac1/Pak1 signaling is critical to MB cell migration and is functionally dependent on PDGFRbeta/ERK activity"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20523167,"Rac1/Cdc42/PAK pathway controls actin reorganization that is necessary for microvesicle shedding"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20508983,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20457839,"Pak1-induced branching morphogenesis in 3D MDCK cell culture requires PIX binding and beta1-integrin signaling."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20426825,"Suggest that Rac1 activity and Pak1 are involved in lymphovascular invasion and lymph node metastasis of urothelial carcinoma of the upper urinary tract , and may be prognostic markers for this disease."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20417602,"A functional requirement for PAK1 binding to the KH(2) domain of the fragile X protein- related FXR1 is reported."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20413688,"Data reveal the involvement of p21-Activated kinase 1 in the pathogenesis and clinical progress of gestational trophoblastic disease."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20400510,"PAK1 is a direct downstream target of LKB1 and plays an essential role in LKB1-induced suppression of cell migration"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20213082,"PKA-induced phosphorylation of ERalpha at serine 305 and high PAK1 levels is associated with sensitivity to tamoxifen in ER-positive breast cancer."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20179234,"Our results suggest that patients with tumors expressing Pak1 and pERalpha(ser305) in combination are a group in which tamoxifen treatment is insufficient"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20131316,"Our studies suggest that Rac1 --> Pak1/Pak2 --> NFkappaB is a separate pathway that contributes to the expression of COX-2 in HPV-induced papillomas, independently of the previously described Rac1 --> p38 --> COX-2 pathway."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20083228,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20079895,"A possible role of Pak1 in the establishment of adenomyosis."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20056178,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,20001745,"PAK-1 and its activator Rac1 are novel HIF-1 targets that may constitute a positive-feedback loop for induction of HIF-1alpha by thrombin and ROS, thus explaining elevated levels of PAK-1, Rac1, and HIF-1alpha in remodeled pulmonary vessels."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,19819966,"Data identify a novel signaling pathway in the endocrine L cell, whereby Cdc42 regulates actin remodeling, activation of the cannonical 1/2-ERK1/2 pathway and PAK1, and GLP-1 secretion in response to insulin."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,19747561,"Basic properties of group I Paks are summarized discuss recently uncovered roles for these kinases in immune function and in viral infection are discussed."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,19628037,"Knockdown of PAK1 inhibits Hepatocyte Growth Factor (HGF) stimulated migration and loss of cell-cell junctions in DU145 prostate carcinoma cells. In PC3 prostate carcinoma cells, knockdown of PAK1 reduces HGF-stimulated migration."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,19610058,"Overexpression of Pak1 was associated with progression, metastasis and prognosis of gastric cancer."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,19574218,"a model for the complex and accurate regulation of PAK1 kinase in vivo at cell protrusions."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,19557173,"LC8 facilitates nuclear import of Pak1 and this function is indispensable during vertebrate development"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,19520772,"study identified p21 activated kinase 1 (PAK1) as a new CDK11(p58) substrate; mapped a new phosphorylation site of Ser174 on PAK1; results indicated PAK1 may serve as a downstream effector of CDK11(p58) during mitosis progression"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,19298660,"We identified a novel mechanism for MMP-9 expression in response to injury signals, which is mediated by PAK1 activation"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,19296259,"Overexpression of PAK1 protein is closely associated with the malignant histological and invasive phenotype of colorectal carcinoma."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,19165420,"Pak protein kinases have a role in cancer [review]"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,19162178,"Pak1 protein plays a critical role in Hepatocyte Growth Factor-induced WASF2 protein transport and lamellipodia formation by directing Pak1 protein-WASF2 protein-kinesin complex."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,19146681,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,19136554,"TH1 interacts with PAK1 and specifically restricts the activation of MAPK modules through the upstream region of the MAPK pathway, thereby influencing cell migration."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18923061,"Expression of active p21-activated kinase-1 induces Ca2+ flux modification with altered regulatory protein phosphorylation in cardiac myocytes."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18922890,"Pak1 is a target of miR-7 and that HoxD10 plays a regulatory role in modifying the expression of miR-7."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18787380,"Data examine possible allelic imbalance in papillary thyroid cancer at EMSY, CAPN5, and PAK1, as candidate genes within 11q13.5-q14 region using a single nucleotide polymorphism-based analysis."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18676874,"PAK1-specific paxillin phosphorylation at Ser(273) is critically involved in positive-feedback regulation."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18656238,"In Cox analysis, higher p21-activated kinase-1 staining extent independently correlated with longer progression-free survival (P = .016) and shorter overall survival (.049) in primary diagnosis and disease recurrence effusions."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18653452,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18586681,"1) PAK plays a required role in hyperosmotic signaling through the PI3K/pTEN/Cdc42/PP2Calpha/p38 pathway, and 2) PAK and PP2Calpha modulate the effects of this pathway on focal adhesion dynamics."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18448666,"alpha2beta1 integrin clustering defines its own entry pathway that is Pak1 dependent but clathrin and caveolin independent and that is able to sort cargo to caveosomes"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18411304,"Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18392133,"Overexpression of p21-activated kinase 1 may be a key coordinator of aberrant cell survival and proteolysis in breast cancer progression."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18354494,"These results provide an insight into the molecular mechanisms of CtBP1/BARS activation in membrane fissioning, and extend the relevance of CtBP1/BARS-induced fission to human viral infection."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18347024,"p21-activated kinase-aberrant activation and translocation may have a role in Alzheimer disease pathogenesis"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18344974,"Clathrin-independent endocytosis used by the IL-2 receptor is regulated by Rac1, Pak1 and Pak2."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18319303,"The data indicate that PAK1 is at the interface between junction destabilization and increased motility during morphogenetic events."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18314909,"In an ovarian carcinoma cohort, RSF1 was amplified in 15% of the cases. It was correlated with serous histology. The 11q13 amplicon in ovarian cancer is likely driven by a cassette of genes rather than by a single oncogene."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18160398,"a VAV1-Rac1-PAK1 signaling axis in mononuclear phagocytes regulating superoxide production in a stimulus-dependent manner."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18065495,"Pak1 overexpression enhanced htt toxicity in cell models and neurons in parallel with its ability to promote aggregation, while Pak1 knockdown suppressed both aggregation and toxicity"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,18006851,"16k PRL inhibits cell migration by blocking the Ras-Tiam1-Rac1-Pak1 signaling pathway in endothelial cells"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,17981134,"Rac1/Pak1/LIMK1 signaling pathway controls cofilin activity within the lamellipodium."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,17911169,"study reports that elevated (alpha6)beta4 integrin-dependent Rac-Pak1 signaling supports resistance to apoptosis in mammary acini by permitting stress-dependent activation of the p65 subunit of NF-kappaB through Pak1"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,17621631,"point to Pak1 as an exciting target for therapy of renal cancer, which remains highly refractory to existing treatments"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,17609315,"we present a model for Pak1 signaling that provides a mechanism for specifically affecting cardiac cellular processes--REVIEW"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,17491012,"ESE-1 functions are coordinately regulated by Pak1 phosphorylation and beta-TrCP-dependent ubiquitin-proteasome pathways."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,17486065,"Amplification of PAK1 is associated with recurrence and tamoxifen resistance in postmenopausal breast cancer"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,17420447,"PAK1 is a physiological upstream kinase for integrin-linked kinase (ILK); PAK1 depletion dramatically increases the nuclear and focal point accumulation of ILK."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,17355222,"Results demonstrate a novel mechanism of signal termination mediated by the Rho-family GTPases Chp and Cdc42, which results in ubiquitin-mediated degradation of one of their direct effectors, Pak1."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,17255101,"p70 S6 kinase activates PAK1 and contributes to phosphatidylinositol 3-kinase- and ERK-mediated regulation of HCV RNA replication"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,17018616,"TGF-ss, via PI3K, recruits the actin cytoskeleton to HER2, which colocalizes with Vav2, activated Rac1, & its effector Pak1 at lamellipodia, leading to prolonged Rac1 activation, enhanced cell motility & survival. Dominant-negative Pak1 abrogates this."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,17012749,"Akt1 and Akt2 have opposing roles in Rac/Pak signaling and cell migration"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,16845324,"Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,16800003,"Phosphorylation of caldesmon by PAK is a dynamic process required to regulate actin dynamics and membrane protrusions in wound-induced cell migration."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,16705121,"Our data support a role for Pak1, particular Pak1 localized to the nucleus, in ERalpha signaling and in tamoxifen resistance."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,16611744,"Myosin II-B resides in a complex with p21-activated kinase 1 (PAK1) and atypical protein kinase C (PKC) zeta (aPKCzeta) and the interaction between these proteins is EGF-dependent."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,16490785,"PI3K through p21-activated kinase 1 regulates FRA-1 proto-oncogene induction by cigarette smoke and the subsequent activation of the Elk1 and cAMP-response element-binding protein transcription factors"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,16449192,"Results show that PAK1 cooperate with different Rho effectors to regulate matrix contraction."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,16407834,"the SH3 domain of betaPix specifically interacts with a proline-arginine motif (PxxxPR) present within the ubiquitin ligase Cbl and Pak1 kinase. Cbl and Pak1 compete for binding to betaPix."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,16091223,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,16026643,"p21-activated kinase 1 has a role in the suppression of anoikis in breast cancer cells"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,16002401,"Data suggest that nischarin, in addition to regulating the p21-activated kinase (PAK) strand of Rac1 signaling, can also regulate other links in the web of Rac1 signaling pathways."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,15893667,"1.8 A resolution structure for the free PAK1 kinase domain was determined."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,15864311,"PAK1 recruitment to the T cell-antigen-presenting cell interface required interaction with PIX."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,15849194,"Pak1-dependent Raf-1 phosphorylation regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,15833848,"The regulation of phosphorylation and function of Snail by Pak1 represents a novel mechanism by which a signaling kinase might contribute to the process of epithelial-mesenchymal transition."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,15831477,"PAK1 phosphorylation of tubulin cofactor B (TCoB)is essential for the polymerization of new microtubules."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,15824732,"Pak1-SHARP interaction plays an essential role in enhancing the corepressor functions of SHARP, thereby modulating Notch1 signaling in human cancer cells."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,15749698,"These findings define the nuclear localization signals (NLSs) of Pak1, its association with chromatin, and the resulting modulation of transcription, thus opening new avenues to further the search for nuclear Pak1 functions."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,15684429,"PAK1 negatively regulates the activity of NET1"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,15638726,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,15611088,"epithelial cell motility is modulated by integrin engagment through RhoA/ROCK and PAK1"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,15561713,"NF-kappaB- and C/EBPbeta-driven interleukin-1beta gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1beta release from Helicobacter pylori lipopolysaccharide-stimulated macrophages"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,15378030,"cell signaling kinase Pak1 is a novel regulator of glucose metabolism through its phosphorylation and regulation of PGM activity."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,15333633,"PAK is a central regulator of endothelial permeability induced by multiple growth factors and cytokines via an effect on cell contractility"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,15225553,"These results support a role for Pak1-mediated RhoGDI phosphorylation as a mechanism for Cdc42-mediated Rac activation, and suggest the possibility of Rac-induced positive feed-forward regulation of Rac activity."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,15161701,"Pak-1 has a role in human colorectal tumor invasiveness and motility"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,15059930,"Src- & ROS-dependent PDK1 activation leads to site-specific PAK1 phosphorylation. This is critically important for PDGF-induced VSMC migration, a process integral to the vascular response to injury that leads to vessel occlusion & plaque formation."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,15047871,"PAK2 is constitutively activated in certain breast cancer cell lines and that this active PAK is mislocalized to atypical focal adhesions in the absence of high levels of activated Rho GTPases."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,14749719,"Phosphorylation of p41-ARC protein by p21-activated kinase 1."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,14694110,"Tat induces actin cytoskeletal rearrangements through PAK1 in human umbilical vein endothelial cells"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,14694110,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,14607331,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,14530270,"Pak1 regulation of cyclin D1 expression might involve an NF-kappaB-dependent pathway; Pak1 is up-regulated in breast tumors"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,12937139,"PAK1 copy number gains were observed in 30% of ovarian carcinomas and PAK1 protein was expressed in 85% of tumors. PAK1 gains were associated with high grade."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,12912914,"PAK1 regulates contact inhibition during epithelial wound healing."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,12887923,"G beta gamma binds PAK1 and, via PAK-associated PIX alpha, activates Cdc42 which, in turn, activates PAK1.  In this pathway, PAK1 is not only an effector for Cdc42, but it also functions as a scaffold protein required for Cdc42 activation."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,12887916,"Activated Cdc42 at the leading edge of a neutrophil in culture helps orient the cell's axis in a signaling complex with G beta gamma, PAK1, and PIXalpha."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,12734410,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,12560069,"results identify a novel signaling pathway linking estrogen action to Pak1 signaling, and Pak1 to FKHR, suggesting that Pak1 is an important mediator of estrogen's cell survival functions"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,12551923,"role in phosphorylating Raf-1 regulates Raf-1 autoinhibition"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,12531429,"phorbol ester induced cell migration is accompanied by selective and transient down-regulation of PAK1, which coincided with the formation of stress fibres."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,12522133,"p21-activated kinase 1 (PAK1) interacts with the Grb2 adapter protein to couple to growth factor signaling"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,12453877,"Cdc42/Rac1-dependent activation of PAK may trigger early platelet shape change, at least in part through the regulation of cortactin binding to PAK."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,12198493,"FLNa may be essential for Pak1-induced cytoskeletal reorganization"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,12151336,"Pak1 interacts with and phosphorylates histone H3 and may thus influence the Pak1-histone H3 pathway, which in turn may influence mitotic events in breast cancer cells"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,12011045,"binding of the Rho family member Cdc42 to PLD1 and the subsequent stimulation of its enzymatic activity are distinct events"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,12009866,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,11948406,"PAK1 primes MEK1 for phosphorylation by Raf-1 kinase during cross-cascade activation of the ERK pathway."
https://pharos.nih.gov/idg/targets/Q13153,Q13153,11804587,"Pak1 forms homodimers in vivo and its dimerization is regulated by the intracellular level of GTP-Cdc42 or GTP-Rac1"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,11689886,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,11463741,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,10713183,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,10559302,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,9792838,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,9371615,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,9070423,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,8939608,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,8862424,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,8709288,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,8709241,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,8108442,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q13153,Q13153,7797518,"The Nef/hnRNPK/PKC-delta/Hck protein complex activates Pak2 activity but inhibits Pak1 activity, which induces paxillin phosphorylation on Ser272/274 and regulates paxillin/TACE association and secretion"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,27142475,"In conclusion, these meta-analytical findings suggest that STK39 might not be a hypertension-susceptibility gene."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,27122160,"Both SPAK and OSR1 kinases entering cells through exosomes are preferentially expressed at the plasma membrane and that the kinases in exosomes are functional and maintain NKCC1 in a phosphorylated state."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,27082544,"Single nucleotide polymorphisms STK39 and WNK1 were associated with hypertension and BP in our multicenter Belgian case-control study"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,26914237,"did not observe any significant difference in allele and genotype distribution between Parkinson's disease patients and controls for rs1955337 in STK39"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,26911228,"Here, we report our replication data showing a significant association of the rs3754777 polymorphism, but not rs35929607, of STK39 with essential hypertension in a male Chinese Han population."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,26673921,"SPAK and OSR1 are both stimulators of Kir2.1 activity."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,26662444,"STK39 mRNA and protein express abnormally in primary hypertension patients with genetic variation, which is related to the blood pressure."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,26584301,"SPAK protein has both the potential to up-regulate KCNQ1/E1 protein abundance in the cell membrane, an effect possibly participating in the regulation of cell volume, excitability, epithelial transport and metabolism."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,26506223,"SPAK and OSR1 are powerful stimulators of the intestinal Na+-coupled phosphate co-transporter NaPi-IIb"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,26469904,"These findings suggested that the STK39 rs1955337 TT genotype is a risk factor for Han-Chinese patients with PD in Taiwan"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,26416847,"Findings indicate that the serine threonine kinase 39 (STK39) mRNA expression is increased in rs3754777 knockin cell lines."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,26233565,"SPAK and OSR1 are powerful negative regulators of the excitatory glutamate transporters EAAT1 and EAAT2."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,26112741,"SPAK and OSR1 are negative regulators of EAAT3 activity"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,25994507,"These observations establish that the CCT domain plays a crucial role in controlling SPAK activity and BP."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,25531585,"Both, SPAK and OSR1, are negative regulators of the creatine transporter SLC6A8"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,25515571,"WNK 1, 3, 4, OSR1, and SPAK signaling system known to play a role in regulating the phosphorylation status, and hence activity of the CCCs in other tissues, is also present in the rat and human lenses."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,25362046,"study identifies a separation of functions for the WNK1-activated protein kinases OSR1 and SPAK in mediating proliferation, invasion, and gene expression in endothelial cells"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,25323061,"SPAK and OSR1 are powerful negative regulators of the cell volume regulatory Cl- channel ClC-2"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,25164821,"SPAK short forms in the kidney are created by aspartyl aminopeptidase (Dnpep)-mediated proteolytic cleavage"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,24873805,"Taken together, our findings suggest the potential interactive role of STK39 gene multiple polymorphisms in the development of hypertension among northeastern Han Chinese."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,24655550,"SPAK may promote KCC3-mediated cervix tumor aggressiveness via the NF-kappaB/p38 MAPK/MMP2 axis."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,24631562,"the association of the loci rs11711441 near STK39 and sporadic Parkinson disease in the Chinese Han population is confirmed"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,24393035,"the WNK-regulated SPAK/OSR1 kinases directly phosphorylate the N[K]CCs and KCCs, promoting their stimulation and inhibition respectively."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,24312176,"STK39 (rs2102808) and CCDC62/HIP1R (rs12817488) do not appear to influence PD risk."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,24191005,"OSR1 and SPAK integrate signals from osmosensing and survival pathways."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,24133122,"SPAK isoforms both inhibit NKCC1 and NKCC2 activity (cation cotransporter)that may be important in renal physiology."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,23894895,"Essential hypertension risk conferred by STK39 rs35929607 polymorphism *A/G) was different from that previously reported in a European population."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,23759979,"In Chinese children, no association of CSK rs1378942, MTHFR rs1801133, CYP17A1 rs1004467, STK39 rs3754777 and FGF5 rs16998073 with BP/risk of hypertension."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,23527223,"The present meta-analysis confirms the significant association of STK39 polymorphism with susceptibility to hypertension in Europeans and East Asians."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,23235358,"A significant association between STK39 genetic variant rs6749447 and hypertension was found in a Finnish cohort."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,23151749,"study found no evidence that STK39 was associated with hypertension in the Chinese population"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,23034389,"SPAK and OSR1, which are oftencoexpressed in cells can form functional heterodimers."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,21705622,"SPAK increases intestinal epithelial permeability; both SPAK-transfected Caco2-cells and SPAK transgenic mice exhibit loss of intestinal barrier function and homeostasis in inflammatory bowel disease."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,21442361,"our results suggest no significant assocation between any of the core autism symptom domains or the four additional previously identified familial features and the rs1807984 SNP on the STK39 gene."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,21321328,"Data demonstrate that hypotonic low-chloride conditions that activate the WNK1-SPAK and OSR1 pathway promote phosphorylation of NKCC2 isoforms."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,21317537,"IRBIT opposes the effects of WNKs and SPAK by recruiting PP1 to the complex to dephosphorylate CFTR and NBCe1-B, restoring their cell surface expression, in addition to stimulating their activities"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,21178783,"Serine/threonine kinase 39 is a candidate gene for primary hypertension especially in women."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,20889219,"STK39 is an independent risk factor for hypertension in men and its intragenic single nucleotide polymorphisms can interact and function in the control of blood pressure."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,20889219,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,20555294,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,20442269,"phosphorylation-induced activation of NKCC1 by osmotic shrinkage does not involve AMP-activated protein kinase and is likely to be due to STE20/SPS1-related proline/alanine-rich kinase activation"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,20003416,"STK39 expression is modified by polymorphisms acting in cis and the typed SNPs are associated with allelic expression of this gene, but there is no evidence for an association with blood pressure in a British Caucasian cohort"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,20003416,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,19717643,"SPAK loss in B-cell lymphomas promotes increased cell survival with DNA damage and provides a potential mechanism for increased resistance to genotoxic stress in cancer."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,19470686,"Brain WNK3 acts in tandem with SPAK, whereas renal WNK3 seems to upregulate NCCT through a SPAK-independent pathway."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,19414679,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,19343169,"data suggest that SPAK, the transcription of which is regulated by hyperosmolarity, plays an important role in epithelial barrier function"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,19114657,"variants in STK39 may influence blood pressure by increasing STK39 expression and consequently altering renal Na(+) excretion"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,19114657,"Observational study, meta-analysis, and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,18787102,"During inflammatory conditions, TNF-alpha is a key regulator of SPAK expression."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,18550547,"PKCdelta acts upstream of SPAK to increase activity of NKCC1 during hyperosmotic stress"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,18348195,"evidence for linkage and association between autism and loci within the 2q24-q33 region, including at STK39"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,18348195,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,18270262,"The WNK1-SPAK/OSR1 signalling pathway plays a key role in controlling the phosphorylation and activity of NCC."
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,16950202,"TNF-related apoptosis-inducing ligand down-regulation of SPAK is an important event that enhances its apoptotic effects"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,16669787,"data establish that the CCT domain functions as a multipurpose docking site, enabling SPAK/OSR1 to interact with substrates (NKCC1) and activators (WNK1/WNK4)"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,16263722,"WNK1 and SPAK/OSR1 mediate the hypotonic stress signaling pathway to cation-chloride-coupled cotransporters"
https://pharos.nih.gov/idg/targets/Q9UEW8,Q9UEW8,12740379,"roles in phosphorylation and activation of the Na-K-Cl cotransporter (NKCC1)"
https://pharos.nih.gov/idg/targets/Q8IVH8,Q8IVH8,28099144,"Authors report that miR-199a-5p and let-7c cooperatively and efficiently inhibit HCC cell migration and invasion by targeting the metastasis promoter MAP4K3 and MAP4K3-mediated drug sensitization."
https://pharos.nih.gov/idg/targets/Q8IVH8,Q8IVH8,27727493,"This report details the first structure of GLK; comparison of its activation loop sequence and P-loop structure to that of Map4k4 suggests ideas for designing inhibitors that can distinguish between these family members to achieve selective pharmacological inhibitors."
https://pharos.nih.gov/idg/targets/Q8IVH8,Q8IVH8,27203390,"Data indicate that GLK/MAP4K3 is a prognostic biomarker for non-small cell lung cancer (NSCLC) recurrence."
https://pharos.nih.gov/idg/targets/Q8IVH8,Q8IVH8,23981581,"ITGB3 and MAP4K3 are directly repressed by let-7c, altering the metastatic potential of lung cancer cells."
https://pharos.nih.gov/idg/targets/Q8IVH8,Q8IVH8,22898570,"MAP4K3 expression is required for leucine-induced mTORC1 activation in human primary fibroblasts."
https://pharos.nih.gov/idg/targets/Q8IVH8,Q8IVH8,22867055,"Significantly higher median frequencies of circulating GLK-expressing T-cells were observed in patients with adult-onset Still's disease (31.85%) than in healthy volunteers (8.93%, P <0.001)."
https://pharos.nih.gov/idg/targets/Q8IVH8,Q8IVH8,21983831,"enhanced expression in systemic lupus erythematosus"
https://pharos.nih.gov/idg/targets/Q8IVH8,Q8IVH8,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8IVH8,Q8IVH8,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8IVH8,Q8IVH8,20227368,"Amino acid sufficiency phosphorylates MAP4K3/Ser170, activating mTORC1, but amino acid restriction causes MAP4K3 to interact with PP2A(T61 epsilon), promoting dephosphorylation of Ser170, MAP4K3 inhibition, and, inhibition of mTORC1 signaling."
https://pharos.nih.gov/idg/targets/Q8IVH8,Q8IVH8,20200978,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8IVH8,Q8IVH8,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8IVH8,Q8IVH8,19587239,"MAP4K3 orchestrates activation of BAX via the concerted posttranscriptional modulation of PUMA, BAD, and BIM."
https://pharos.nih.gov/idg/targets/P52564,P52564,27181679,"MEK2 was essential for the phosphorylation of MKK3/MKK6 and p38 MAPK that directly impacted on cyclin D1 expression."
https://pharos.nih.gov/idg/targets/P52564,P52564,25214442,"Data indicate that mitogen-activated protein kinase kinase 6 (MKK6) levels were substantially higher in monocytes than in neutrophils."
https://pharos.nih.gov/idg/targets/P52564,P52564,25019214,"Data show significant increase in the expression of MKK6 in Esophageal, Stomach, and Colon cancers as compared to controls."
https://pharos.nih.gov/idg/targets/P52564,P52564,24936062,"uncover a new mechanism of deactivation of MKK6-p38 and substantiate a novel regulatory role of FBXO31 in stress response"
https://pharos.nih.gov/idg/targets/P52564,P52564,24742347,"The interaction of HIV-1 Tat with cellular transcription factors CDK9 and Sp1 is required for Tat activation of MAP2K3-, MAP2K6-, and IRF7-mediated luciferase transcription"
https://pharos.nih.gov/idg/targets/P52564,P52564,24085465,"Serine phosphorylation of p66shc is carried out by active MKK6. beta-Amyloid-induced ROS production and apoptosis increased in the presence of MKK6 and p66shc, which directly associate."
https://pharos.nih.gov/idg/targets/P52564,P52564,23744074,"The models confirmed the reaction order, revealed processivity in the phosphorylation of MEK6 by ASK1, and suggested that the order of phosphorylation is dictated by both binding and catalysis rates."
https://pharos.nih.gov/idg/targets/P52564,P52564,23535064,"The interaction of HIV-1 Tat with cellular transcription factors CDK9 and Sp1 is required for Tat activation of MAP2K3-, MAP2K6-, and IRF7-mediated luciferase transcription"
https://pharos.nih.gov/idg/targets/P52564,P52564,22383536,"crystal structure of human non-phosphorylated MAP2K6 (npMAP2K6) complexed with an ATP analogue was determined at 2.6 A resolution and represents an auto-inhibition state of MAP2K6"
https://pharos.nih.gov/idg/targets/P52564,P52564,22164285,"the balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC"
https://pharos.nih.gov/idg/targets/P52564,P52564,22154358,"Data suggest aberrant MAP2K protein (MKK3, MKK4, MKK6, and MKK7) expression indicates that altered cellular signal transduction mediated via JNK and p38 may be common in bladder cancer."
https://pharos.nih.gov/idg/targets/P52564,P52564,21926646,"activation by mechanical stretch induces HMGB1 and cytokine expression in A549 cells"
https://pharos.nih.gov/idg/targets/P52564,P52564,21368234,"Impaired cytokine production in natural killer (NK)T cells is demonstrated from MKK3-deficient6+/- mice."
https://pharos.nih.gov/idg/targets/P52564,P52564,21308746,"Results suggest that the p38alpha, MAPK, and MKK6 play prominent roles in IL-1beta and C/EBP-beta-mediated C3 gene expression in astrocytes."
https://pharos.nih.gov/idg/targets/P52564,P52564,21078955,"MKK6 and other MAP2Ks are a distinct class of cellular redox sensors"
https://pharos.nih.gov/idg/targets/P52564,P52564,20869211,"we demonstrated that MKK6 has a role for regulation of dendricity in melanocytes."
https://pharos.nih.gov/idg/targets/P52564,P52564,20805296,"Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P52564,P52564,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P52564,P52564,20364819,"Mechanism of oxidative stress-induced ASK1-catalyzed MKK6 phosphorylation.("
https://pharos.nih.gov/idg/targets/P52564,P52564,20162623,"These results demonstrate that activin A induces erythroid differentiation of K562 cells through activation of MKK6-p38alpha/p38beta pathway and follistatin inhibits those effects."
https://pharos.nih.gov/idg/targets/P52564,P52564,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P52564,P52564,19846005,"MKK6 p38 alpha signaling pathway regulates the expression of RAGE induced by mechanical stretch in A549 cells."
https://pharos.nih.gov/idg/targets/P52564,P52564,19672773,"Data provide evidence that p38 Map kinase pathway is activated leading to increased upregulation of mixed lineage kinase 3, MKK3/6, MSK1, and Mapkapk2, upon treatment of BCR/ABL expressing cells with dasatinib."
https://pharos.nih.gov/idg/targets/P52564,P52564,19141286,"Gel filtration and small-angle X-ray scattering analysis confirm that the crystallographically observed ellipsoidal dimer is a feature of MEK6/DeltaN/DD and full-length unphosphorylated wild-type MEK6 in solution"
https://pharos.nih.gov/idg/targets/P52564,P52564,19047046,"as a mediator of SF- and Src-stimulated NF-kappaB activity. Finally, the Src/Rac1/MKK3/6/p38 and Src/TAK1/NF-kappaB-inducing kinase pathways exhibited cross-talk at the level of MKK3."
https://pharos.nih.gov/idg/targets/P52564,P52564,18327563,"Data suggest that sequence variations of ASK1 and MAP2K6 lead to partially sex-specific changes in the levels and/or phosphorylation states of p38 and p38-regulated proteins that might contribute to the observed delaying effects in the age of onset of HD."
https://pharos.nih.gov/idg/targets/P52564,P52564,18327563,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P52564,P52564,16960152,"Conditional induction of a dominant active form of MAPK kinase 6, a direct upstream kinase of p38, in Langerhans cells induces up-regulation of costimulatory molecules & enhances their T-cell stimulatory capacity."
https://pharos.nih.gov/idg/targets/P52564,P52564,16728640,"findings show that Yersinia YopJ acted as an acetyltransferase, using acetyl-coenzyme A (CoA) to modify the critical serine and threonine residues in the activation loop of MAPKK6 and thereby blocking phosphorylation"
https://pharos.nih.gov/idg/targets/P52564,P52564,16342939,"selectivity pocket compounds prevent MKK6-dependent activation of p38alpha in addition to inhibiting catalysis by activated p38alpha"
https://pharos.nih.gov/idg/targets/P52564,P52564,15790570,"MEK6E activates p38 and results in phosphorylation of its downstream substrate, heat shock protein 27"
https://pharos.nih.gov/idg/targets/P52564,P52564,15778394,"MKK3 and MKK6 make individual contributions to p38 activation in fibroblast-like synoviocytes after cytokine stimulation"
https://pharos.nih.gov/idg/targets/P52564,P52564,15722372,"MKK6 promotes the development of cardiomyopathy by activation of a kinase cascade"
https://pharos.nih.gov/idg/targets/P52564,P52564,15677464,"H-Ras-specific activation of Rac-MKK3/6-p38 pathway has a role in invasion and migration of breast epithelial cells"
https://pharos.nih.gov/idg/targets/P52564,P52564,15550393,"PAK6 kinase activity was repressed by a p38 mitogen-activated protein (MAP) kinase antagonist and could be strongly stimulated by constitutively active MAP kinase kinase 6 (MKK6)"
https://pharos.nih.gov/idg/targets/P52564,P52564,15516490,"MAP kinase kinase3- and 6-dependent activation of the alpha-isoform of p38 MAP kinase is required for the cytoskeletal changes induced by neutrophil adherence and influences subsequent neutrophil migration toward endothelial cell junctions"
https://pharos.nih.gov/idg/targets/P52564,P52564,15492008,"role in cardioprotection"
https://pharos.nih.gov/idg/targets/P52564,P52564,15375157,"a specific requirement for p150(Glued)/dynein/functional microtubules in activation of MKK3/6 and p38 MAPKs in vivo."
https://pharos.nih.gov/idg/targets/P52564,P52564,12509443,"MKK6 is involved in a positive feedback loop regulating macrophage signaling with p38 MAP kinase"
https://pharos.nih.gov/idg/targets/P52564,P52564,11971971,"Results show that oncogenic ras provokes premature senescence by sequentially activating the MEK-ERK and MKK3/6-p38 pathways in normal, primary cells."
https://pharos.nih.gov/idg/targets/P52564,P52564,11727828,"active MKK6 in HepG2 cells enhanced basal activity or IL-6-induced transcriptional activation of a SOCS3 promoter"
https://pharos.nih.gov/idg/targets/P41279,P41279,29084252,"RelAp43 interacts with the p105-ABIN2-TPL2 complex and we observe a strong perturbation of this complex in presence of M protein."
https://pharos.nih.gov/idg/targets/P41279,P41279,28361341,"Taken together, these results suggest that Cot kinase might play a critical role in Helicobacter pylori type IV secretion apparatus-dependent early IL-8 secretion and CagA-dependent late IL-8 secretion as an alternative signaling molecule in the Erk pathway."
https://pharos.nih.gov/idg/targets/P41279,P41279,27835990,"Results show that the binding of miR-589-5p to the MAP3K8 3'-UTR inhibits MAP3K8 expression and suppresses CD90+ cancer stem cells characteristics in hepatocellular carcinoma."
https://pharos.nih.gov/idg/targets/P41279,P41279,27717821,"MAP3K8 is a direct target of miR-144-3p, and miR-144-3p downregulation is a factor in renal cell carcinoma progression through potentiation of MAP3K8 expression."
https://pharos.nih.gov/idg/targets/P41279,P41279,27002000,"miRNA-509-3p mimics or inhibitor transfection tests in KGN cells further confirmed that miRNA-509-3p improved oestradiol (E2) secretion by inhibiting the expression of MAP3K8"
https://pharos.nih.gov/idg/targets/P41279,P41279,26300007,"role of p105/Tpl2 signaling in lung homeostasis"
https://pharos.nih.gov/idg/targets/P41279,P41279,26215868,"rs1042058 GG Crohn's disease -risk polymorphism in TPL2 results in a gain-of-function by increasing TPL2 expression and signalling, thereby amplifying Pattern recognition receptor -initiated outcomes."
https://pharos.nih.gov/idg/targets/P41279,P41279,25918157,"structurally versatile active site significantly impacts the design of potent, low molecular weight COT kinase inhibitors"
https://pharos.nih.gov/idg/targets/P41279,P41279,25815776,"the results of the present study demonstrated that the miR-509-3p RCC suppressor was a significant regulator of the MAP3K8 oncogene, suggesting that it may have a potential therapeutic role in the treatment of renal cell carcinoma"
https://pharos.nih.gov/idg/targets/P41279,P41279,25723737,"Studies indicate that Tpl2, a MAP3K, participates in a broad range of cancer-related signaling pathways and induces tumorigenesis and progression of many cancers."
https://pharos.nih.gov/idg/targets/P41279,P41279,25674762,"Aberrant expression of A-, B-, and C-RAF, and COT is frequent in PTC; increased expression of COT is correlated with recurrence of PTC."
https://pharos.nih.gov/idg/targets/P41279,P41279,25531326,"findings provide a novel perspective on the role of the IL-33/ST2/COT signaling pathway in supporting cancer-associated inflammation in the tumor microenvironment"
https://pharos.nih.gov/idg/targets/P41279,P41279,25316791,"Following epithelial injury, intestinal myofibroblasts sense innate or inflammatory signals and activate, via Tpl2, the cyclooxygenase-2 (Cox-2)-prostaglandin E2 (PGE2) pathway, which are essential for the epithelial homeostatic response."
https://pharos.nih.gov/idg/targets/P41279,P41279,25274482,"Tpl2 overexpression and downregulation showed significant stimulatory and inhibitory effects on tumorigenic and metastatic potential of ADI PC cells."
https://pharos.nih.gov/idg/targets/P41279,P41279,24998852,"TPL2 mediates the phosphorylation of a fraction of nucleophosmin at threonine 199, an event required for its proteasomal degradation and maintenance of steady-state nucleophosmin levels."
https://pharos.nih.gov/idg/targets/P41279,P41279,24819603,"MAP3K8 and miR-17-5p expression were inversely correlated with treatment response"
https://pharos.nih.gov/idg/targets/P41279,P41279,24723682,"Coregulation of TLR2 and TLR6 expression correlating with local processing of versican, a proteoglycan TLR2/6 agonist linked to carcinoma progression."
https://pharos.nih.gov/idg/targets/P41279,P41279,24642963,"Tpl2 regulates various inflammatory pathways by activating the ERK mediated MAP kinase pathway in innate immune cells such as macrophages and dendritic cells in humans but not in mice."
https://pharos.nih.gov/idg/targets/P41279,P41279,24586913,"High MAP3K8 expression affects obesity-induced adipose tissue inflammation without systemic effects."
https://pharos.nih.gov/idg/targets/P41279,P41279,24404585,"this report have defined a novel network leading to ERK1/ERK2 activation in cysticfibrosis airway epithelial cells in response to P. aeruginosa that involves both the TPL2 and EGFR protein kinases and contributes to inflammation of CF airways."
https://pharos.nih.gov/idg/targets/P41279,P41279,24275658,"MAP3K8 mediates the phosphorylation and repression of IRF3 homodimers to promote greater transcriptional activity through utilization of IRF3:IRF7 heterodimers."
https://pharos.nih.gov/idg/targets/P41279,P41279,24265246,"COT interacts with and phosphorylates Pin1 on Ser16. Consequently, Pin1 Ser16 phosphorylation by COT increases cyclin D1 abundance and enhances tumorigenecity of MCF7 cells."
https://pharos.nih.gov/idg/targets/P41279,P41279,23982215,"data indicate that Tpl2 kinase is associated with and contributes to disease progression of clear cell renal cell carcinoma"
https://pharos.nih.gov/idg/targets/P41279,P41279,23828905,"High Tpl2 expression is associated with peritoneal dissemination in gastric tumor."
https://pharos.nih.gov/idg/targets/P41279,P41279,23533274,"TPL2 was found to antagonize oncogene-induced cell transformation and survival through a pathway involving p53 downstream of cJun N-terminal kinase (JNK) and be required for optimal p53 response to genotoxic stress."
https://pharos.nih.gov/idg/targets/P41279,P41279,23527104,"The protein kinase TPL2 is essential for ERK1/ERK2 activation and cytokine gene expression in airway epithelial cells exposed to pathogen-associated molecular patterns."
https://pharos.nih.gov/idg/targets/P41279,P41279,23322277,"Overexpression of MAP3K8 is associated with early-onset colorectal cancer."
https://pharos.nih.gov/idg/targets/P41279,P41279,23252623,"Authors report constitutive activation of MAP3K8 kinase-dependent pathways that regulate the magnitude and extent of inflammatory activity of monocytes/macrophages within myeloma niches."
https://pharos.nih.gov/idg/targets/P41279,P41279,23125217,"High TPL2 expression is associated with tumor progression."
https://pharos.nih.gov/idg/targets/P41279,P41279,21868363,"the role of Tpl2 in GPCR-mediated Ca(2+) signaling and cell migration"
https://pharos.nih.gov/idg/targets/P41279,P41279,21741362,"Cot protein is responsible for the constitutive Erk1/2 activation in the anaplastic large-cell lymphoma cells."
https://pharos.nih.gov/idg/targets/P41279,P41279,21539449,"OPN knockdown chemosensitized MDA-MB-231 cells to CTX, which is dependent on p38 MAPK pathway activation"
https://pharos.nih.gov/idg/targets/P41279,P41279,21267413,"TPL2 kinase plays a critical role in the promotion of androgen depletion-independent prostate cancer progression."
https://pharos.nih.gov/idg/targets/P41279,P41279,21107320,"identification of MAP3K8 (the gene encoding COT/Tpl2) as a MAPK pathway agonist that drives resistance to RAF inhibition in B-RAF(V600E) cell lines"
https://pharos.nih.gov/idg/targets/P41279,P41279,20945381,"Oncoprotein Cot1 represses kinase suppressors of Ras1/2 and 1,25-dihydroxyvitamin D3-induced differentiation of human acute myeloid leukemia cells."
https://pharos.nih.gov/idg/targets/P41279,P41279,20603871,"Tensile strain and magnetic particle force application do not induce MAP3K8 and IL-1B differential gene expression in a similar manner to fluid shear stress in human mesenchymal stem cells."
https://pharos.nih.gov/idg/targets/P41279,P41279,20487506,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P41279,P41279,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P41279,P41279,20227498,"MAP3 kinase COT1 is up-regulated by 1,25-dihydroxyvitamin D3 in parallel with activated c-jun during differentiation of human myeloid leukemia cells"
https://pharos.nih.gov/idg/targets/P41279,P41279,19939924,"endogenous Tpl2 promotes efficient murine gammaherpesvirus 68 lytic replication through AP-1-dependent upregulation of RTA expression"
https://pharos.nih.gov/idg/targets/P41279,P41279,19804365,"Cot protein, expressed in HEK293 cells and immunoprecipitated, was used in a peptide-based substrate screening assay. The results of this assay suggested that Polo-like kinase 1 (Plk1) was a substrate of Cot."
https://pharos.nih.gov/idg/targets/P41279,P41279,19272346,"Data support MAP3K8-induced activation of different MAPK signaling pathways in response to different profiles of shear stress, possibly as a consequence of shear-induced IL1B expression."
https://pharos.nih.gov/idg/targets/P41279,P41279,19054068,"Selected 'Tpl2/Cot-YL ribozyme' efficiently cleaves its target sequence in cis and in trans; furthermore, the ribozyme efficiently cleaves a longer target sequence of 54 nucleotides in trans, as well as the full-length mRNA."
https://pharos.nih.gov/idg/targets/P41279,P41279,19001140,"These data underscore the role of Tpl2 as a regulator of T helper cell lineage decisions and demonstrate that Tpl2 has an important functional role in the regulation of Th1 responses."
https://pharos.nih.gov/idg/targets/P41279,P41279,18984674,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P41279,P41279,18795070,"the results from recent studies suggest that Tpl2/Cot and COX-2 could be prognostic factors in breast cancer [review]"
https://pharos.nih.gov/idg/targets/P41279,P41279,18572386,"The increase in COX2 expression and the activation of Erk1/2 regulated by Cot are essential for the induction of cell migration."
https://pharos.nih.gov/idg/targets/P41279,P41279,18518937,"Cot/Tpl2 did not function as a member of MAPK family, but as a promoter of renal cell apoptosis in ischemia reperfusion injury."
https://pharos.nih.gov/idg/targets/P41279,P41279,18439422,"Cot was identified as a novel p65 interacting protein kinase."
https://pharos.nih.gov/idg/targets/P41279,P41279,18319612,"Results describe the proteomics analysis of immunoprecipitated proteins associated with the oncogenic kinase Cot."
https://pharos.nih.gov/idg/targets/P41279,P41279,18187448,"processing of pre-TNF alpha in LPS-stimulated macrophages is regulated by TPL2-mediated activation of ERK1 and ERK2"
https://pharos.nih.gov/idg/targets/P41279,P41279,17848581,"inhibition of Tpl2 in primary human cell types can decrease the production of TNFalpha and other pro-inflammatory mediators during inflammatory events"
https://pharos.nih.gov/idg/targets/P41279,P41279,17724252,"the transforming ability of Cot results from the coordinated activation of histone H3, which ultimately converges on the regulation of the transcriptional activity of the c-fos promoter, followed by AP-1 transactivation activity"
https://pharos.nih.gov/idg/targets/P41279,P41279,17398070,"MAP3K8 and PRKCZ cooperate in the regulation of the transcriptional activity of NFATC2 through the phosphorylation of its amino-terminal domain."
https://pharos.nih.gov/idg/targets/P41279,P41279,17324460,"TPL-2 is not targeted by mutation in diffuse large B cell lymphoma and myeloid leukemia"
https://pharos.nih.gov/idg/targets/P41279,P41279,17290588,"MAP3K8 was found overexpressed in 30% of the endometrial carcinoma samples"
https://pharos.nih.gov/idg/targets/P41279,P41279,16806191,"Mutagenesis experiments indicated that COT activation is initiated by Thr290 phosphorylation catalysed by an IL-1-stimulated protein kinase distinct from IKKbeta, while Ser62 phosphorylation is an autophosphorylation event required for maximal activation."
https://pharos.nih.gov/idg/targets/P41279,P41279,16565081,"deregulated activation of Tpl2/Cot may occur in human cancer cells"
https://pharos.nih.gov/idg/targets/P41279,P41279,16385451,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P41279,P41279,16371247,"Data highlight the specific requirements for activation of the Cot-MKK1-ERK1/ERK2 pathway and provide evidence that Cot controls the functions of IL-1 that are mediated by ERK1/ERK2."
https://pharos.nih.gov/idg/targets/P41279,P41279,16087150,"Our results using purified proteins indicate that p105 binding improves COT solubility and stability while down-regulating kinase activity, consistent with cellular data showing that p105 functions as an inhibitor of COT."
https://pharos.nih.gov/idg/targets/P41279,P41279,15670770,"These results indicate a distinction between TNF Receptor family members CD40 and TNFR1 in their utilization of MAP3Ks, and demonstrate TRAF-dependence of Tpl2 association with the CD40 receptor complex."
https://pharos.nih.gov/idg/targets/P41279,P41279,15575964,"Tpl2/Cot is overexpressed in large granular lymphocyte proliferative disorders but not other T-cell neoplasias."
https://pharos.nih.gov/idg/targets/P41279,P41279,15466476,"phosphorylation of Cot at Thr-290 is necessary but not sufficient for full kinase activity in the MEK/ERK pathway"
https://pharos.nih.gov/idg/targets/P41279,P41279,15287022,"Data support a role for MAP3K8 activity in cellular transformation, but suggest that mutational activation of the gene is a rare event in lung cancer."
https://pharos.nih.gov/idg/targets/P41279,P41279,15169888,"optimal TPL-2 stability in vivo requires interaction with ABIN-2 as well as p105"
https://pharos.nih.gov/idg/targets/P41279,P41279,14517305,"the COOH-terminal domain of wild-type Cot regulates its stability and kinase specific activity"
https://pharos.nih.gov/idg/targets/P41279,P41279,12975377,"hKSR-2, a new member of the KSR family, negatively regulates Cot-mediated MAP kinase and NF-kappaB pathway signaling"
https://pharos.nih.gov/idg/targets/P41279,P41279,12667451,"Tpl2 is inhibited by and is a partner of NFkappab p105"
https://pharos.nih.gov/idg/targets/P41279,P41279,12138205,"suggest that the activation of different signaling pathways by Cot and other MAP3Ks may be regulated separately and may provide evidence for how such discrimination by one member of this kinase family occurs."
https://pharos.nih.gov/idg/targets/P41279,P41279,11932422,"contributes to LMP1-induced NF-kB signaling downstream of TRAF2"
https://pharos.nih.gov/idg/targets/Q99759,Q99759,27787230,"All these suggest that the MAP3K M1P site is a potential interacting partner of MAP3K SH3 domain, which may mediate the intermolecular recognition between hPTTG1 and MAP3K."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,27027284,"studies identify gain of MEKK3 signalling and KLF2/4 function as causal mechanisms for cerebral cavernous malformations pathogenesis that may be targeted to develop new CCM therapeutics"
https://pharos.nih.gov/idg/targets/Q99759,Q99759,26997451,"MAP3K3 overexpression is an independent poor prognostic indicator in ovarian carcinoma."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,26304632,"Polymorphisms in MAP3K3, MMP24 and IGF1R are associated with greater height and act additively on height in children of an admixed population."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,26088427,"MAP3K3 may potentially not only serve as diagnostic/prognostic markers for patients with lung cancer but also provide an indicator for future investigations into immunomodulatory therapies for lung cancer."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,25824786,"High MEKK3 expression is associated with renal clear cell carcinoma."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,25728774,"Our finding that Verrucous venous malformation contains a MAP3K3 mutation supports our impression that this lesion is a venous anomaly."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,25388155,"MEKK3 expression was significantly higher in patients with renal clear cell carcinoma than in controls."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,25043814,"This study identified an NBR1-MEKK3 complex as a key regulator of JNK signaling and adipose tissue inflammation in obesity."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,25040987,"MEKK3 expression was positively correlated with survivin."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,24975362,"Inhibitors of apoptosis proteins regulate myogenic differentiation by directly suppressing MEKK2/3-MEK5-ERK5 signaling."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,24418622,"We provide evidence for an intimate mutual control of the IKK complex by mitogen-activated protein kinase kinase kinase 3 (MEKK3) and transforming growth factor beta activated kinase 1 (TAK1)."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,24383423,"Alterations in MEKK3 expression occur in early stages of development of esophageal squamous cell carcinoma and are sustained during disease progression."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,22105580,"Proliferation of human IVD cells is regulated by exogenous and autocrine growth factors mainly via the MEK/ERK and PI-3K/Akt pathways."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99759,Q99759,20615764,"The regulation of NHEJ by EGFR was only blocked when ERK was affected by siRNA but not when AKT was knocked down. These data indicate that EGFR modulates DSB repair by regulating NHEJ via MAPK signalling."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,20495538,"EGFR and MAPK are actively involved in the pathobiology of serous cystic neoplasms of the pancreas."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,20448038,"PP2A plays an important role in the termination of LPA-mediated NF-kappaB activation through dephosphorylating and inactivating MEKK3"
https://pharos.nih.gov/idg/targets/Q99759,Q99759,20068038,"we report the identification of two regulatory phosphorylation sites at Thr-516 and Ser-520 within the kinase activation loop that is essential for MEKK3-mediated IkappaB kinase beta (IKKbeta)/NF-kappaB activation"
https://pharos.nih.gov/idg/targets/Q99759,Q99759,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99759,Q99759,19903815,"The rear end acidic cluster of the p62 PB1 domain is used to organize cytosolic aggregates or speckles-associated TRAF6-p62-MEKK3 complex for control of NF-kappaB activation."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,19560753,"These results strongly suggested that Hsp90 could work as the molecular chaperone of MEKK3."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,19265138,"Specific ablation of MEKK3 in T cells of conditional knockout mice does not significantly alter thymic T cell development, but leads to a peripheral T cell homeostasis defect."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,18308725,"identifies a potentially important regulatory step in MEKK3 signaling via dephosphorylation of Thr(294), which reduces 14-3-3 binding correlating with MEKK3 pathway activation"
https://pharos.nih.gov/idg/targets/Q99759,Q99759,17985933,"structural details of MEKK3 PB1 and its binding properties with mitogen-activated protein kinase kinase 5, human PB1."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,16737960,"TLR8-mediated MEKK3-dependent IKKgamma phosphorylation might play an important role in the activation of IKK complex, leading to IkappaBalpha phosphorylation"
https://pharos.nih.gov/idg/targets/Q99759,Q99759,16407301,"Serine526 is the only phosphorylation site within the activation loop of MEKK3; phosphorylation occurs in response to exogenous stimuli like osmotic stress."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,16260783,"TAK1 is recruited to the TNF-R1 complex via RIP and likely cooperates with MEKK3 to activate NF-kappaB in TNF-alpha signaling"
https://pharos.nih.gov/idg/targets/Q99759,Q99759,16039990,"We find that while hKSR-2 blocks MEKK3 activation, it has little to no effect on other members of the MAP3K family, including MEKK4, TAK1, and Ras-Raf, suggesting that its effects are selective."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,15572679,"RIP-dependent recruitment of MEKK3 plays a specific role in TNF-alpha signaling."
https://pharos.nih.gov/idg/targets/Q99759,Q99759,15047705,"MEKK3 has a role in NF-kappaB activation by the chemopreventive dithiolethione oltipraz"
https://pharos.nih.gov/idg/targets/Q99759,Q99759,15001576,"MEKK3 signaling and apoptosis is potentiated by TRAF7"
https://pharos.nih.gov/idg/targets/Q99759,Q99759,14662759,"results established that elevated expression of mitogen-activated protein kinase kinase kinase 3(MEKK3) appears to be a frequent occurrence in breast and ovarian cancers"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,28349059,"Pretreatment by IRE1 agonist tunicamycin or JNK agonist anisomycin attenuated the effect of psoralen on osteoporotic osteoblasts. Psoralen inhibited apoptosis of osteoporotic osteoblasts by regulating IRE1-ASK1-JNK pathway"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,28028021,"These results suggest that the platelet Ask1 plays an important role in regulation of hemostasis and thrombosis."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,27989136,"Shotgun mass spectrometry and manual validation identified 12 distinct ASK1 phosphosites. Targeted parallel reaction monitoring assays were used to track the phosphorylation dynamics of each confirmed site in response to treatment."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,27890558,"ASK1 phosphorylated and stabilized TLX, which led induction of HIF-1alpha, and its downstream VEGF-A in an Akt dependent manner."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,27869172,"CD40 activation resulted in down-regulation of Thioredoxin (Trx)-1 to permit ASK1 activation and apoptosis. Although soluble receptor agonist alone could not induce death, combinatorial treatment incorporating soluble CD40 agonist and pharmacological inhibition of Trx-1 was functionally equivalent to the signal triggered by mCD40L"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,27775615,"the data show that miRNA-mediated down-regulation of ASK1 protects mesenchymal stem cells during post-transplantation, leading to an increase in the efficacy of MSC-based cell therapy."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,27588831,"from the two catalytic cysteines of TRX1 the residue C32 is responsible for the high-affinity binding of TRX1 to the ASK1-TRX-binding domain in reducing conditions"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,27514745,"phosphorus NMR and time-resolved tryptophan fluorescence measurements suggest that 14-3-3zeta interacts with the kinase domain of ASK1 in close proximity to its active site, thus indicating this interaction might block its accessibility and/or affect its conformation."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,27221474,"Our results thus suggest that GSK-3beta is a key factor involved in ASK1 activation and reactive oxygen species-induced cell death."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,27050273,"Apoptosis signal-regulating kinase 1 (ASK1) expression was dramatically suppressed and correlated with hepatocyte nuclear factor 4alpha (HNF4alpha) levels in hepatocellular carcinoma (HCC) tissues."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,27045525,"ASK1 signalling regulates brown and beige adipocyte function."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,26912789,"Cross-talk between arginine methylation and serine phosphorylation in ASK1.PRMT5 is an ASK1-binding protein.PRMT5 mediates arginine methylation of ASK1."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,26773495,"Together, we suggest that 4SC-202 activates ASK1-dependent mitochondrial apoptosis pathway to potently inhibit human HCC cells."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,26707143,"curcumin and ABT-737 on HCC cells was investigated for the first time, to the best of our knowledge. It was found that curcumin markedly enhanced the antitumor effects of ABT-737 on HepG2 cells and activate ROS-ASK1-c-Jun N-terminal kinase pathway . ."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,26694167,"results suggest that baicalein-mediated ASK1/JNK activation regulates the mitochondria-dependent apoptosis pathway through the up-regulation of TAp63 and down-regulation of NF-kappaB and CD74/CD44 in B-cell malignancies"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,26661061,"The present findings thus support our notion that ROR1 sustains lung adenocarcinoma survival, at least in part, through direct physical interaction with ASK1"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,26405834,"ASK1 MAP kinase signaling cascade is an important regulator of chondrocyte terminal differentiation."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,26243192,"Data show that the MAPKKK6 ASK2, a modulator of MAPKKK5 ASK1 signaling, was essential for ASK1-dependent apoptosis, but not for inducing interferon-beta (IFNB) expression."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,26191261,"The expression of ASK1 is correlated with the level of claudin-6 in cervical carcinoma cells and tissues."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,26165383,"These results implicate the TNF/TRAF2/ASK1/p38 kinase pathway in modulating risk of pulmonary complications."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,26134265,"TNF-alpha-induced ASK1-p38/JNK pathway is an important mediator of cytokine synthesis and enhanced expression of adhesion molecules in rheumatoid arthritis and is inhibited by thymoquinone."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,26095851,"Cyclophilin A regulates JNK/p38-MAPK signaling through its physical interaction with ASK1."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,25982447,"Data indicates that ASK1 expression is regulated by MiR-19a by targeting specific sites in the 3' untranslated region of its mRNA."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,25901786,"ASK1 stabilizes APOBEC3G and binds HIV-1 Vif, disrupting assemble of the Vif-ubiquitin ligase complex, thus restoring the antiviral activity of APOBEC3g."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,25901786,"ASK1 restricts the replication of HIV-1 by inhibiting Vif activity and promoting APOBEC3G incorporation into virions in CD4+ T-cells"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,25797626,"Knockdown of IRE1alpha by siRNA dramatically abrogated CXC195-induced activation of TRAF2, ASK and JNK, formation of an IRE1alpha-TRAF2-ASK1 complex and caspase- and mitochondrial-dependent apoptosis in T24 cells"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,25752609,"Because the phosphorylation site mutants of NR4A2 cannot rescue the cell death-promoting activity, ASK1-p38 pathway-dependent phosphorylation and subsequent cytoplasmic translocation of NR4A2 may be required for oxidative stress-induced cell death."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,25391652,"Siah1 is a substrate of ASK1 for activation of the GAPDH-Siah1 oxidative stress signaling cascade."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,25135476,"Data show that ASK1 is critical for IFN gamma-induced DAPK1 via ATF6 recruitment."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,25116390,"Collectively, these data reveal that activation of the PI3K/Akt pathway limits JNK-mediated apoptosis by phosphorylating and inactivating ASK1 during human enterovirus 71 infection."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,25068797,"Findings suggest that methyl isocyanate inhibits angiogenesis by inducing mitogen-activated protein kinase kinase kinase 5 ASK1-JNK-dependent endothelial cell death."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,24912301,"It is activated in response to various stresses, such as reactive oxygen species (ROS)and endoplasmic reticulum (ER) stress, and plays pivotal roles in a wide variety of cellular responses, including cell death, differentiation and inflammation. (review)"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,24574456,"TNF-signaling dependence of ASK1-mediated apoptosis in melanoma cells."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,24448648,"data suggest that degradation of ASK1 mediated by Roquin-2 is an evolutionarily conserved mechanism required for the appropriate regulation of stress responses, including pathogen resistance and cell death"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,24082073,"In gastric epithelial cells, H. pylori activates ASK1 in a reactive oxygen species - and cag pathogenicity island-dependent manner, and ASK1 regulates sustained JNK activation and apoptosis induced by H. pylori."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,24008424,"MAP3K5 R256C mutation revealed attenuation of MKK4 activation through increased binding of the inhibitory protein thioredoxin (TXN/TRX-1/Trx), resulting in increased proliferation and anchorage-independent growth of melanoma cells."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,23986795,"ASK1 restricts the replication of HIV-1 by inhibiting Vif activity and promoting APOBEC3G incorporation into virions in CD4+ T-cells"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,23982205,"Data indicate that the ASK1-FoxO3a-TRADD-caspase 8 pathway is present in neural tube defects (NTDs)-affected tissues."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,23847689,"ASK1 restricts the replication of HIV-1 by inhibiting Vif activity and promoting APOBEC3G incorporation into virions in CD4+ T-cells"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,23799149,"Identification of the domain through which HIV-1 Nef interacts with ASK1 and inhibits its function."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,23799149,"ASK1 restricts the replication of HIV-1 by inhibiting Vif activity and promoting APOBEC3G incorporation into virions in CD4+ T-cells"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,23744074,"The models confirmed the reaction order, revealed processivity in the phosphorylation of MEK6 by ASK1, and suggested that the order of phosphorylation is dictated by both binding and catalysis rates."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,23580093,"Activation of ASK1/JNK signaling pathways by oridonin induces growth inhibition and apoptosis in cultured HuH-6 cells."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,23569274,"ASK1 signal cascades are negatively regulated by Notch1-IC."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,23556445,"Our data suggest that these MAP3K5 variants are indicative of beta-thalassemia disease severity and response to HU treatment."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,23416061,"ER stress-induced ASK1-p38 activation, which is triggered by the accumulation of Ins(C96Y), plays an important role in the pathogenesis of diabetes."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,23382671,"ASK1 restricts the replication of HIV-1 by inhibiting Vif activity and promoting APOBEC3G incorporation into virions in CD4+ T-cells"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,23319048,"Which activates the ASK-1 kinase pathway."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,23219526,"These results indicate that IL-6 activation occurs through ASK1 and p38, which in turn activates AP-1, resulting in the activation of VEGF expression."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,23102700,"Suggest that Slim/KLHDC10 is an activator of ASK1, contributing to oxidative stress-induced cell death through the suppression of PP5."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,23087182,"Ask1 is a direct target of miR-20a. Overexpression of miR-20a led to a global decrease in ASK1 protein in BLP- and LPS-activated cells indicating that miR-20a regulates the expression of ASK1 at the translational level."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,23031789,"ASK1 activates c-jun N-terminal kinase and p38 in response to various stimuli such as oxidative stress, endoplasmic reticulum stress, infection and calcium influx. (Review)"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,23015639,"Report changes in ASK1 cell signaling associated with ischemic/idiopathic cardiomyopathies."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,22925655,"ASK1 signal may play a positive role in the inhibitory effect of claudin-6 in breast cancer."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,22844345,"ASK1 restricts the replication of HIV-1 by inhibiting Vif activity and promoting APOBEC3G incorporation into virions in CD4+ T-cells"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,22723553,"A novel mechanism underlying the regulation of survival in normal and malignant plasma cells by ASK1."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,22609355,"MCRS2 plays a negative role in stress-induced ASK1 activation."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,22399290,"S100A1 and permanently active S100P inhibited the apoptosis signal-regulating kinase 1 (ASK1) and PP5 interaction, resulting the inhibition of dephosphorylation of phospho-ASK1 by PP5"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,22197930,"It was found that 24% of melanoma cell lines have mutations in the protein-coding regions of either MAP3K5 or MAP3K9."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,22167179,"TAK1 and its adapter protein, TAB2, reciprocally regulate both TAK1- and ASK1-mediated signaling pathways to direct the activations of NF-kappaB and AP-1."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,22095282,"Results indicate that arginine methylation of ASK1 by PRMT1 contributes to the regulation of stress-induced signaling that controls a variety of cellular events including apoptosis."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,21771788,"ZPR9 was found to physically interact with ASK1 through a disulfide linkage;ZPR9 functions as a novel positive regulator of ASK1."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,21764682,"The expression of MAP3K5 and miR-BART22 is inversely correlated, suggesting the possibility of MAP3K5 to serve as target gene of EBV miR-BART22 in nasopharyngeal carcinoma."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,21738216,"Stimulation of human aortic endothelial cells with TNF-alpha led to an increased expression of p73 protein and a reduction in the levels of p53 involving apoptosis signal-regulating kinase 1 (ASK1)."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,21725208,"These results suggest that p34 (SEI-1) inhibits ROS-induced cell death through by indirectly inducing ubiquitination of ASK1."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,21594902,"apoptosis signal-regulating kinase 1 has a role in chondrosarcoma cell apoptosis along with endoplasmic reticulum stress due to FPipTB"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,21510938,"knockdown of TXNIP prevented high glucose-induced cell apoptosis and activation of ASK1 may be via reduction of oxidative stress in mesangial cells."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,21496457,"Data show that ASK1 stabilizes SMN protein by inhibiting SMN poly-ubiquitination."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,21383696,"a monitoring mechanism of c-Myc and ASK1/p38 against abnormal ribosome biogenesis through controlling the stability and activity of p53 protein"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,21378396,"iron chelators significantly reduced ASK1-thioredoxin complex formation, resulting in the increased phosphorylation of ASK1, which activates the JNK and p38 pathways"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,21187402,"Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,20800594,"the blockage of the GSK-3beta-beta-catenin pathway resulting from the knockdown of ASK1 modulates the migration of breast cancer cells."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,20674765,"Data suggest that, despite structural divergence, PPEF and PP5 phosphatases may share common interacting partners and functions."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,20661259,"TLR4-mediated SphK1 activation was found to be critical for the redox-dependent activation of HIF-1alpha and ASK1, and the prevention of lipopolysaccharide-induced activation of caspase 3 and the expression interleukin-6."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,20609399,"ASK1 may be critical for the development of rheumatoid arthritis (RA) and ASK1 may be involved in the production of proinflammatory mediators in response to TNF-alpha stimulation in the RA joint."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,20601186,"These results indicate that the ASK1-p38 MAPK cascade may regulate LPS-induced TF expression in pulmonary microvasculature."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,20512919,"These results strongly indicate ST13 mediated by adenovirus triggers colorectal cell apoptosis via ASK1-JNK signaling cascade"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,20430109,"Down-regulation of thioredoxin, increased intracellular reactive oxygen species, and activation of ASK1-ERK/p38 MAPK signaling all were associated with Japanese encephalitis virus-induced apoptosis."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,20364819,"data suggest that oxidative stress rapidly increases ASK1 catalytic efficiency for MKK6 phosphorylation by increasing MKK6 binding affinity within the ASK1"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,20213747,"DJ-1, by directly inhibiting ASK1, may act as a negative regulator in ASK1 signaling cascades."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,20185809,"ASK1 variants may increase susceptibility to type 2 diabetes by decreasing insulin sensitivity via reduced ASK1 expression."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,20185809,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,20130137,"These results reveal that, during influenza A virus infection, the PI3K/Akt pathway negatively regulates the JNK pathway via ASK1, thereby inhibiting JNK-dependent, Bax-mediated apoptosis."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,20068037,"ASK1 restricts the replication of HIV-1 by inhibiting Vif activity and promoting APOBEC3G incorporation into virions in CD4+ T-cells"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,20048146,"apoptosis inducers also induced phosphorylation of ASK1 in a ROS-dependent manner. Suppression of ASK1 expression blocked the effects of apoptosis, in hypertonic conditions, on both regulatory volume increase induction and Akt activation"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,20035634,"genes MAP3K5 and PDIA3 are associated with malignant stages of prostate cancer and therefore provide novel potential biomarkers"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19961619,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19940360,"Study shows an essential role for apoptosis signal-regulating kinase 1 (ASK1), together with both c-jun-N-terminal kinase (JNK) and p38 pathways, and caspase-8 in Fas-induced apoptosis."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19935702,"Upstream signals couple ASK2 S964 phosphorylation to the ASK1 signalosome through dual engagement of 14-3-3."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19920149,"results provide evidence that PDK1 and ASK1 directly interact and phosphorylate each other and act as negative regulators of their respective kinases in resting cells"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19903888,"Data show that DAB2IP is a potent growth inhibitor by inducing G(0)/G(1) cell cycle arrest and is proapoptotic in response to stress, and that DAB2IP can suppress the PI3K-Akt pathway and enhance ASK1 activation leading to cell apoptosis."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19880523,"STRAP can act as a negative regulator of ASK1."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19748889,"Inhibition of apoptosis by GIP is mediated via a key pathway involving Akt-dependent inhibition of apoptosis signal-regulating kinase 1, which subsequently prevents the pro-apoptotic actions of p38 MAPK and JNK."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19590015,"Results suggest that this member of the PGAM family has crossed over from small molecules to protein substrates and been adapted to serve as a specialized activator of ASK1."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19570911,"Data show that Cys250 is essential for H(2)O(2)-dependent JNK signaling downstream from ASK1 but at a step subsequent to the phosphorylation of ASK1 Thr838."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19449444,"ASK1 restricts the replication of HIV-1 by inhibiting Vif activity and promoting APOBEC3G incorporation into virions in CD4+ T-cells"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19351724,"An Ask1-MKK4-p38MAPK/JNK pathway reflects adipocyte stress associated with adipose tissue inflammation, linking visceral adiposity to whole-body insulin resistance in obesity."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19306926,"beta-Arrestins play a negative regulatory role in hydroegn peroxide-induced apoptosis signaling through associating with ASK1 and CHIP and facilitating ASK1 degradation."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19293155,"Cytoprotective binding of DJ-1 to ASK1 depends on the central redox-sensitive Cys-106 and may be modulated by peripheral cysteine residues."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19287004,"JAK2-SOCS1 and SHP2 reciprocally regulate ASK1 phosphorylation and stability in response to cytokines."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19149577,"ASK1 restricts the replication of HIV-1 by inhibiting Vif activity and promoting APOBEC3G incorporation into virions in CD4+ T-cells"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19004820,"an essential role for ASK1 in cell death induced by ER stress."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,19001375,"the molecular interactions of arrestin2 and arrestin3 and their individual domains with the components of the two MAPK cascades, ASK1-MKK4-JNK3 and c-Raf-1-MEK1-ERK2"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,18841476,"Data show that nitric oxide derived from S-nitrosoglutathione activates ASK1 in THP-1 human myeloid macrophages, induces accumulation of HIF-1alpha protein, and induces accumulation of p53 in normal but not HIF-1alpha knockdown THP-1 cells."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,18822283,"DDTD, an isoflavone derivative, induces cell apoptosis through the reactive oxygen species/apoptosis signal-regulating kinase 1 pathway in human osteosarcoma cells."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,18759454,"The precursor of atrial natriuretic peptide, natriuretic peptide precursor (NPPA), physically interacts with the N-terminus of apoptosis signal-regulating kinase 1 (ASK1), negatively impacting NPPA processing and/or secretion."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,18501712,"These findings suggest a negative role of Prx-1 in ASK1-induced apoptosis."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,18380010,"Data suggest that in nonapoptotic cells, endogenous ASK1 protein is normally cleaved at a number of specific sites, some of which are in the kinase domain."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,18327563,"Data suggest that sequence variations of ASK1 and MAP2K6 lead to partially sex-specific changes in the levels and/or phosphorylation states of p38 and p38-regulated proteins that might contribute to the observed delaying effects in the age of onset of HD."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,18292600,"PP2A and AIP1 cooperatively induce activation of ASK1-JNK signaling and vascular endothelial cell apoptosis."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,18219322,"SENP1 mediates TNF-induced desumoylation and translocation of HIPK1, leading to an enhanced ASK1-dependent apoptosis."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,18211888,"ROS-mediated activation of the ASK1-p38 MAPK pathway downstream of P2X(7) receptor is required for ATP-induced apoptosis in macrophages."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,18178252,"The present study thus defines a novel role for ASK1 as a mediator of C5b-9-dependent cell injury."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,18054391,"present study shows that inhibition of PI3 kinase by LY294002 in THP-1 cells exposed to LPS attenuated down-regulation of ASK1 activity followed by programmed cell death"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,18028450,"these results indicate that activation of the ASK1/p38 MAPK/p47phox cascade plays a central role in PPD/TLR2-induced ROS generation and suggests the existence of a 'ROS/ASK1' inflammatory amplification feedback loop in monocytes/macrophages."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,17937911,"the structure of the human ASK1 catalytic domain in complex with staurosporine"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,17883330,"discusses the molecular mechanisms by which ASK1 functions in stress and immune responses and discuss the possible involvement of ASK1 in human diseases [review]"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,17827388,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,17652454,"These results indicate that Ask1 oxidation is required at a step subsequent to activation for signaling downstream of Ask1 after H(2)O(2) treatment."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,17595347,"ASK1 expression levels can be regulated by G alpha13, at least in part via control of ASK1 ubiquitination and degradation"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,17543279,"ghrelin inhibits ASK1-mediated apoptosis and ASK1 activation by a mechanism involving induction of HSP70"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,17541429,"Gemin5 functions as a scaffold protein for the ASK1-JNK1 signaling module and thereby potentiates ASK1-mediated signaling events."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,17456047,"These results suggest that PP2Cepsilon maintains ASK1 in an inactive state by dephosphorylation in quiescent cells, supporting the possibility that PP2Cepsilon and PP5 play different roles in H2O2-induced regulation of ASK1 activity."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,17389591,"TNF-induced TRAF2-RIP1-AIP1-ASK1 complex formation and for the activation of ASK1-JNK/p38 apoptotic signaling."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,17331470,"ASK1 is activated by arsenic trioxide through reactive oxygen species accumulation and may negatively regulate apoptosis in leukemic cells without activating p38 and JNK"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,17325029,"Binding of cyclin-dependent kinase inhibitor 1A to ASK1 requires ASK1 kinase function and may involve phosphorylation of S98"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,17244475,"Current findings for the relationship between pathogenesis and ASK1-MAPK pathways."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,17220297,"TNFR2 signaling induces selective c-IAP1-dependent ASK1 ubiquitination and terminates mitogen-activated protein kinase signaling"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,17210579,"Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,16644673,"TNF-alpha increases mitochondrial ROS and activates ASK1 in human hepaatoma cells and these TNF-alpha-induced phenomena contribute to impaired insulin signaling."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,16636664,"Glutathione S-transferase P1-1 attenuate TRAF2-enhanced apoptosis signal-regulating kinase 1 (ASK1) (MAP3K5)autophosphorylation"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,16532036,"reactive oxygen species generated by Nox4, at least in part, transmit cell survival signals through the AKT-ASK1 pathway in pancreatic cancer cells and their depletion leads to apoptosis."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,16515547,"This study clearly shows the route from ROS generation by 6-OHDA to initiation of p38/JNK signalling via activation of ASK1 in the studied Parkinson disease model."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,16512785,"E2 promoter-binding factors regulate the expression of ASK1. overexpression and RNA interference experiments support the requirement of endogenous E2F/DP (E2F dimerization partner) activity for ASK-1 expression."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,16476732,"concomitant induction of E2F1 targets ASK1 and Bim by HDACIs warrants an effective activation of E2F1-dependent apoptosis in response to suberoylanilide hydroxamic acid"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,15925322,"Raf-1 may mediate its anti-apoptotic function by interrupting ASK1-dependent phosphorylation of ALG-2."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,15864780,"ASK1-p38 cascade regulates the innate immunity of the skin by forming an immune barrier consisting of hBD, LL37, and TLR2 during epidermal differentiation."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,15843568,"ASK1 kinase is a central player upstream of p38 MAPK activation when secreted Helicobacter pylori antigen HP0175 effects induction of apopotosis in human gastric epithelial cell line AGS."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,15782121,"Hsp90-Akt forms a complex with ASK1 and protect vascular endothelium from stress-induced apoptosis."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,15755722,"PKD is a critical mediator in H2O2- but not TNF-induced ASK1-JNK signaling"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,15701637,"TNFalpha-induced desumoylation and cytoplasmic translocation of HIPK1 are critical in TNFalpha-induced ASK1-JNK/p38 activation"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,15670787,"Taken together, our data suggested that the JNK/c-Jun signaling cascade plays a crucial role in Cd-induced neuronal cell apoptosis and provides a molecular linkage between oxidative stress and neuronal apoptosis."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,15328343,"PP5 plays an important role in the survival of cells in a low oxygen environment by suppressing a hypoxia-induced ASK-1/MKK4/JNK signaling cascade that promotes an apoptotic response"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,15310755,"AIP1 is a novel transducer in TNF-induced TRAF2-dependent activation of ASK1 that mediates a balance between JNK versus NF-kappaB signaling"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,15246877,"apoptosis signal-regulating kinase 1 is activated by S-nitrosation of thioredoxin in the nitrogen monoxide/superoxide system"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,15218033,"ASK1 signaling is activated by PP5, which is regulated by mTOR"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,15210709,"apoptosis signal-regulating kinase 1 binds directly to retinoblastoma protein and has roles in apoptotic signaling and cell cycle"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,14688258,"ASK1 is regulated by reactive oxygen species through dephosphorylation at serine 967 and 14-3-3 dissociation"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,14668338,"results suggest that nitric oxide mediates the interferon-gamma-induced inhibition of apoptosis signal regulating kinase 1(ASK1) in L929 cells through a thiolredox mechanism"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,12968034,"glucose deprivation activates the ASK1-SEK1-JNK1-HIPK1 pathway, relocalizing Daxx from the nucleus to the cytoplasm, where Daxx binds to ASK1, and subsequently leads to ASK1 oligomerization"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,12813029,"These data suggest that AIP1 mediates TNF-alpha-induced ASK1 activation by facilitating dissociation of inhibitor 14-3-3 from ASK1, a novel mechanism by which TNF-alpha activates ASK1."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,12566458,"ASK1 is one of the factors involved in the caspase-independent pathway of LTbetaR-induced cell death."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,12556535,"Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis through this enzyme."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,12482984,"Tumorigenic mutants of p53 bind to Daxx and inhibit Daxx-dependent activation of the apoptosis signal-regulating kinase 1 stress-inducible kinases and Jun NH(2)-terminal kinase."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,12473108,"ASK1 binds to PKR and is involved in apoptosis signalling pathways"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,12189133,"role in activating the JNK and p38 MAP kinase cascades in response to environmental stresses such as reactive oxygen species"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,11493600,"Ask1 has a caspase-independent killing function independent of kinase activity and activable by interaction with Daxx. Induced after translocation of Daxx from the nucleus to the cytoplasm, which occurs following activation of the death receptor Fas."
https://pharos.nih.gov/idg/targets/Q99683,Q99683,11323689,"ASK1 restricts the replication of HIV-1 by inhibiting Vif activity and promoting APOBEC3G incorporation into virions in CD4+ T-cells"
https://pharos.nih.gov/idg/targets/Q99683,Q99683,11298454,"ASK1 restricts the replication of HIV-1 by inhibiting Vif activity and promoting APOBEC3G incorporation into virions in CD4+ T-cells"
https://pharos.nih.gov/idg/targets/P36507,P36507,28178421,"High MEK2 expression is associated with inflammation."
https://pharos.nih.gov/idg/targets/P36507,P36507,27956260,"There are no other biomarkers correlated with treatment responses following MEK1/2 inhibition."
https://pharos.nih.gov/idg/targets/P36507,P36507,27751966,"The patient showed a paternally inherited 16p13.11 microduplication and a de novo 19p13.3 microdeletion involving the mitogen-activated protein kinase kinase 2 gene (MAP2K2), in which mutations cause the cardio-facio-cutaneous (CFC) syndrome"
https://pharos.nih.gov/idg/targets/P36507,P36507,27181679,"MEK2 was essential for the phosphorylation of MKK3/MKK6 and p38 MAPK that directly impacted on cyclin D1 expression."
https://pharos.nih.gov/idg/targets/P36507,P36507,27098723,"the purpose of this paper was to investigate MAPK downstream signalling molecules in Natural killer cell phenotypes from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients."
https://pharos.nih.gov/idg/targets/P36507,P36507,26973648,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,26956845,"there were significant decreases in intercellular adhesion molecules 1 (ICAM1), ezrin (EZR), mitogen-activated protein kinase kinase 2 (MAP2K2), and nitric oxide synthase 3 (NOS3) gene expressions in metabolic syndrome patients."
https://pharos.nih.gov/idg/targets/P36507,P36507,26858456,"Endocytosis separates EGF receptors from endogenous fluorescently labeled HRas and diminishes receptor signaling to MAP kinases in endosomes."
https://pharos.nih.gov/idg/targets/P36507,P36507,26625317,"Data show that mitogen-activated protein kinase kinases MEK1/2 inhibitor pimasertib (MEKI) sensitized the cells to apoptosis through its ability to promote a G1 cell cycle arrest."
https://pharos.nih.gov/idg/targets/P36507,P36507,26163823,"MEK1 levels are upregulated at transcriptional level whereas MEK2 levels are downregulated at posttranslational level."
https://pharos.nih.gov/idg/targets/P36507,P36507,26155939,"at clinically relevant concentrations, cDDP binds to and inhibits MEK1/2 and both the binding and inhibitory activity are related to its interaction with Cu bound to MEK1/2"
https://pharos.nih.gov/idg/targets/P36507,P36507,26078274,"MK2 attenuates dendritic cell-mediated Th1 differentiation and autoimmune encephalomyelitis."
https://pharos.nih.gov/idg/targets/P36507,P36507,25722381,"MEK1/2 inhibitor trametinib showed similar PFS and a response rate as docetaxel in patients with previously treated KRAS-mutant-positive non-small cell lung carcinoma."
https://pharos.nih.gov/idg/targets/P36507,P36507,25487361,"We report on a fourth familial case with transmission of CFC syndrome from father to son due to a novel heterozygous sequence change c.376A>G (p.N126D) in exon 3 of MEK2 gene."
https://pharos.nih.gov/idg/targets/P36507,P36507,25463315,"We documented three novel mutations in the BRAF gene in cardio-facio-cutaneous syndrome patients and correlated clinical findings with causative mutations in the BRAF or MEK1/MEK2 genes"
https://pharos.nih.gov/idg/targets/P36507,P36507,25425646,"CCR7 can also promote survival of mDCs through a novel MEK1/2-ERK1/2-AMPK signaling axis."
https://pharos.nih.gov/idg/targets/P36507,P36507,25218145,"Both ACE inhibition and MEK1/2 inhibition have beneficial effects on left ventricular function in Lmna(H222P/H222P) mice and both drugs together have a synergistic benefit when initiated after the onset of left ventricular dysfunction."
https://pharos.nih.gov/idg/targets/P36507,P36507,24501087,"our data emphasizes the importance of the translational regulation of p21 by the MEK1/2-ERK1/2-p70S6K pathway to negatively control the cell cycle progression."
https://pharos.nih.gov/idg/targets/P36507,P36507,24311457,"we report familial patients with multiple cafe au lait spots and Noonan syndrome-like facial features who carried mutations in MAP2K2."
https://pharos.nih.gov/idg/targets/P36507,P36507,24011934,"Data indicate that dual targeted inhibitors of PI3K/mTOR in combination with inhibitors of RAS/ERK signalling as a potentially effective approach to treating ovarian cancer."
https://pharos.nih.gov/idg/targets/P36507,P36507,23684925,"Report a synthetic lethal interaction between PI3K/mTOR and MEK inhibitors in rhabdomyosarcoma."
https://pharos.nih.gov/idg/targets/P36507,P36507,23555914,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,23423222,"Gene expression changes due to neurofibromin modulation but independent of NRAS and MEK1/2 regulation in malignant peripheral nerve sheath tumor cells indicated bone morphogenetic protein 2 (Bmp2) signaling as a key pathway."
https://pharos.nih.gov/idg/targets/P36507,P36507,23379592,"Our cohort of seven individuals with MEK2 deletions has overlapping features associated with RASopathies."
https://pharos.nih.gov/idg/targets/P36507,P36507,23237773,"JTP-74057 is a novel MEK1/2 inhibitor able to sustain MEK in an unphosphorylated form resulting in pronounced suppression of the downstream signaling pathways involved in cellular proliferation."
https://pharos.nih.gov/idg/targets/P36507,P36507,22946697,"Data indicate that of the 32 cardio-facio-cutaneous syndrome (CFC) patients, 28 (88%) had a known mutation in a gene that is causative for CFC, including BRAF (n = 21), MEK1 (n = 2), MEK2 (n = 4), and KRAS (n = 1)."
https://pharos.nih.gov/idg/targets/P36507,P36507,22935974,"osteosarcoma patients whose tumors expressed pMEK2 had a poorer clinical outcome than those whose tumors did not."
https://pharos.nih.gov/idg/targets/P36507,P36507,22902540,"IL1beta treatment reduces SHBG production in HepG2 cells by the down-regulation of HNF-4A via the MAPK kinase (MEK)-1/2 and c-Jun N-terminal kinase (JNK) MAPK signaling pathways."
https://pharos.nih.gov/idg/targets/P36507,P36507,22895183,"MEK2 regulates ribonucleotide reductase activity through functional interaction with ribonucleotide reductase small subunit p53R2."
https://pharos.nih.gov/idg/targets/P36507,P36507,22833572,"C-MYC as a key driver of cell proliferation downstream of RAF-->MEK1/2-->ERK signaling."
https://pharos.nih.gov/idg/targets/P36507,P36507,22805292,"Data show substantial clinical activity of MEK1/2 inhibitor trametinib in melanoma and suggest that MEK is a valid therapeutic target."
https://pharos.nih.gov/idg/targets/P36507,P36507,22805291,"Define the maximum tolerated dose and recommended phase 2 dose of MEK1/2 inhibitor trametinib and to assess its safety, pharmacokinetics, pharmacodynamics, and response rate in individuals with advanced solid tumours."
https://pharos.nih.gov/idg/targets/P36507,P36507,22298595,"Findings indicate that Ras-induced nuclear accumulation of activated MEK1/2 was reliant on downregulation of the spatial regulator Sef."
https://pharos.nih.gov/idg/targets/P36507,P36507,22197931,"Screening a cohort of individuals with melanoma revealed the presence of recurring somatic MAP2K1 and MAP2K2 mutations, which occurred at an overall frequency of 8%."
https://pharos.nih.gov/idg/targets/P36507,P36507,22185284,"E-cadherin is necessary for localization of DLG1 but not phosphorylated MEK2 to the midbody ring during cytokinesis."
https://pharos.nih.gov/idg/targets/P36507,P36507,22052387,"LPS increased IL-8 and IL-6 and decreased EVT invasion through activation of MEK1/2 MAPK signaling"
https://pharos.nih.gov/idg/targets/P36507,P36507,21969554,"Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b."
https://pharos.nih.gov/idg/targets/P36507,P36507,21615688,"hDlg acts as a MEK2-specific scaffold protein for the ERK signaling pathway."
https://pharos.nih.gov/idg/targets/P36507,P36507,21509657,"Data report the full-length structure of MEK2 obtained by homology modeling and molecular dynamics simulations."
https://pharos.nih.gov/idg/targets/P36507,P36507,21458501,"Data show that mitogen-activated protein kinase kinases direct mitochondrial biogenesis by selectively inducing PGC-1beta expression."
https://pharos.nih.gov/idg/targets/P36507,P36507,21447798,"Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells."
https://pharos.nih.gov/idg/targets/P36507,P36507,21445343,"ETS1 is probably mediating high CIP2A expression in human cancers with increased EGFR-MEK1/2-ERK pathway activity"
https://pharos.nih.gov/idg/targets/P36507,P36507,21365009,"In the absence of other MKK, MEK2 is sufficient for SK-MEL-28 cell proliferation and anchorage-dependent growth."
https://pharos.nih.gov/idg/targets/P36507,P36507,21178588,"familial inheritance of cardiofaciocutaneous syndrome with MEK2 mutation"
https://pharos.nih.gov/idg/targets/P36507,P36507,20885957,"Apoptosis induction by MEK1/2 inhibition in human lung cancer cells is mediated by Bim."
https://pharos.nih.gov/idg/targets/P36507,P36507,20837746,"MEK1 and MEK2 play a part in the induction of the proinflammatory cytokine."
https://pharos.nih.gov/idg/targets/P36507,P36507,20404718,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,20358587,"This first reported case of a vertically transmitted functional Cardio-facio-cutaneous syndrome MEK mutation."
https://pharos.nih.gov/idg/targets/P36507,P36507,20302979,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P36507,P36507,20172001,"These results demonstrate that MEK1 and MEK2 act differently and that herpes simplex virus type 2 hijacks host MEK1 for its own amplification."
https://pharos.nih.gov/idg/targets/P36507,P36507,19884766,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,19858308,"This study demonstrated that H. pylori LPS may be a pathogenic factor causing gastric tumors by enhancing cell proliferation and inflammation via the MAPK cascade in gastric epithelial cells."
https://pharos.nih.gov/idg/targets/P36507,P36507,19816936,"Data show that oncogenic level of ERK1/2 phosphorylation appears to be MEK1 and MEK2 dependent in basal condition."
https://pharos.nih.gov/idg/targets/P36507,P36507,19681119,"Investigated the prevalence of PTPN11, HRAS, KRAS, NRAS, BRAF, MEK1, and MEK2 mutations in a relatively large cohort of primary embryonal Rhabdomyosarcoma (RMS) tumors. No mutation was observed in BRAF and MEK genes."
https://pharos.nih.gov/idg/targets/P36507,P36507,19500021,"Different mutations in the MAPK pathway play distinct roles in the growth and invasion of thyroid cancer cells"
https://pharos.nih.gov/idg/targets/P36507,P36507,19496172,"SDF-1alpha acts through CXCR4 to activate MEK and ERK, which in turn activates IKKalpha/beta and NF-kappaB, resulting in the activations of alphavbeta3 integrins and contributing the migration of human osteosarcoma cells."
https://pharos.nih.gov/idg/targets/P36507,P36507,19453261,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P36507,P36507,19447520,"SGK1 expression during liver regeneration is a part of a signaling pathway that is necessary for enhancing ERK signaling activation through modulating the MEK/ERK complex formation."
https://pharos.nih.gov/idg/targets/P36507,P36507,19206169,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P36507,P36507,19164283,"MEK1/2 phosphorylates ERK1/2, which phosphorylates Sp1 and AP-1 that in turn bind to their respective binding sites to regulate the expression of human VIL2 in ESCC cells."
https://pharos.nih.gov/idg/targets/P36507,P36507,19156172,"Spectrum of MEK2 gene mutations in cardio-facio-cutaneous syndrome and genotype-phenotype correlations"
https://pharos.nih.gov/idg/targets/P36507,P36507,19156172,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P36507,P36507,19014680,"MEK1 & MEK2 isoforms have similar transforming properties & are able to induce formation of metastatic intestinal tumors in mice; results suggest MEK2 plays a more important role than MEK1 in sustaining proliferation of human colorectal cancer cells"
https://pharos.nih.gov/idg/targets/P36507,P36507,18617556,"Esophageal cells from GERD patients with Barrett's esophagus have elevated MEK1 phosphorylation and decreased MEK1/MEK2 activity."
https://pharos.nih.gov/idg/targets/P36507,P36507,18569454,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,18424438,"the induction of inflammatory genes by farnesol is mediated by the activation of the NF-kappaB pathway and involves MEK1/2-ERK1/2-MSK1-dependent phosphorylation of p65/RelA(Ser(276))"
https://pharos.nih.gov/idg/targets/P36507,P36507,18413255,"study describes the biochemical characterization of novel BRAF and MEK germline mutations in cardio-facio-cutaneous syndrome"
https://pharos.nih.gov/idg/targets/P36507,P36507,18390968,"Phase I trial of MEK1/2 inhibitor AZD6244 in tumor patients."
https://pharos.nih.gov/idg/targets/P36507,P36507,18060073,"BRAF and MEK1/2 mutations may be more common than anticipated in ovarian cancer which could have important implications for treatment of patients with this disease and suggests potential new therapeutic avenues"
https://pharos.nih.gov/idg/targets/P36507,P36507,18042262,"the results of HRAS, BRAF and MAP2K1/2 mutation screening in a large cohort of patients with CS and CFC"
https://pharos.nih.gov/idg/targets/P36507,P36507,17981815,"study reports data concerning the biochemical functions of novel MEK1 and MEK2 mutants found in patients with cardio-facio-cutaneous syndrome, as well as the roles of these genes in the MAPK signaling cascade"
https://pharos.nih.gov/idg/targets/P36507,P36507,17704260,"3 novel mutations for MEK2 (L46_E55del, K61T, A62P) were identified in 15 patients with cardio-facio-cutaneous syndrome."
https://pharos.nih.gov/idg/targets/P36507,P36507,17461449,"These results indicated that the activation of CXCR4 and its signaling pathways (MEK1/2 and Akt) are essential for CXCL12-induced cholangiocarcinoma cell invasion."
https://pharos.nih.gov/idg/targets/P36507,P36507,17419998,"Mek1/2 are functionally redundant in the epidermis, where they act as a linear relay in the MAPK pathway to mediate development and homeostasis."
https://pharos.nih.gov/idg/targets/P36507,P36507,17366577,"mutational analysis of KRAS, BRAF, and MAP2K1/2 in 56 patients with CFC syndrome; comparison of the genotype-phenotype correlation of CFC with that of Costello syndrome suggest a significant clinical overlap but not genotype overlap."
https://pharos.nih.gov/idg/targets/P36507,P36507,17101779,"MEK1 exports PPARgamma from the nucleus, and this finding was supported by small interfering RNA knockdown of MEK1 and use of a cell-permeable interaction-blocking peptide, which prevented tetradecanoyl phorbol acetate-induced export of PPARgamma."
https://pharos.nih.gov/idg/targets/P36507,P36507,17038630,"Inhibition of overactive ras-MEK-ERK pathway in HepG2 cells can correct the defect in VLDL assembly leading to the secretion of VLDL-sized particles, similar to primary hepatocytes, implicating the MEK-ERK cascade in VLDL assembly in the HepG2 model."
https://pharos.nih.gov/idg/targets/P36507,P36507,16957420,"Taxotere and MEK1/2 inhibitors have the potential to suppress mammary tumor growth in vivo."
https://pharos.nih.gov/idg/targets/P36507,P36507,16651638,"These data suggest a role for mitochondrially generated reactive oxygen species and Ca(2+) in the redox cell signaling path-ways, leading to ERK activation and adaptation of the pathological stress mediated by oxidized lipids such as lysoPC."
https://pharos.nih.gov/idg/targets/P36507,P36507,16454711,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,16439621,"findings demonstrate that heterogeneous de novo missense mutations in three genes within the mitogen-activated protein kinase pathway, BRAF, MEK1 and MEK2 cause cardio-facio-cutaneous syndrome"
https://pharos.nih.gov/idg/targets/P36507,P36507,16332685,"a novel signaling pathway involving MKK-2 and ERK1/2 may down-regulate the activity of PABP and eIF4E by controlling their phosphorylation and compensates for the effect of excess cellular PABP"
https://pharos.nih.gov/idg/targets/P36507,P36507,16239230,"PP2A ABalphaC and ABdeltaC holoenzymes function as positive regulators of Raf1-MEK1/2-ERK1/2 signaling by targeting Raf1"
https://pharos.nih.gov/idg/targets/P36507,P36507,16103188,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,15979847,"The ability of constitutively-active human MEK2 to stimulate ERK phosphorylation and to induce the neoplastic transformation of NIH 3T3 cells required the integrity of the D-site was found."
https://pharos.nih.gov/idg/targets/P36507,P36507,15638726,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,15543157,"X-ray structures of human MEK1 and MEK2, each determined as a ternary complex with MgATP and an inhibitor to a resolution of 2.4 A and 3.2 A, respectively"
https://pharos.nih.gov/idg/targets/P36507,P36507,15292274,"Molecular cross-talk between MEK1/2 and mTOR signaling during recovery of 293 cells from hypertonic stress."
https://pharos.nih.gov/idg/targets/P36507,P36507,15284233,"Has distinct ways to contribute to a regulated ERK activity and cell cycle progression."
https://pharos.nih.gov/idg/targets/P36507,P36507,15071496,"Results suggest a physiological link between beta-dystroglycan and mitogen-activated protein kinase kinase 2 (MEK2), and localize MEK with dystroglycan in membrane ruffles."
https://pharos.nih.gov/idg/targets/P36507,P36507,14672918,"Stress-related signaling pathways in epithelial cells are modulated by hypoxia and confer protection from reoxygenation, since hypoxia and chemical inhibition of p38mapk and MEK1/2 similarly increase cytolysis resulting from O2-."
https://pharos.nih.gov/idg/targets/P36507,P36507,14656894,"MEK1,2 response element that mediates angiotensin II-stimulated PAI-1 promoter activation and shows that activation of this element requires Sp1 and AP-1 co-activation."
https://pharos.nih.gov/idg/targets/P36507,P36507,14517288,"HuR and MK2 in regulating the expression of uPA and uPAR genes at the posttranscriptional level"
https://pharos.nih.gov/idg/targets/P36507,P36507,14499342,"MAPK activated protein kinase-2 mediates both ERK- and p38 MAPK-dependent neutrophil responses."
https://pharos.nih.gov/idg/targets/P36507,P36507,12839928,"results show that p38-mediated dephosphorylation of MEK1,2 mediates initiation of apoptosis"
https://pharos.nih.gov/idg/targets/P36507,P36507,12775419,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,12612059,"Inhibition of either phosphatidylinositol 3-kinase (PI3-K) or Mek1/2 signaling pathways completely abrogated the IGF-I-induced increase in VEGF secretion and promoter activity"
https://pharos.nih.gov/idg/targets/P36507,P36507,12582162,"MK2 phosphorylates TSC2, which creates a 14-3-3 binding site and thus regulates the cellular function of the TSC2 tumor suppressor protein"
https://pharos.nih.gov/idg/targets/P36507,P36507,12531514,"Data show that p-MEK1/2 and p-ERK1/2 are present in neurons in the initial stages of neurofibrillary degeneration in Alzheimer's disease, before deposition of beta-amyloid."
https://pharos.nih.gov/idg/targets/P36507,P36507,12505790,"MEK2 and p38 in IFN-gamma-mediated signal transduction and induction of C/EBP beta expression and activity associated with interleukin-6 (IL-6) secretion in colon epithelial cells."
https://pharos.nih.gov/idg/targets/P36507,P36507,12482669,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,12167619,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,12089333,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,12063167,"Activation of a Src-dependent Raf-MEK1/2-ERK signaling pathway is required for IL-1alpha-induced upregulation of beta-defensin 2 in human middle ear epithelial cells."
https://pharos.nih.gov/idg/targets/P36507,P36507,12032872,"MEK2 activity ad dual-phosphorylation were undetectable in expanding and self-renewing hematopoietic progenitors (HP). Adding IL-3, inducing maturation and cell death in HP, led to sustained high levels of MEK2 activity and dual-phosphorylation."
https://pharos.nih.gov/idg/targets/P36507,P36507,11726657,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,11579140,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,11409852,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,11260070,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,11134045,"MEK2 interacts with ERK2.  This interaction is mediated via a conserved N-terminal docking site in MEK2.  Note that this interaction was demonstrated using rat ERK2."
https://pharos.nih.gov/idg/targets/P36507,P36507,11134045,"MEK2 interacts with ERK1.  This interaction is mediated via a conserved N-terminal docking site in MEK2."
https://pharos.nih.gov/idg/targets/P36507,P36507,11044099,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,10982368,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,10799874,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,10780709,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,10509564,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,9621077,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,9558095,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,9325171,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/P36507,P36507,9223324,"HIV-1 Tat activates PRKCQ (PKC-theta) kinase activity, which leads to RELA (NFkB), NRAS, RAF1, MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK3 (ERK1), and MAPK1 (ERK2) activation, in Jurkat T cells that stably express Tat"
https://pharos.nih.gov/idg/targets/Q7RTN6,Q7RTN6,27170158,"We identified for the first time a homozygous point mutation in STRADA causing PMSE. Additional bi-allelic mutations related to PMSE thus far have not been observed in Baylor approximately 6,000 consecutive clinical WES cases, supporting the rarity of this disorder."
https://pharos.nih.gov/idg/targets/Q7RTN6,Q7RTN6,20424326,"aberrant nuclear accumulation of LKB1 caused by STRADalpha deficiency contributes to hyperactivation of mTORC1 signaling and disruption of neuronal lamination during corticogenesis"
https://pharos.nih.gov/idg/targets/Q7RTN6,Q7RTN6,19892943,"study describes structure of the core heterotrimeric LKB1-STRADalpha-MO25alpha complex, revealing an unusual allosteric mechanism of LKB1 activation; structure also reveals how mutations in Peutz-Jeghers syndrome & sporadic cancers impair LKB1 function"
https://pharos.nih.gov/idg/targets/Q7RTN6,Q7RTN6,19513107,"ATP and MO25alpha cooperate to maintain STRADalpha in an \"active\" closed conformation required for LKB1 activation."
https://pharos.nih.gov/idg/targets/Q7RTN6,Q7RTN6,19386264,"These data define a brush border induction pathway downstream of the Lkb1/Strad/Mo25 polarization complex, yet separate from other polarity events."
https://pharos.nih.gov/idg/targets/Q7RTN6,Q7RTN6,18854318,"STRADalpha.MO25alpha complexes containing LKB1 variants were equally effective at phosphorylating and activating AMPK, BRSK1, and BRSK2"
https://pharos.nih.gov/idg/targets/Q7RTN6,Q7RTN6,18687677,"LKB1 deacetylation is regulated by SIRT1 and that this in turn influences its intracellular localization, association with STRAD, kinase activity, and ability to activate AMPK."
https://pharos.nih.gov/idg/targets/Q7RTN6,Q7RTN6,18256292,"identify a multifactored mechanism to control LKB1 localization, and they suggest that the STRADbeta-LKB1 complex might possess unique functions in the nucleus"
https://pharos.nih.gov/idg/targets/Q7RTN6,Q7RTN6,17921699,"Several novel splice isoforms of STRADalpha that differentially affect the kinase activity, complex assembly, subcellular localization of LKB1 and the activation of the LKB1-dependent AMPK pathway were discovered."
https://pharos.nih.gov/idg/targets/Q7RTN6,Q7RTN6,12805220,"Identification and characterization of an LKB1-specific adaptor protein and substrate, STRAD. Results imply that STRAD plays a key role in regulating the tumor suppressor activities of LKB1."
https://pharos.nih.gov/idg/targets/O96013,O96013,28577975,"miR-1271/Zic2/PAK4 axis plays an important role in hepatocellular carcinoma progression."
https://pharos.nih.gov/idg/targets/O96013,O96013,28534509,"PAK4 downregulation decreased PPARgamma-mediated Nox1 expression and suppressed EMT in IR-treated glioma cells."
https://pharos.nih.gov/idg/targets/O96013,O96013,28432261,"Data suggest that signaling via ANP/ANPR (atrial natriuretic factor/ANP receptor) in vascular endothelial cells activates PAK4 (p21-activated kinase 4) and CCM2 (cerebral cavernous malformation 2 protein), resulting in phosphorylation of MLC (myosin light chain), cytoskeletal reorganization, and cell spreading; kinase homology domain of ANPRA (guanylyl cyclase-A) activates downstream targets of ANP/ANPR signaling."
https://pharos.nih.gov/idg/targets/O96013,O96013,28407679,"findings suggest that PAK4-activated PI3K/AKT signaling is both kinase-dependent and -independent, which contributes to breast cancer progression"
https://pharos.nih.gov/idg/targets/O96013,O96013,28393218,"Study demonstrated that PAK4 interacted with eEF1A1 to promote migration and invasion of gastric cancer cells, thereby providing new insights into the function of PAK4 and eEF1A1 in the progression of gastric cancer."
https://pharos.nih.gov/idg/targets/O96013,O96013,28288786,"The results support a novel connection between HIF-1a and Pak4 in hypoxic cancer cells, and provide insights into mechanisms whereby tumors respond to and thrive under oxygen-deficient conditions."
https://pharos.nih.gov/idg/targets/O96013,O96013,28096095,"Functional role and therapeutic targeting of PAK4 in multiple myeloma has been presented."
https://pharos.nih.gov/idg/targets/O96013,O96013,27919028,"these results indicate that PAK4 confers CDDP resistance via the activation of MEK/ERK and PI3K/Akt pathways. PAK4 and PI3K/Akt pathways can reciprocally activate each other."
https://pharos.nih.gov/idg/targets/O96013,O96013,27903866,"PAK4 activity was markedly decreased in postmortem brain tissue from Parkinson's disease (PD) patients and in rodent models of PD. Expression of constitutively active PAK4(S445N/S474E) (caPAK4) protected DA neurons in both the 6-hydroxydopamine and alpha-synuclein rat models of PD and preserved motor function."
https://pharos.nih.gov/idg/targets/O96013,O96013,27700527,"Our results indicate that PAK4 plays an important role in the potentiation of insulin secretion by fatty acids downstream of GPR40."
https://pharos.nih.gov/idg/targets/O96013,O96013,27496712,"PAK4 overexpression in hepatocellular carcinoma (HCC) promotes metastatic invasion by regulating p53 phosphorylation."
https://pharos.nih.gov/idg/targets/O96013,O96013,27297086,"High expression of PAK4 is associated with breast cancer."
https://pharos.nih.gov/idg/targets/O96013,O96013,26841865,"PAK4 methylation by SETD6 promotes the activation of the Wnt/beta-catenin pathway."
https://pharos.nih.gov/idg/targets/O96013,O96013,26614788,"In gastric cancer, High PAK4 expression was significantly correlated with clinicopathological variables related to tumour progression, including depth of invasion, metastatic lymph nodes, pathological stage, distant metastasis or recurrent disease. High PAK4 expression was significantly associated with poorer disease-specific survival and relapse-free survival."
https://pharos.nih.gov/idg/targets/O96013,O96013,26607847,"PAK4 catalytic domain binds cellular ATP and the Inka1 inhibitor. The crystal lattice consists only of PAK4-PAK4 contacts, which form a hexagonal array with channels of 80 A in diameter that run the length of the crystal."
https://pharos.nih.gov/idg/targets/O96013,O96013,26598620,"PAK4 and RhoU cooperate to drive adhesion turnover and promote cell migration."
https://pharos.nih.gov/idg/targets/O96013,O96013,26546043,"data show decreased nuclear accumulation and transcriptional activity of STAT3 in PAK4-silenced pancreatic cancer cells"
https://pharos.nih.gov/idg/targets/O96013,O96013,26411419,"Study has confirms prognostic role of PAK4 level in cervical cancer patients and recognizes the regulatory role in cervical cancer progression. PAK4 also confers the chemoresistance of cervical cancer cells in a PI3K/Akt-dependent way."
https://pharos.nih.gov/idg/targets/O96013,O96013,26218748,"Nuclear Pak4 is involved in the pathogenesis of endometrial cancer especially in postmenopausal women."
https://pharos.nih.gov/idg/targets/O96013,O96013,26124003,"this report reveals that high level of p-Pak4 correlates with poor prognosis in gastric cancer (GC), thereby suggesting that p-Pak4 might be a potential prognostic marker for GC."
https://pharos.nih.gov/idg/targets/O96013,O96013,26068882,"PAK4 localizes to cell-cell junctions and contributes to estblishing cell polarity.PAK4 phosphorylate beta-catenin Serine-675.PAK4 binding to cell-cell junctions is dependent on Cdc42."
https://pharos.nih.gov/idg/targets/O96013,O96013,25975262,"PAK4 mediated LIMK1 phosphorylation regulates the migration and invasion in NSCLC. Therefore, PAK4 might be a significant prognostic marker and potential therapeutic molecular target in NSCLC."
https://pharos.nih.gov/idg/targets/O96013,O96013,25791829,"PAK1 and PAK4 expression were associated with colorectal cancer metastasis and infiltration"
https://pharos.nih.gov/idg/targets/O96013,O96013,25662318,"PAK4 phosphorylates Par6B at Ser143 blocking its interaction with Cdc42."
https://pharos.nih.gov/idg/targets/O96013,O96013,25637478,"Increased Pak4 expression can lead to development of adenomyosis by enhancing the invasiveness of endometrial cells through regulation of MMP-2 and -9 activities."
https://pharos.nih.gov/idg/targets/O96013,O96013,25560280,"PAK4 promotes alpha-MSH/UVB-induced melanogenesis via the CREB and Wnt/beta-catenin signaling pathways and suggest that PAK4 may be a potential therapeutic target in pigmentation disorders."
https://pharos.nih.gov/idg/targets/O96013,O96013,25410752,"microRNA-433 (miRNA-433 directly targets PAK4 through the miRNA-433 binding sequence at the 3'-UTR of PAK4 mRNA."
https://pharos.nih.gov/idg/targets/O96013,O96013,25359780,"CXCL12/CXCR4 signaling has a role in docetaxel-induced microtubule stabilization via p21-activated kinase 4-dependent activation of LIMK1"
https://pharos.nih.gov/idg/targets/O96013,O96013,25238288,"Suggest that PAK4 is a regulator of NF-kappaB pathway in pancreatic cancer cells, controlling cell proliferation and survival."
https://pharos.nih.gov/idg/targets/O96013,O96013,24829151,"PAK4 is known to act as a transporter for beta-catenin nuclear translocation."
https://pharos.nih.gov/idg/targets/O96013,O96013,24704155,"Both indole and indazole of KY-04031 are responsible for PAK4 hinge interaction."
https://pharos.nih.gov/idg/targets/O96013,O96013,24374310,"Mutation of this residue was sufficient to switch the phosphorylation site preference for multiple kinases, including the serine-specific kinase PAK4 and the threonine-specific kinase MST4."
https://pharos.nih.gov/idg/targets/O96013,O96013,24366569,"p21-activated kinase 4 inhibitor PF-3758309 shows anti-metastatic effect."
https://pharos.nih.gov/idg/targets/O96013,O96013,23934187,"The results document an oncogenic role of PAK4 in repression of Smad2/3 transactivation that involved in tumorigenesis, and suggest PAK4 as a potential therapeutic target for gastric cancer."
https://pharos.nih.gov/idg/targets/O96013,O96013,23893240,"PAK4-SCG10 signaling occurs in gastric cancer cell invasion."
https://pharos.nih.gov/idg/targets/O96013,O96013,23841590,"PAK4 regulation by showing that phosphorylation at Ser99 is required for its targeting to the leading edge. This phosphorylation is mediated by PKD1 (protein kinase D1)."
https://pharos.nih.gov/idg/targets/O96013,O96013,23790167,"Pak4 is an important regulator of Endometrial cancer cell migration and invasion"
https://pharos.nih.gov/idg/targets/O96013,O96013,23652058,"Genotype TT for rs9676717 in PAK4 gene and no drinking may be predictive of the interferon-a treatment success."
https://pharos.nih.gov/idg/targets/O96013,O96013,23642861,"PAK4 should be considered a signalling integrator regulating numerous fundamental cellular processes. [Review]"
https://pharos.nih.gov/idg/targets/O96013,O96013,23293332,"increased expression of Pak4 might lead to the establishment and progression of endometriosis by enhanced cellular viability and invasiveness in endometrial cells."
https://pharos.nih.gov/idg/targets/O96013,O96013,23254288,"Interaction between PAK4 and MMP-2 regulated anoikis, cell migration and invasion in glioma."
https://pharos.nih.gov/idg/targets/O96013,O96013,23233484,"Results support a role for the PAK4 and PAK1 in the proliferation of mutant KRAS-driven colorectal carcinoma cells via pathways not involving RAF/MEK/ERK and PI3K/AKT signaling."
https://pharos.nih.gov/idg/targets/O96013,O96013,23229348,"we confirmed that the mechanisms of the Pak4-induced cell cycle arrest invovlve the activation of the ATM/Chk1/2/p53 pathway."
https://pharos.nih.gov/idg/targets/O96013,O96013,22988085,"Full-length PAK4 is constitutively autoinibited, but mutation of the pseudosubstrate releases this inhibition."
https://pharos.nih.gov/idg/targets/O96013,O96013,22766504,"these findings demonstrate that miR-145 downregulates P-ERK expression by targeting PAK4 and leads to inhibition of tumor growth."
https://pharos.nih.gov/idg/targets/O96013,O96013,22710715,"PAK4 regulated cAMP-induced neuroendocrine differentiation, which is known to promote tumor progression.in prostate neoplasms"
https://pharos.nih.gov/idg/targets/O96013,O96013,22689056,"Overexpression of PAK4 harbouring a somatic mutation, E329K, increased the HGF-driven motility of metastatic prostate carcinoma cells."
https://pharos.nih.gov/idg/targets/O96013,O96013,22653441,"PAK4 is strongly inhibited by an auto-inhibitory domain formed by amino acids 20 to 68."
https://pharos.nih.gov/idg/targets/O96013,O96013,22450748,"PAK4 is required for metaphase spindle positioning and anchoring."
https://pharos.nih.gov/idg/targets/O96013,O96013,22085492,"Small-molecule PAK4 kinase inhibitor LCH- 7749944 was identified to be capable of inhibiting PAK4 signaling pathways and suppressing PAK4-mediated gastric cancer cell behaviors including proliferation, migration and invasion."
https://pharos.nih.gov/idg/targets/O96013,O96013,21832093,"PKD can also regulate LIMK through direct phosphorylation and activation of its upstream kinase p21-activated kinase 4 (PAK4)."
https://pharos.nih.gov/idg/targets/O96013,O96013,21385901,"Findings reveal that CDK5RAP3 is widely overexpressed in hepatocellular carcinoma and that overexpression of CDK5RAP3 promotes HCC metastasis through PAK4 activation"
https://pharos.nih.gov/idg/targets/O96013,O96013,20926745,"Pak4 overexpression promoted ovarian cancer cell migration and invasion in a c-Src, MEK-1, MMP2, and kinase-dependent manner, and induced cell proliferation through the Pak4/c-Src/EGFR pathway that controls cyclin D1 and CDC25A expression."
https://pharos.nih.gov/idg/targets/O96013,O96013,20719960,"PAK4 is activated by cell attachment to vitronectin as mediated by PAK4 binding partner integrin alphavbeta5."
https://pharos.nih.gov/idg/targets/O96013,O96013,20631255,"This study demonstrates that controlled regulation of PAK4 is required for apical junction formation in lung epithelial cells and highlights potential cross-talk between two Cdc42 targets, PAK4 and Par6B."
https://pharos.nih.gov/idg/targets/O96013,O96013,20578242,"Data show that active PAK4 can affect (cap-independent) translation from specific IRES sequences in vivo, and that the N-terminal domain is critical for this regulation."
https://pharos.nih.gov/idg/targets/O96013,O96013,20564219,"Data show that both Pak5 and constitutively active Pak4, the founding member of the Group B Paks, directly phosphorylate p120 in vitro."
https://pharos.nih.gov/idg/targets/O96013,O96013,20507994,"p21-activated kinase 4 phosphorylation of integrin beta5 Ser-759 and Ser-762 regulates cell migration"
https://pharos.nih.gov/idg/targets/O96013,O96013,20501374,"PAK4 is closely correlated to the progression and metastasis of breast cancer."
https://pharos.nih.gov/idg/targets/O96013,O96013,20406887,"regulates prostate cancer cell adhesion"
https://pharos.nih.gov/idg/targets/O96013,O96013,19778628,"DGCR6L, a novel PAK4 interacting protein, regulated PAK4-mediated migration of human gastric cancer cells via LIMK1."
https://pharos.nih.gov/idg/targets/O96013,O96013,19594544,"PAK4 overexpression through amplification or other mechanisms promotes the proliferation and/or survival of oral squamous-cell carcinoma cells"
https://pharos.nih.gov/idg/targets/O96013,O96013,19460752,"Knockdown of p21 protein (Cdc42/Rac)-activated kinase 4 (PAK4) by shRNA library screening inhibits HIV-1 replication in cultured Jurkat T-cells"
https://pharos.nih.gov/idg/targets/O96013,O96013,19050074,"Like RIOK3, PAK4 promotes pancreas ductal cell motility and invasion in pancreatic cancer"
https://pharos.nih.gov/idg/targets/O96013,O96013,18836286,"although the PAK4 gene is not activated by mutation in cell lines with gene amplification, an oncogenic form of the KRAS2 gene is present in these cells and oncogenic KRAS2 can activate PAK4"
https://pharos.nih.gov/idg/targets/O96013,O96013,18782768,"pneumolysin selectively induced expression of MKP1 via a TLR4-dependent MyD88-TRAF6-ERK pathway, which inhibited the PAK4-JNK signaling pathway,leading to up-regulation of MUC5AC mucin production"
https://pharos.nih.gov/idg/targets/O96013,O96013,18636970,"human Mbt homologue PAK4 leads to anchorage-independent growth and provide a functional link between a PAK protein and the cadherin-catenin complex."
https://pharos.nih.gov/idg/targets/O96013,O96013,18628988,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O96013,O96013,18424072,"These results support a model whereby hepatocyte growth factor-stimulated cell migration also requires a cofilin phosphorylation step that is mediated by PAK4."
https://pharos.nih.gov/idg/targets/O96013,O96013,18319301,"RNAi-mediated or dominant-negative suppression of Pak4, major regulators of cytoskeletal signaling downstream of Cdc42 or Rac1, markedly inhibits EC lumen and tube formation."
https://pharos.nih.gov/idg/targets/O96013,O96013,17555715,"bring novel insights into our understanding of synergistic regulation of MUC5AC mucin by both pathological and physiological inducers"
https://pharos.nih.gov/idg/targets/O96013,O96013,16897755,"PAK4 and alphaPIX can induce highly localized changes in actin dynamics and thereby regulate size and number of podosomes in primary human macrophages."
https://pharos.nih.gov/idg/targets/O96013,O96013,16227624,"PAK4 has a role in TNF-alpha induced cell survival pathyways by facilitating TRADD binding to the TNF Receptor"
https://pharos.nih.gov/idg/targets/O96013,O96013,15827085,"PAK4 mediates morphological changes through regulation of GEF-H1"
https://pharos.nih.gov/idg/targets/O96013,O96013,14625312,"PAK4 can negatively regulate the activation of Rho through a direct protein-protein interaction with G protein-linked Rho GEFs"
https://pharos.nih.gov/idg/targets/O96013,O96013,12529371,"PAK4 interacts with KGF receptor and mediate anti-apoptosis effects of KGF on epithelial cells."
https://pharos.nih.gov/idg/targets/O00506,O00506,26553096,"STK25 regulates lipid partitioning in human liver cells by controlling TAG synthesis as well as lipolytic activity and thereby NEFA release from lipid droplets for beta-oxidation and TAG secretion."
https://pharos.nih.gov/idg/targets/O00506,O00506,25550858,"Our results suggest that MST4, STK25 and PDCD10 are upregulated in prostate cancer and may play roles in prostate tumorigenesis."
https://pharos.nih.gov/idg/targets/O00506,O00506,23889253,"This review notes that all 3 human germinal center kinase III genes consist of 12 exons and are ubiquitously expressed. In SOK1 and MST4, exon 1 encodes a 5' untranslated region, but this is not the case for MST3."
https://pharos.nih.gov/idg/targets/O00506,O00506,22782892,"Down-modulation of STK25, but not STK24, rescued medulloblastoma cells from NGF-induced TrkA-dependent cell death, suggesting that STK25 is part of the death-signaling pathway initiated by TrkA and CCM2."
https://pharos.nih.gov/idg/targets/O00506,O00506,22652780,"PDCD10 might be a regulatory adaptor required for STK25 functions, which differ distinctly depending on the redox status of the cells that may be potentially related to tumor progression."
https://pharos.nih.gov/idg/targets/O00506,O00506,22391949,"Significantly higher STK25 levels were observed in the skeletal muscle of type 2 diabetic patients, compared with individuals with normal glucose tolerance."
https://pharos.nih.gov/idg/targets/O00506,O00506,21396913,"The results of the study results indicate that attenuation of SOK1 enhanced cell migration and lead to changes in the expression of migration-associated proteins such as FAK and GM130."
https://pharos.nih.gov/idg/targets/O00506,O00506,20592472,"In cultured human endothelial cells, CCM3 and STK25 regulated barrier function in a manner similar to CCM2, and STKs negatively regulated Rho by directly activating moesin."
https://pharos.nih.gov/idg/targets/O00506,O00506,18364353,"SOK1 entry into the nucleus is important for the cell death response"
https://pharos.nih.gov/idg/targets/O00506,O00506,17253963,"Ste20 family member (MAP4K3) that is required for maximal S6K (S6 kinase)/4E-BP1 [eIF4E (eukaryotic initiation factor 4E) that is required for maximal S6K (S6 kinase)."
https://pharos.nih.gov/idg/targets/O00506,O00506,15037601,"14-3-3zeta is a specific substrate for YSK1 that localizes to the Golgi apparatus, and potentially links YSK1 signaling at the Golgi apparatus with protein transport."
https://pharos.nih.gov/idg/targets/O95382,O95382,26243192,"Data show that the MAPKKK6 ASK2, a modulator of MAPKKK5 ASK1 signaling, was essential for ASK1-dependent apoptosis, but not for inducing interferon-beta (IFNB) expression."
https://pharos.nih.gov/idg/targets/O95382,O95382,25340522,"MAP3K6 acts as a tumor suppressor, and studies showing the presence of somatic mutations in MAP3K6 in non-hereditary gastric cancers and gastric cancer cell lines, point towards MAP3K6 variants as a predisposing factor for familial gastric cancer"
https://pharos.nih.gov/idg/targets/O95382,O95382,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O95382,O95382,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O95382,O95382,19246638,"regulation of VEGF by MAP3K6 may play a crucial role in both angiogenesis and tumorigenesis."
https://pharos.nih.gov/idg/targets/O95382,O95382,18327563,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O95382,O95382,17210579,"Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1."
https://pharos.nih.gov/idg/targets/Q13163,Q13163,28329290,"results confirmed the association of BTBD9 and MAP2K5/SKOR1 with primary Restless Legs Syndrome in Chinese population"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,27878304,"Insights into a molecular mechanism by which MEK5 transcriptionally upregulated by Stat3 augments breast cancer cell EMT, which subsequently enhances cancer cell invasion and metastasis. This finding may suggest that Stat3 and MEK5/Erk5 pathways could be an effective therapeutic target for inhibition of breast cancer invasion and metastasis."
https://pharos.nih.gov/idg/targets/Q13163,Q13163,27160304,"Results revealed the expression of MEK5 was higher in tumor tissues and provide evidence that MEK5 plays an important role in colorectal cancer progression."
https://pharos.nih.gov/idg/targets/Q13163,Q13163,26498236,"Our findings confirm an association between the BTBD9, MEIS1, and MAP2K5/SKOR1 SNPs and periodic limb movements of sleep in an elderly cohort."
https://pharos.nih.gov/idg/targets/Q13163,Q13163,25662172,"High MEK5 expression is associated with colorectal cancer."
https://pharos.nih.gov/idg/targets/Q13163,Q13163,25637721,"SEC16B, MC4R, MAP2K5 and KCTD15 (rs17782313, rs543874, rs2241423 and rs11084753) polymorphisms are associated with the risk for children obesity in China."
https://pharos.nih.gov/idg/targets/Q13163,Q13163,25142570,"Periodic leg movements during sleep are associated with polymorphisms in BTBD9, TOX3/BC034767, MEIS1, MAP2K5/SKOR1, and PTPRD"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,24975362,"Inhibitors of apoptosis proteins regulate myogenic differentiation by directly suppressing MEKK2/3-MEK5-ERK5 signaling."
https://pharos.nih.gov/idg/targets/Q13163,Q13163,24436253,"MiR-330-3p and MAP2K5 are potentially important contributors to mood and anxiety-related traits"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,24205826,"Specifically, CKS1B and MAP2K5 significantly inhibited hepatitis C viral RNA replication. PACSIN1, by contrast, inhibited hepatitis C virus infection by decreasing the level of viral protein p7."
https://pharos.nih.gov/idg/targets/Q13163,Q13163,23950888,"MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis."
https://pharos.nih.gov/idg/targets/Q13163,Q13163,22594783,"Single nucleotide polymorphism in the MAP2K5 gene is associated with BMI and obesity."
https://pharos.nih.gov/idg/targets/Q13163,Q13163,21925394,"Variants in MEIS1, BTBD9, and MAP2K5/SKOR1 confer a significant risk of restless legs syndrome in a United States population."
https://pharos.nih.gov/idg/targets/Q13163,Q13163,21861603,"data indicate that the rs3743354 polymorphism in the MEK5 promoter may affect the risk of developing colorectal cancer"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,21820407,"These results suggest that MEK5/ERK5 is important for FLT3-ITD induced hematopoietic transformation."
https://pharos.nih.gov/idg/targets/Q13163,Q13163,21767578,"HCVne particles are capable of inducing the recently discovered ERK5 pathway, in a dose dependent way."
https://pharos.nih.gov/idg/targets/Q13163,Q13163,21166929,"MEK5 activation by laminar shear stress inhibits inflammatory responses in microvascular endothelial cells, in part through ERK5-dependent induction of KLF4"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,20396431,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,19822783,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,19605361,"MEK5/ERK5 signaling modulates endothelial cell migration and focal contact turnover"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,19279021,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,19223043,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,18071319,"ERK5 nuclear staining has been shown to be an independent marker of prognosis in CaP, and may prove useful as a stratification tool to identify a more aggressive/metastatic phenotype"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,17872495,"Data suggest that HGF-induced effects in some mesothelioma cells are mediated via activation of a novel PI3K/ERK5/Fra-1 feedback pathway"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,17637780,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,16758967,"Genistein can affect the ERK5 MAPK signaling transduction pathway and induce the expressions of apoptosis related proteins to inhibit the proliferation of MDA-MB-231 cells."
https://pharos.nih.gov/idg/targets/Q13163,Q13163,15378007,"MEK5 may be one of the Stat3-regulated genes and plays its essential roles in oncogenesis"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,15075238,"nuclear localization of MEK5 and ERK5 is different from that of ERK1/2 and MEK1/2 in resting cells, indicating that each MAPK cascade uses distinct mechanisms"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,14583600,"alternative splicing of MEK5alpha and MEK5beta may play a critical role in BMK1 activation and subsequent cell proliferation"
https://pharos.nih.gov/idg/targets/Q13163,Q13163,12618764,"MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion.  MEK5 is a key signalling molecule associated with prostate carcinogenesis."
https://pharos.nih.gov/idg/targets/Q13163,Q13163,12219026,"overexpression of MEK5 in APO- MCF-7 breast carcinoma cells shows that this MAPK signaling protein represents a potent survival molecule."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,28707321,"leukaemic cells explicitly require PAK2 to grow towards an extracellular matrix. PAK2-deficient cells fail to form colonies in methylcellulose and to induce lymphomas in vivo. PAK2 might therefore be the critical isoform in leukaemic cells by controlling tumour growth"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,27889207,"Results show that PAK2 kinase plays an alternative anti-apoptotic role, phosphorylating caspase-7 and promoting unfettered cell growth and chemotherapeutic resistance."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,26412398,"PAK2 is a direct effector of TSC1-TSC2-RHEB signaling and a new target for rational drug therapy in TSC."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,26363097,"Findings indicate that repression of microRNA miR-134 and consequent up-regulation of p21-activated kinase 2 (Pak2) might contribute to paclitaxel resistance."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,26350970,"Nef exploits PAK2 in a stepwise mechanism in which its kinase activity cooperates with an adaptor function for the exocyst complex to inhibit host cell actin dynamics."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,26350970,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,26218748,"Cytoplasmic Pak2 may promote cell proliferation in normal endometrium during menstrual cycle."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,26186482,"We found that overexpression of miR-137 inhibited the proliferation of melanoma cells, which could be phenocopied by knockdown of PAK2 using siRNAs."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,26150340,"Further analyses show that HDAC6 may promote growth of GBM cells through inhibition of SMAD2 phosphorylation to downregulate p21"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,26078008,"Pak1 and Pak2 counteract centrosome separation in a kinase-dependent manner."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,25807049,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,25596744,"Data show that group I p21-activated kinases (Paks) Pak1 and Pak2 were much more abundant than Pak3 in meningioma."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,25050916,"Results identified Pak2 as a possibly important mediator of ovarian cancer cell migration on extracellular matrix."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,25029025,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,24840740,"Inhibition of PAK activation at late G2-phase centrosomes caused by Rac1 inactivation coincides with impeded activation of Aurora A and the CyclinB/Cdk1 complex and delayed mitotic entry."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,24621074,"PAK2 activation may be associated with advanced tumor progression and poor prognosis of gastric cancer"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,24434518,"Prostasin repress cancer cells and contribute to chemoresistance by modulating the CASP/PAK2-p34/actin pathway."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,24237970,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,24187576,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,24172637,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,24025335,"thrombin induces monocyte/macrophage migration via PAR1-Galpha12-dependent Pyk2-mediated Gab1 and p115 RhoGEF interactions, leading to Rac1- and RhoA-targeted Pak2 activation."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,23847689,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,23746211,"Authors demonstrate that HIV-1 Nef expression mediates phosphorylation of Mek1 on serine298 and Pak2 on serine192/197 in T cell lines as well as primary human T cells."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,23746211,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,23559827,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,23499762,"Cytokine-induced migration correlated with phosphorylation of PAK1 in primary myeloma cells & cell lines. Downregulation of PAK1 with siRNA in INA-6 cells resulted in decreased cytokine-driven migration."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,23317503,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,23227982,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,22844345,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,22651890,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,22537596,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,22534017,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,22393057,"PAK2 negatively modulate TGF-beta signaling by attenuating the receptor-Smad interaction and thus Smad activation"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,22323535,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,22175768,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,22103838,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,22103837,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,22103831,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,21994733,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,21892329,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,21850710,"Low-to-moderate penetrance protein coding mutations or non-coding mutations at DLG1 and/or PAK2, or a nearby gene, may reproduce the behavioral characteristics of the 3q29 microdeletion."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,21819585,"The ability of Nef to associate with PAK2 correlates with the ability to enhance HIV-1 replication."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,21819585,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,21555521,"highly expressed PAK2 mediates chemotherapeutic resistance in human breast invasive ductal carcinoma by negatively regulating caspase-7 activity"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,21336563,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,21321123,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,21177766,"High PAK2 is associated with melanoma."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,21098037,"Mechanistic studies of the autoactivation of PAK2: a two-step model of cis initiation followed by trans amplification."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,20724730,"The association between the CD4 receptor and protein kinase pp58 and the protein-tyrosine kinase within the cell introduces a specific pathway by which T lymphocytes become activated."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,20691406,"Observational study, meta-analysis, and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,20594957,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,20523167,"Rac1/Cdc42/PAK pathway controls actin reorganization that is necessary for microvesicle shedding"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,20209159,"analysis of evolutionary conserved residues that are crucial for the catalytic activity of PKA and Pak2"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,20147394,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,20131316,"Our studies suggest that Rac1 --> Pak1/Pak2 --> NFkappaB is a separate pathway that contributes to the expression of COX-2 in HPV-induced papillomas, independently of the previously described Rac1 --> p38 --> COX-2 pathway."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,20056178,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,19923322,"MYO18A is a novel binding partner of the PAK2/betaPIX/GIT1 complex and suggest that MYO18A may play an important role in regulating epithelial cell migration via affecting multiple cell machineries."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,19683683,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,19628037,"Knockdown of PAK2 enhances loss of cell-cell junctions and increases lamellipodium extension but does not affect migration speed Hepatocyte Growth Factor (HGF) stimulated DU145 prostate carcinoma cells."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,19324886,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,19242610,"PAK-2 activity controls the apoptotic response by regulating levels of activated caspase 3 and thereby its own cleavage to the proapoptotic PAK-2p34 fragment"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,19240112,"Huntingtin exerts anti-apoptotic effects by binding to Pak2, which reduces the abilities of caspase-3 and caspase-8 to cleave Pak2 and convert it into a mediator of cell death."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,18808677,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,18653452,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,18411304,"Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,18344974,"Clathrin-independent endocytosis used by the IL-2 receptor is regulated by Rac1, Pak1 and Pak2."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,18319301,"Data show RNAi-mediated or dominant-negative suppression of Pak2, major regulators of cytoskeletal signaling downstream of Cdc42 or Rac1, markedly inhibits EC lumen and tube formation."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,18176785,"protein phosphatase 1alpha can act directly on phosphorylated Thr-402 in the activation loop of PAK2 and down-regulate its kinase activity"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,18094167,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,18030346,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,17881449,"interaction of Nef with PAK2 does not play a major role in T-cell activation, viral replication, and apoptosis."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,17881449,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,17707624,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,17632570,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,17632197,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,17586321,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,17555715,"bring novel insights into our understanding of synergistic regulation of MUC5AC mucin by both pathological and physiological inducers"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,17543336,"define a new class of PAK-interacting proteins, which play an important role in actin cytoskeletal reorganization"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,17077296,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,16979207,"This study of tissue-derived HIV-1 Nefs demonstrates that CD4 and MHC-I downregulation are highly conserved Nef functions, while Pak2 association is variable in late stage AIDS patients."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,16979207,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,16916529,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,16912329,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,16867995,"c-Abl represents a target downstream of phosphatidylinositol 3-kinase-activated PAK2, which differentiates TGF-beta signaling in fibroblasts and epithelial cell lines."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,16687395,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,16617111,"Posttranslational myristoylation of PAK2 might be part of a unique series of mechanisms involved in the regulation of the later events of apoptosis."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,16501114,"Nef protein amino acids at positions 85, 89, 187, 188, and 191 (L, H, S, R, and F in the clade B consensus, respectively) are critical for Pak2 association and activation"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,16501114,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,16282498,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,16281055,"Pak2 binds to and phosphorylates initiation factor eIF4G, which inhibits association of eIF4E with m7GTP, reducing translation initiation."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,16272310,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,16204230,"binding of Cdc42 localizes Pak2 to the endoplasmic reticulum, where autophosphorylation alters association of the two proteins"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,15908432,"PAK-2 is activated in 1-LN prostate cancer cells by a proteinase inhibitor, alpha 2-macroglobulin"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,15847608,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,15638726,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,15471851,"PS-GAP is a novel regulator of caspase-activated PAK-2"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,15234964,"Pak2 has a role in the down-regulation of translation initiation in apoptosis by phosphorylation of Mnk1"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,15194762,"interacts with Nef proteins from SIV infected chimpanzees"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,15194762,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,15187108,"PAK2 kinase activity is increased in response to TCR stimulation; results suggest a novel role for PAK2 as a positive regulator of T cell activation."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,15047871,"PAK2 is constitutively activated in certain breast cancer cell lines and that this active PAK is mislocalized to atypical focal adhesions in the absence of high levels of activated Rho GTPases."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,15047825,"Nef induces signal transduction via the recruitment of a signaling machinery including Pak2 into lipid rafts, thereby mimicking a physiological cellular mechanism to initiate the TCR cascade."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,15047825,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,14965316,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,14749374,"Pak2 phosphorylates Myc at three sites (T358, S373, and T400) and affects Myc functions both in vitro and in vivo"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,12907671,"sites of PAK2 autophosphorylation in the regulatory and the catalytic domains and their kinetic effect; multiple regions of PAK2 are involved in the enzyme-substrate recognition"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,12855553,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,12853446,"Caspase-activated PAK-2 is regulated by subcellular targeting and proteasomal degradation"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,12823590,"The opposing effects of Core protein on the transcription pf P21 might be important in the progression of liver disease in HCV-positive patients."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,12734410,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,12549935,"The enzymatic phosphorylation reaction of PAK2 can be best interpreted by a rapid-equilibrium random bi-bi reaction model; the catalysis reaction is partially limited by both the phosphoryl group transfer and the product release steps."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,12453877,"Cdc42/Rac1-dependent activation of PAK may trigger early platelet shape change, at least in part through the regulation of cortactin binding to PAK."
https://pharos.nih.gov/idg/targets/Q13177,Q13177,11463741,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,11448168,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,11160719,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,11070003,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,10607567,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,9151826,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q13177,Q13177,9075929,"HIV-1 Nef requires the GTPase interaction site of PAK2 to facilitate interactions of Nef with EXOC"
https://pharos.nih.gov/idg/targets/Q9C0K7,Q9C0K7,12048196,"a novel XIAP-interacting protein that acts as a co-factor enhancing XIAP-mediated activation of JNK1 and the caspase-independent protection of XIAP against apoptosis"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,27889261,"These findings highlight the importance of NIK in tumor pathogenesis and invite new therapeutic strategies that attenuate mitochondrial dysfunction through inhibition of NIK and Drp1."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,27678221,"results suggest that changes in the relative concentrations of RelB, NIK:IKK1, and p100 during noncanonical signaling modulate this transitional complex and are critical for maintaining the fine balance between the processing and protection of p100."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,27555280,"OLFM1 is a negative regulator of non-canonical NF-kappaB signalling by interacting with and inhibiting NIK. Thus, OLFM1 may serve as a valuable biomarker and therapeutic target for colorectal cancer (CRC) patients."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,27499151,"The expression of OTUD7B and NIK were negatively correlated in non-small cell lung cancer tumor samples. the higher expression of NIK was related to more lymph node metastasis and later TNM stage. high OTUD7B/low NIK index can predict an good prognosis."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,27416764,"report a detailed state-of-the-art mass spectrometry-based protein-protein interaction network including the noncanonical NF-kappaB signaling nodes TRAF2, TRAF3, IKKalpha, NIK, and NF-kappaB2/p100; also provide a differential interactome of NIK mutants that cause immunodeficiency"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,26823811,"NIK expression was significantly increased in the tumor tissue of patients with breast carcinoma, which may be an important factor that affects the prognosis of these patients."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,26602079,"Data suggest microRNA302c, but not microRNA520e, promotes replication of influenza A virus H3N2 although the two microRNAs target same site of NFkappaB-inducing kinase (MAP3K14) 3prime untranslated region; studies were conducted in lung epithelial cells."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,26498133,"This study identified two novel independent loci (MAP3K14 and CARD9) strongly associated with joint damage in Mexican Americans and European Americans and a few shared loci showing suggestive evidence for association."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,26269411,"The forced expression of NDRG2 in ATL cells down-regulates not only the canonical pathway by inhibiting AKT signaling but also the non-canonical pathway by inducing NF-kappaB-inducing kinase (NIK) dephosphorylation via the recruitment of PP2A"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,26195760,"Membrane attack complexes activate noncanonical NF-kappaB by forming a novel Akt(+)NIK(+) signalosome on Rab5(+) endosomes."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,26178280,"NIK(+) endothelial cells may play an important role in the persistence of synovitis"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,25766331,"by demonstrating a critical role of NIK in mediating NF-kappaB activation and BAG3 induction upon ST80/Bortezomib cotreatment, our study provides novel insights into mechanisms of resistance to proteotoxic stress in RMS"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,25622756,"TWEAK induces noncanonical NF-kappaB signaling and signal-specific regulation of NIK mRNA expression."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,25406581,"Loss-of-function mutations in NIK can cause B-cell lymphopenia, hypogammaglobulinemia, impaired ICOSL expression, and disordered T helper cell and NK cell function."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,25246529,"Identification and function of the NIK IAP binding motif, which promotes c-IAP1-dependent ubiquitylation of NIK."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,25187543,"Authors show that activation of NF-kappaB by Kaposi's sarcoma-associated herpesvirus K15 protein involves the recruitment of NF-kappaB-inducing kinase (NIK) and IKK alpha/beta to result in the phosphorylation of p65/RelA on Ser536."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,25079338,"ARC is regulated via BIRC2/MAP3K14 signalling and its overexpression in AML or MSCs can function as a resistant factor to birinapant-induced leukaemia cell death."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,25043127,"These studies provide evidence for a role of NF-kappaB-inducing kinase (NIK) and subsequent non-canonical NF-kappaB signalling in pathological angiogenesis"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,24533079,"NIK plays a key role in constitutive NF-kappaB activation and the progression of ovarian cancer cells"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,24362935,"NIK is a new therapeutic target for Mantle cell lymphoma treatment, particularly for lymphomas that are refractory to B cell receptor pathway inhibitors."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,23536439,"A pivotal role for NIK in nuclear factor kappa B activation and regulation of gene expression in T-cell lymphoma."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,23301098,"TRAF2/NIK/NF-kappaB2 pathway regulates pancreatic ductal adenocarcinoma cell tumorigenicity"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,22968463,"we found that NIK and the noncanonical pathway are very prevalent in Hodgkin lymphoma"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,22718757,"a molecular basis for the recent observation of gain-of-function activity for an N-terminal deletion mutant (DeltaN324) of NIK, leading to constitutive non-canonical NF-kappaB signaling with enhanced B-cell adhesion and apoptosis resistance."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,22685329,"APPL1 regulates basal NF-kappaB activity by modulating the stability of NIK, which affects the activation of p65."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,22474019,"NIK activity in nonhematopoietic cells controls Th2 cell development and prevents eosinophil-driven inflammatory disease, most likely using a signaling pathway that operates independent of the known NIK substrate IKKalpha."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,22469134,"Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,22105365,"NIK is one of the direct target genes of miR-520e."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,21963849,"NIK mediates both beta-catenin and NF-kappaB regulated transcription to modulate melanoma survival and growth"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,21887257,"Cigarette smoke and TNFalpha increase NIK levels causing phosphorylation of IKKalpha, which leads to histone acetylation."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,21869881,"A role for NF-kappaB noncanonical pathway activation in modulating diabetes-induced inflammation in renal tubular epithelium."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,21846802,"Adiponectin treatment inhibited NIK-induced NF-kappaB activation and restored insulin sensitivity by restoring phosphatidylinositol 3 kinase activation and subsequent serine-threonine kinase phosphorylation."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,21273489,"study shows API2-MALT1 fusion oncoprotein induces proteolytic cleavage of NF-kappaB-inducing kinase (NIK); resulting deregulated NIK activity is associated with constitutive noncanonical NF-kappaB signaling, enhanced B cell adhesion and apoptosis resistance"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,21257964,"findings suggest that the CC genotype of NIK rs7222094 is associated with increased mortality and organ dysfunction in septic shock patients, perhaps due to altered regulation of NF-kappaB pathway genes, including CXCL10"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,21048031,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,20937806,"TNF-alpha and carrageenan in combination act to increase NIK phosphorylation, thereby increasing activation of the non-canonical pathway of NF-kappaB activation"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,20823135,"Results show that nuclear factor-kappa B inducing kinase has a role in graft-versus-host disease by maintaining the viability of activated alloreactive T lymphocytes."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,20735436,"Data suggest that NIK and genes induced by the NIK-mediated constitutive NF-kappaB activation could be therapeutic targets of basal-like breast cancer."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,20682767,"An atypical E3 ligase zinc finger protein 91 stabilizes and activates NF-kappaB-inducing kinase via Lys63-linked ubiquitination."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,20501937,"Data show that NIK with mutations in the IKKalpha-targeted serine residues was more stable than wild-type NIK and resulted in increased noncanonical NF-kappaB signaling."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,20466000,"Lipopolysaccharide induces activation of both canonical and non-canonical pathways of NF-kappaB and the non-canonical pathway requires phosphorylations of BCL10 (serine 138) and NIK."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,20348096,"the LTbetaR modifies the ubiquitin:NIK E3 ligase, and also acts as an allosteric regulator of the ubiquitin:TRAF E3 ligase"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,20338663,"plays a key role in constitutive NF-kappaB activation in non-small cell lung cancer cells"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,20125184,"These results suggest that augmentation of NF-kappaB-inducing kinase, IkappaB kinase-alpha, and pH3 in response to oxidative stress is involved in cell death after cerebral ischemia (or stroke)."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,19909783,"Data provide analysis of the IKK/NIK inter-relationship and its impact on NF-kappaB control by mathematical modelling."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,19897484,"These findings indicate an upstream signaling role for BCL10, in addition to its effects on IKKgamma, the regulatory component of the IKK signalosome, and a requirement for BCL10 in both canonical and noncanonical pathways of NF-kappaB activation."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,19646419,"These results clearly indicate that NIK is involved in the constitutive activation of the alternative pathway and controls cell proliferation in pancreatic cancer cells."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,19641890,"Report suppression of hepatitis B virus-derived human hepatocellular carcinoma by NF-kappaB-inducing kinase-specific siRNA using liver-targeting liposomes."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,19453261,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,19262425,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,18976975,"Knockdown of mitogen-activated protein kinase kinase kinase 14 (MAP3K14) by siRNA inhibits HIV-1 replication in HeLa P4/R5 cells"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,18752500,"Translocation of NF-kappa B to the nucleus in prostatic cancer might be due to overexpression of several components of the NIK pathway."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,18439422,"NIK functions downstream of Cot to mediate p65 phosphorylation."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,18434448,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,18056702,"NF-kappaB-inducing kinase phosphorylates and blocks the degradation of Down syndrome candidate region 1"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,17729113,"This study demonstrates that NF-kappaB-inducing kinase (NIK) is a critical target of the endogenous ROS in NF-kappaB pathways."
https://pharos.nih.gov/idg/targets/Q99558,Q99558,17543278,"in addition to activating NF-kappaB/p52, LIGHT also activates Stat3 through the NIK pathway"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,16009713,"Results for the first time place NF-kappa B-inducing kinase (NIK), previously shown to function in TNF signaling, within the interferon signal transduction pathway"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,15252129,"subcellular distribution of NIK to different compartments might be a means of regulating the function of this kinase"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,15084608,"induction of noncanonical NF-kappaB signaling may involve the rescue of NIK from TRAF3-mediated negative regulation"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,12393548,"results demonstrate that IKK2 is essential for dendritic cell activation induced by CD40L or contact with allogeneic T cells, but not by LPS, whereas NIK is not required for any of these signals"
https://pharos.nih.gov/idg/targets/Q99558,Q99558,11511100,"HIV-1 Tat enhances the capacity of NF-kappaB-inducing kinase (NIK) to accelerate degradation of IkappaB"
https://pharos.nih.gov/idg/targets/Q7Z2Y5,Q7Z2Y5,27634343,"The results suggest that Nrk suppresses the excessive proliferation of mammary epithelial cells during pregnancy, and the impairment of this regulatory system leads to frequent occurrence of breast tumor in Nrk mutant mice."
https://pharos.nih.gov/idg/targets/O75914,O75914,27474226,"Abnormalities in the PAK1 and PAK3 mRNA levels as well as their altered coexpression patterns were observed in the postmortem brain of subjects with depression. Dysregulated PAK1/PAK3 dependent signaling may be a key factor responsible for volumetric abnormalities observed in the hippocampus and in the prefrontal cortex in depression resulting in altered connectivity of these regions."
https://pharos.nih.gov/idg/targets/O75914,O75914,25981171,"This study showed that PARK3 messenger RNA levels was significantly upregulated in subjects with schizophrenia in laminar and cellular samples."
https://pharos.nih.gov/idg/targets/O75914,O75914,25666757,"This study identified predicted pathogenic, hemizygous variants on chromosome X in disease genes PAK3."
https://pharos.nih.gov/idg/targets/O75914,O75914,25596744,"Data show that group I p21-activated kinases (Paks) Pak1 and Pak2 were much more abundant than Pak3 in meningioma."
https://pharos.nih.gov/idg/targets/O75914,O75914,25109462,"Cdc42Hs binds to the effector domain of PAK3"
https://pharos.nih.gov/idg/targets/O75914,O75914,23818969,"Results show elevated PAK3 expression at both the mRNA and protein level in cJun/AP-1-over-expressing Rat1a fibroblasts, as well as in transformed human fibroblasts."
https://pharos.nih.gov/idg/targets/O75914,O75914,23622267,"Group I p21-activated kinases augment Tax-mediated transcriptional activation of human T-cell leukemia virus type 1 long terminal repeats in a kinase-independent manner."
https://pharos.nih.gov/idg/targets/O75914,O75914,21949127,"p21-Activated kinase 3 (PAK3) protein regulates synaptic transmission through its interaction with the Nck2/Grb4 protein adaptor."
https://pharos.nih.gov/idg/targets/O75914,O75914,20960100,"potential role of PAK3 in the progression of ACTH-producing thymic carcinoid"
https://pharos.nih.gov/idg/targets/O75914,O75914,18805672,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O75914,O75914,18523455,"PAK3 mutations result in a specific form of X-linked mental retardation with fairly constant clinical features."
https://pharos.nih.gov/idg/targets/O75914,O75914,15574732,"PAK3 is a key regulator of synapse formation and plasticity in the hippocampus. The MRX30 mutation might contribute to the cognitive deficits underlying this form of X-linked mental retardation."
https://pharos.nih.gov/idg/targets/O75914,O75914,15099969,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O75914,O75914,12464619,"PAK3 codes for a splice variant that contains a 45-bp alternatively spliced exon. The exon encodes 15 aa that are inserted in the regulatory domain. PAK3b displays a high kinase activity in starved cells that is not further stimulated by active GTPases."
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,28232500,"Data suggest expression of ECAD (E-cadherin) in bladder cancer cell lines correlates with presence of intercellular junctions and level of PAK5 (p21-activated kinase PAK5 protein) expression; endogenous PAK5 is localized to intercellular junctions and interacts with ECAD; depletion of PAK5 expression reduces integrity of intercellular junctions; PAK5 mRNA levels are reduced in bladder cancer compared with normal controls."
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,28005267,"PAK7 expression is significantly downregulated in human masticatory mucosa during wound healing"
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,27323857,"These findings indicate that aberrant PAK7 expression is associated with the occurrence of metastasis and poor clinical outcomes of human colon cancer by promoting the epithelial to mesechymal transition"
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,27095851,"model suggests PAK5 self-association interferes with AID binding to the catalytic domain, thus maintaining its high activity."
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,26682509,"PAK7 is overexpressed in human esophageal squamous cell cancer samples and correlated with lymph node metastasis."
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,26212009,"E47 is a novel substrate of PAK5, and PAK5-mediated phosphorylation of E47 promotes epithelial-mesenchymal transition and metastasis of colon cancer."
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,26116538,"miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma."
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,25632266,"results suggest that the inhibition of PAK5 by RNA interference might efficiently suppress tumor development of glioma cells with PAK5 high expression."
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,25436453,"Aurora-A induced PAK7 expression in esophageal cancer cells."
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,25052921,"PAK7 promotes cell proliferation and tumorigenesis"
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,24869804,"PAK5 functions as an oncogenic kinase in tumor cellular regulation"
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,24474471,"Results demonstrate that PAK7 is developmentally co-expressed with another known psychosis risk gene (DISC1) suggesting a potential molecular mechanism involving aberrant synapse development and plasticity."
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,24062079,"It inhibits glioma cell migration and invasion potentially through the PAK5-Egr1-MMP2 signaling pathway."
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,23877225,"PAK5 is correlated to human epithelial ovarian cancer (EOC) and increased PAK5 expression promotes EOC progression."
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,23836671,"identified three kinases with gain-of-function mutations in lung cancer, namely FGFR4, MAP3K9, and PAK5. Mutations in these kinases are activating toward the ERK pathway, and targeted depletion of the mutated kinases inhibits proliferation"
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,23696025,"The PAK5-Egr1-MMP2 signaling pathway is a critical regulator of cell migration and invasion in lung cancer cells."
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,23106939,"PAK7 is a new hallmark of gastric cancer, PAK7 may contribute to gain of tumor growth potential, acting by affecting the expression of cell cycle regulators."
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,20877624,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,20564219,"Data show that both Pak5 and constitutively active Pak4, the founding member of the Group B Paks, directly phosphorylate p120 in vitro."
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,19415746,"Study demonstrated that PAK5 expression increased significantly with malignant progression of CRC (colorectal cancer), and that PAK5 might promote CRC metastasis by regulating CRC cell adhesion and migration."
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,18628988,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,16581795,"Nucleocytoplasmic shuttling of PAK7 regulates its antiapoptotic properties."
https://pharos.nih.gov/idg/targets/Q9P286,Q9P286,16014608,"PAK5 suppresses the activity of microtubule affinity-regulating kinase 2 (MARK2) toward its target, tau protein."
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,28486133,"RhoD recruits Pak6 to the plasma membrane to antagonize RhoC signaling during cell contraction and blebbing"
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,26598554,"PAK6 localization to cell-cell adhesions is Cdc42-dependent"
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,26459798,"PAK6 is directly targeted by miR-328. miR-328 inhibits cell growth and promotes cell apoptosis in prostate cancer cells."
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,26442588,"negative correlation between PAK6 and EZH2 expression was observed in hepatoma tissues from HCC patients. These data identified the tumor suppressive role and potential underlying mechanism of PAK6 in hepatocarcinogenesis"
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,26375402,"p21-activated kinase 6 (PAK6) as a novel interactor of leucine-rich repeat kinase 2 (LRRK2), a kinase involved in Parkinson's disease"
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,26058485,"the results of the present study suggested that miR-429 inhibits the migration and invasion of colon cancer cells, partly at least, by mediating the expression of PAK6, as well as the activity of cofilin signaling"
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,25426562,"we report that in colon cancer PAK6 promotes tumor progression and chemoresistance both in vitro and in vivo"
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,24576777,"PAK6 is overexpressed in hepatocellular carcinoma, compared with the adjacent noncancerous liver tissues, and is associated with poor prognosis."
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,24352566,"PAK6 is specifically required for carcinoma cell-cell dissociation downstream of hepatocyte growth factor (HGF) for both DU145 prostate cancer and HT29 colon cancer cells."
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,24130878,"These results demonstrate that androgen-stimulated PAK6 activation is mediated through a direct interaction between AR and PAK6 and PAK6 activation promotes prostate cancer cells motility and invasion."
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,23685956,"PAK5 plays an essential role in the initiation and progression of hepatocellular carcinoma."
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,23132866,"PAK6 phosphorylates Mdm2 on Thr-158 and Ser-186, which is critical for AR ubiquitin-mediated degradation."
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,20524398,"Hypermethylation of PAK6 gene is associated with adenocarcinoma."
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,20453000,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,19692168,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,19625176,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,19170196,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,18676680,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,18642328,"PAK6 was weakly expressed in normal prostate epithelium. Its expression was increased in primary and metastatic prostate cancer, and was further increased in tumors that relapsed after androgen deprivation therapy."
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,18465753,"PAK5 is a potent regulator of Raf-1 activity and may control Raf-1 dependent signaling at mitochondria"
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,17584649,"Results indicate that all of the 3 prostate cancer specimens showed positive staining in the stroma, suggesting that PAK6 may participate in the stroma-cancer cell interaction in prostate cancer."
https://pharos.nih.gov/idg/targets/Q9NQU5,Q9NQU5,15550393,"The activation of PAK6 by both p38 MAP kinase and MKK6 suggests that PAK6 plays a role in the cellular response to stress-related signals."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,28152516,"TNFAIP8 regulates Hippo (MST1/2) signaling through its interaction with LATS1."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,28103766,"Findings indicate that long-term exposure to IM results in dysregulation of stem cell renewal-regulatory Hippo (MST1/2)/YAP signaling, and that inhibition of miR-181a using a microRNA sponge inhibitor resulted in decreased transcription of SOX2 and SALL4."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,28099921,"Data suggest that Hippo (MST1/2 protein kinases) - Yes associated protein 1 (YAP) pathway involved in carcinogenesis of pancreatic cancer and in the inhibition effect of stiehopus japonieus acidic mucopolysaccharide (SJAMP) to the proliferation of pancreatic cancer cell."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,27566175,"These findings reveal a novel layer of regulation for MST2 in mitosis and its role in tumorigenesis."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,27238285,"H-ras, via an Erk-dependent mechanism, downregulates Mst1/Mst2 activity by inducing the formation of inactive Mst1/Mst2 heterodimers."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,26908611,"Results show that STK3 is targeted by Casp6 and demonstrate that alterations in STK3 protein expression levels and post-translational modifications are detected in a cellular model of HD and caspase-mediated generation of STK3 fragments observed under conditions of stress in cells expressing mhtt."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,25814670,"using an Mst2 mutation that disrupts homotypic dimerization, we showed that the monomeric Mst2-SARAH domain could form a stable complex of 1:1 stoichiometric ratio with WW45 refolded under acidic pH."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,25367221,"The MST1/2-SAV1 complex, a core component of the Hippo pathway, promotes ciliogenesis."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,25035424,"results reveal a novel role of Mst2 in stress-dependent cardiac hypertrophy and remodeling in the adult mouse and likely human heart"
https://pharos.nih.gov/idg/targets/Q13188,Q13188,24992339,"These results suggest that AIF downregulation is a common event in kidney tumor development. AIF loss may lead to decreased STK3 activity, defective apoptosis and malignant transformation"
https://pharos.nih.gov/idg/targets/Q13188,Q13188,24881775,"Hippo and Yap regulate cardiomyocyte death and regeneration."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,24255178,"Results indicate that changes in phosphorylation orchestrate interactions between kinases and phosphatases in Hippo (MST1/2 protein kinases) signaling, providing a putative mechanism for pathway regulation."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,24180524,"results of the present study revealed that, in addition to the phosphorylated YAP/TAZ, the Hippo pathway can suppress the Wnt/beta-catenin pathway directly through MST1/2"
https://pharos.nih.gov/idg/targets/Q13188,Q13188,23972470,"RASSF5 can act as an inhibitor or a potential positive regulator of Mst2, depending on whether it binds to Mst2 before or after activation-loop phosphorylation."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,23459937,"The ability of K-Ras to activate MST2 and MST2-dependent apoptosis is determined by the differential activation kinetics of mutant K-Ras and wild type K-Ras."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,22590567,"The identification of the c-Abl tyrosine kinase as a novel upstream activator of MST2 suggests that the conserved c-Abl-MST signaling cascade plays an important role in oxidative stress-induced neuronal cell death."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,22195963,"The small number of tumors with co-expression of mutant K-Ras and MST2 has elevated apoptosis rates."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,22102242,"crystals of MST2 belonged to space group P2, with unit-cell parameters a = 62.0, b = 119.2, c = 62.0 A, alpha = 90.0, beta = 90.5, gamma = 90.0 degrees , or to space group P6(1)22, with unit-cell parameters a = 54.5, b = 54.5, c = 303.1 A"
https://pharos.nih.gov/idg/targets/Q13188,Q13188,21944251,"The mammalian ste20-like kinase mediated phosphorylation of four residues within SAV1 may be important in the induction of cell death by the MST pathway."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,21199877,"Through binding to MST1/2, RASSF1A supports maintenance of MST1/2 phosphorylation, promoting an active state of the MST kinases and favoring induction of apoptosis."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,21104395,"MST and hSAV act as novel co-regulators of ERalpha and may play an important role in breast cancer pathogenesis."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,21076410,"Study reports that two Hippo pathway components, Mst2 and the scaffold protein hSav1, directly interact with Nek2A and regulate its ability to localize to centrosomes, and phosphorylate C-Nap1 and rootletin."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,20231902,"ste20-like kinase MST2 is regulated by the IGF1-Akt pathway"
https://pharos.nih.gov/idg/targets/Q13188,Q13188,20212043,"studies reveal a more complex role for Mst2 than previously thought. The Mst2 --> LATS1/2 pathway, by maintaining PP2A-C levels, may, in some situations, positively affect mitogenic signaling"
https://pharos.nih.gov/idg/targets/Q13188,Q13188,20145135,"hnRNP H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,20086174,"Data show T117/T384 as Akt phosphorylation sites in MST2, and mutation of these sites inhibited MST2 binding to Raf-1 but enhanced binding to RASSF1A, accentuating downstream c-jun N-Terminal Kinase and p38 MAPK signaling and promoting apoptosis."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,19822666,"Data suggest thta MST kinases 1/2 serve to monitor cytoskeletal integrity and couple the JNK1/SAPK1 pathway to the regulation of the cell cycle regulatory protein p21Waf1."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,19525978,"MST2 and RASSF2 form an active complex in vivo, in which RASSF2 is maintained in a phosphorylated state and protects MST2 from degradation and turnover"
https://pharos.nih.gov/idg/targets/Q13188,Q13188,19327996,"Results suggest that MST2-, Fry-, and MOB2-mediated activation of NDR1 is crucial for the fidelity of mitotic chromosome alignment in mammalian cells."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,18640976,"Overexpression of YAP2 in cells promoted apoptosis, whereas the Mst2/Lats1-induced phosphorylation of YAP partially rescued the cells from apoptotic death."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,18362890,"phosphorylation of MOB1 at Thr74 by MST2 is essential to make a complex of MOB1, MST2 and NDR1, and to fully activate NDR1"
https://pharos.nih.gov/idg/targets/Q13188,Q13188,17889669,"These results describe an MST2-dependent effector pathway for RASSF1A proapoptotic signaling and indicate that silencing of RASSF1A in tumors removes a proapoptotic signal emanating from p73."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,17538946,"our results suggest that alteration of the Sav-RASSF1-Hpo tumor suppressor pathway may occur through hypermethylation of the CpG island promoter of MST1, MST2 and/or RASSF1A in human sarcomas."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,15688006,"Mst2-like kinases regulate Lats kinase activities in an evolutionarily conserved regulatory pathway."
https://pharos.nih.gov/idg/targets/Q13188,Q13188,15618521,"proteomic analysis of Raf-1 signaling complexes was used to show that Raf-1 counteracts apoptosis by suppressing the activation of mammalian sterile 20-like kinase (MST2)"
https://pharos.nih.gov/idg/targets/Q13188,Q13188,12554736,"novel mechanism for MST2 regulation in apoptotic cells postulated; during apoptosis MST2 is cleaved by caspase-3 and undergoes irreversible autophosphorylation resulting in the accumulation of active MST2"
https://pharos.nih.gov/idg/targets/Q13188,Q13188,11964314,"Caspase-catalyzed cleavage and activation of Mst2 correlates with eosinophil but not neutrophil apoptosis."
